UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 FORM 10-K

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal period ended
 December 31, 2024

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition
period from to

 Commission File Number: 001-41047

 Chain Bridge I

 (Exact name of registrant as specified in its charter)

 Cayman Islands

 95-1578955

 (State or other jurisdiction of

incorporation or organization)

 (I.R.S. Employer

Identification Number)

 8 The Green # 17538, Dover, DE

 19901

 (Address of principal executive offices)

 (Zip Code)

 Registrant's telephone number, including area code: (302) 597-7438

 Securities registered pursuant
to Section 12(b) of the Act: None

 Securities registered pursuant
to Section 12(g) of the Act:

 Title of each class

 Trading Symbol(s)

 Name of each exchange on which registered

 Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant to acquire one Class A ordinary share

 CBGGF

 OTC Markets Group Expert Market Tier

 Class A ordinary shares, par value $0.0001 per share

 CBRRF

 OTC Markets Group OTCQB Tier

 Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

 CBRGF

 OTC Markets Group Expert Market Tier

 Indicate by check mark if the
registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

 Indicate by check mark if the
registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes No

 Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes No

 Indicate by check mark whether
the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to
submit such files). Yes No

 Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
growth company. See definition of "large accelerated filer," "accelerated filer", "smaller reporting company"
and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 Emerging growth company

 If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 Indicate by check mark whether the registrant has filed a report
on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 If securities are registered pursuant to Section 12(b) of the Act,
indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to
previously issued financial statements.

 Indicate by check mark whether any of those error corrections are restatements
that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during
the relevant recovery period pursuant to §240.10D-1(b).

 Indicate by check mark whether
the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 Based on the closing price of
$11.21 per share on June 30, 2024, the aggregate market value of our voting and non-voting ordinary shares held by non-affiliates was
$ 11,284,916.

 As of June 16, 2025, there were 29,707 units, each unit consisting
of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant, 3,014,736 Class A ordinary shares,
including the Class A ordinary shares including in the Company's outstanding units, 3,191,000 Class B ordinary shares, par value
$0.0001 per share, and 22,035,138 warrants of the company issued and outstanding.

 Documents Incorporated by
Reference: None.

 PAGE

 Item 1.

 Business

 Item 1A.

 Risk Factors

 Item 1B.

 Unresolved Staff Comments

 Item 1C.

 Cybersecurity

 Item 2.

 Properties

 Item 3.

 Legal Proceedings

 Item 4.

 Mine Safety Disclosures

 Item 5.

 Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

 Item 6.

 [Reserved]

 Item 7.

 Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A.

 Quantitative and Qualitative Disclosures About Market Risk

 Item 8.

 Financial Statements and Supplementary Data

 Item 9.

 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 Item 9A.

 Controls and Procedures

 Item 9B.

 Other Information

 Item 9C.

 Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 Item 10.

 Directors, Executive Officers and Corporate Governance

 Item 11.

 Executive Compensation

 Item 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

 Item 13.

 Certain Relationships and Related Transactions, and Director Independence

 Item 14.

 Principal Accountant Fees and Services

 Item 15.

 Exhibits and Financial Statement Schedules

 Item 16.

 Form 10-K Summary

 EXHIBIT INDEX

 SIGNATURES

 i

 CERTAIN TERMS

 Unless otherwise stated in this
Annual Report on Form 10-K or the context otherwise requires, references to:

 "Board" are to the Company's board of directors;

 "CB Co-Investment" are to CB Co-Investment LLC, an affiliate of one of the underwriters of
the Initial Public Offering;

 "CB Co-Investment loan" are to the loan CB Co-Investment made to us simultaneously with the
closing of the Initial Public Offering;

 "CBG" or "sponsor" are to Chain Bridge Group, a Cayman Islands limited liability
company and our original sponsor;

 "Class B Shares" are to our Class B ordinary shares outstanding as of this Annual Report on
Form 10-K and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time
of our initial business combination (for the avoidance of doubt, such Class A ordinary shares will not be "public shares");

 "Companies Act" are to the Companies Act (2023 Revision) of the Cayman Islands as the same
may be amended from time to time;

 "Company," "we," "us," "our" or "our Company"
are to Chain Bridge I, a Cayman Islands exempted company;

 "Cowen" are to Cowen and Company, LLC, one of the underwriters in the Initial Public Offering;

 "forward purchase agreement" are to the agreement between Franklin and us, providing for the
sale to Franklin of 4,000,000 Class A ordinary shares and 2,000,000 redeemable warrants, for an aggregate purchase price of $40,000,000,
in a private placement that will close substantially concurrently with the closing of our initial business combination;

 "forward purchase securities" are to the forward purchase shares and forward purchase warrants
(and the Class A ordinary shares issuable upon exercise of the forward purchase warrants) to be issued to Franklin pursuant to the forward
purchase agreement;

 "forward purchase shares" are to the Class A ordinary shares to be issued to Franklin pursuant
to the forward purchase agreement;

 "forward purchase warrants" are to the redeemable warrants to be issued to Franklin pursuant
to the forward purchase agreement;

 "forward transferee" are to any third party to which Franklin transfers any portion of its
obligation to purchase the forward purchase securities under the forward purchase agreement;

 "founders" are to Christopher Darby, Michael Rolnick, and Stephen Bowsher, Chairman of the
sponsor;

 "Franklin" are to Franklin Strategic Series — Franklin Growth Opportunities
Fund;

 "Fulton AC" are to Fulton AC I LLC;

 "Fulton AC loan" are to are to the working capital loan that Fulton AC made to us simultaneously
with the closing of the Securities Purchase Agreement;

 "Initial Public Offering" are to the Company's initial public offering on November 15,
2021 of 23,000,000 units (which included units issued pursuant to the exercise in full of the underwriters' option to purchase additional
units to cover overallotments) at a price of $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable
warrant;

 ii

 "Nasdaq" are to The Nasdaq Stock Market;

 "ordinary shares" are to our Class A Ordinary Shares and our Class B Ordinary Shares;

 "OTC" are to The OTC Market systems;

 "OTCQB" are to the OTCQB Market;

 "our team" are to our executive officers and directors;

 "preference shares" are to our Preference Shares;

 "private placement warrants" are to the warrants sold to our sponsor and CB Co-Investment
in a private placement simultaneously with the closing of the Initial Public Offering and upon conversion of the CB Co-Investment loan,
extension loans, if any, or working capital loans, if any;

 "public shareholders" are to the holders of our public shares, including our sponsor and our
team to the extent our sponsor and/or members of our team purchase public shares, provided that our sponsor's and each member of
our team's status as a "public shareholder" will only exist with respect to such public shares;

 "public shares" are to our Class A ordinary shares sold as part of the units in the Initial
Public Offering (whether they were purchased in the Initial Public Offering or thereafter in the open market);

 "trust account" are to the trust account established for the benefit of the persons holding
Public Shares, located in the United States with Continental Stock Transfer & Trust Company acting as trustee;

 "Wells Fargo Securities" are to Wells Fargo Securities, LLC, one of the underwriters in the
Initial Public Offering.

 Any forfeiture of shares
described in this Annual Report on Form 10-K will take effect as a surrender of shares for no consideration of such shares as a matter
of Cayman Islands law. Any conversion of the Class B ordinary shares described in this Annual Report on Form 10-K will take effect as
a redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. Any share dividends
described in this Annual Report on Form 10-K will take effect as share capitalizations as a matter of Cayman Islands law.

 iii

 CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS

 Some of the statements contained
in this Annual Report on Form 10-K may constitute "forward-looking statements" for purposes of the federal securities laws.
Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations,
hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other
characterizations of future events or circumstances, including any underlying assumptions, are forward- looking statements. The words
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intends," "may," "might," "plan," "possible," "potential," "predict,"
"project," "should," "would" and similar expressions may identify forward-looking statements, but
the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Annual Report on
Form 10-K may include, for example, statements about:

 our ability to select an appropriate partner business or businesses;

 our ability to complete our initial business combination;

 our expectations around the performance of a prospective partner business or businesses;

 our officers and directors allocating their time to other businesses and potentially having conflicts
of interest with our business or in approving our initial business combination;

 our potential ability to obtain additional financing to complete our initial business combination;

 our pool of prospective partner businesses;

 the ability of our officers and directors to generate a number of potential business combination opportunities;

 our public securities' potential liquidity and trading;

 the use of proceeds not held in the trust account or available to us from interest income on the trust
account balance;

 the trust account not being subject to claims of third parties; or

 our financial performance in the periods following December 31, 2024.

 The forward-looking statements
contained in this Annual Report on Form 10-K are based on our current expectations and beliefs concerning future developments and their
potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These
forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may
cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These
risks and uncertainties include, but are not limited to, those factors described under the heading "Item 1A. Risk Factors."
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary
in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities
laws.

 iv

 SUMMARY OF THE MATERIAL RISKS ASSOCIATED
WITH OUR BUSINESS

 An investment in our securities
involves a high degree of risk. The occurrence of one or more of the events or circumstances described in the section titled "Risk
Factors," alone or in combination with other events or circumstances, may materially adversely affect our business, financial condition
and operating results. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.
Such risks include, but are not limited to:

 We are a recently incorporated company with no operating history and no revenues, and you have no basis
on which to evaluate our ability to achieve our business objective.

 Past performance by our team, our controlling shareholder or their affiliates may not be indicative of
future performance of an investment in us.

 Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination,
which means we may complete our initial business combination even though a majority of our shareholders do not support such a combination.

 Your only opportunity to affect the investment decision regarding a potential business combination may
be limited to the exercise of your right to redeem your shares from us for cash.

 If we seek shareholder approval of our initial business combination, Fulton AC, CBG, CB - Co Investment
and certain of our past and present officers and directors have agreed to vote in favor of such initial business combination, regardless
of how our public shareholders vote.

 The ability of our public shareholders to redeem their shares for cash may make our financial condition
unattractive to potential business combination partners, which may make it difficult for us to enter into a business combination with
a partner.

 The ability of our public shareholders to exercise redemption rights with respect to a large number of
our shares may not allow us to complete the most desirable business combination or optimize our capital structure or to complete a business
combination at all which would require you to wait for liquidation in order to redeem your shares.

 The requirement that we consummate an initial business combination by November 15, 2025 may give potential
partner businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence
on potential business combination partners, in particular as we approach our dissolution deadline, which could undermine our ability to
complete our initial business combination on terms that would produce value for our shareholders.

 Our
search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially
adversely affected by current or anticipated military conflict, including between Russia and Ukraine and in the Middle East, the Israel
Ukraine wars, terrorism, sanctions, changes to foreign trade policies or other geopolitical events globally, a pandemic, including new
variant strains of the COVID-19 virus, and the status of debt and equity markets.

 v

 We may not be able to consummate an initial business combination by November 15, 2025, in which case we
would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate.

 If we seek shareholder approval of our initial business combination, Fulton AC, other holders of our Class
B Shares, our directors, executive officers, advisors and their affiliates may elect to purchase public shares or warrants, which may
influence a vote on a proposed business combination and reduce the public "float" of our Class A ordinary shares or public
warrants.

 If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our
initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.

 You will not have any rights or interests in funds from the trust account, except under certain limited
circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.

 The Company's securities have been delisted from trading on Nasdaq and currently trade on the OTC
Markets, which may adversely affect the flexibility of investors' to resell their securities in the secondary market.

 You will not be entitled to protections normally afforded to investors of many other blank check companies.

 If we seek shareholder approval of our initial business combination and we do not conduct redemptions
pursuant to the tender offer rules, and if you or a "group" of shareholders are deemed to hold in excess of 15% of our Class
A ordinary shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares.

 Because of our limited resources and the increased competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we do not complete our initial business combination within the required time period, our public shareholders may, as of June 16, 2025, receive only approximately $11.88 per public share, without taking into account any taxes owed but not paid by such date and less $100,000 of interest to pay dissolution expenses, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.

 If the funds not being held in the trust account are insufficient to allow us to operate until November
15, 2025, it could limit the amount available to fund our search for a partner business or businesses and complete our initial business
combination, and we will depend on loans from Fulton AC or officers or directors or their affiliates to fund our search and to complete
our initial business combination.

 Subsequent to our completion of our initial business combination, we may be required to take write-downs
or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition,
results of operations and the share price of our securities, which could cause you to lose some or all of your investment.

 vi

 Item
1. Business Overview

 We are a blank check company
incorporated on January 21, 2021 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout
this Annual Report on Form 10-K as our initial business combination. We seek to advance the innovation economy by offering an alternate
path to the public markets and partner with founders, operators and entrepreneurs to build a successful public company. To date, our efforts
have been limited to organizational activities as well as activities related to the Initial Public Offering. Since the Initial Public
Offering in November 2021, we have held introductory conversations with a number of companies. While we have not selected a target for
a business combination, our team has identified several potential target companies that it believes are compelling opportunities for a
business combination. There are ongoing discussions about the suitability of those potential target companies and we have commenced discussions
with several such companies - directly and through intermediaries. We have generated no operating revenues to date, and we do not expect
that we will generate operating revenues until we consummate our initial business combination.

 On February 3, 2021, CBG
and CB Co-Investment paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of an aggregate
of 8,625,000 Class B ordinary shares. CBG purchased 7,195,714 of the Class B Shares and CB Co-Investment purchased 1,429,286 of the Class
B Shares. On April 9, 2021, CB Co-Investment transferred 28,571 Class B Shares to CBG at their original purchase price. On October 1,
2021, CBG forfeited 2,408,095 and CB Co-Investment forfeited 466,905 Class B Shares, in each case, for no consideration. On November 9,
2021, CBG transferred an aggregate of 156,000 Class B Shares to three of the Company's directors, the chief financial officer and
two of the Company's advisors. As a result, CBG owned 4,660,190 Class B Shares and CB Co-Investment owned 933,810 Class B Shares.
On October 13, 2022, Nathanial Fick agreed to a transfer all 25,000 of the Class B Shares held by Mr. Fick to CBG.

 On November 15, 2021, the
Company consummated the Initial Public Offering of 23,000,000 units, including the issuance of 3,000,000 units as a result of the underwriters'
exercise in full of their over-allotment option. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant,
each whole warrant entitling the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject
to adjustment. The units were sold at an offering price of $10.00 per unit, generating gross proceeds to the Company of $230,000,000.
Simultaneously with the consummation of the Initial Public Offering and the issuance and sale of the units, the Company consummated the
private placement of 10,550,000 private placement warrants (including 1,050,000 private placement warrants purchased in connection with
the exercise of the underwriters' over-allotment option) at a price of $1.00 per private placement warrant, generating total gross
proceeds of $10,550,000. In addition, upon closing of the Initial Public Offering, CB Co-Investment loaned the Company approximately $1,150,000
at no interest.

 On May 10, 2023, the Company,
CBG, and CB Co-Investment entered into non-redemption agreements with several unaffiliated third parties in exchange for such third parties
agreeing not to redeem an aggregate of 4,000,000 ordinary shares of the Company sold in its IPO at an extraordinary general meeting of
its shareholders held on May 12, 2023 (the "Special Meeting"). In exchange for the foregoing commitments not to redeem such
shares, our sponsor and CB Co-Investment, as applicable, agreed to transfer to such third parties an aggregate of 1,000,000 ordinary shares
of the Company held by our sponsor or CB Co-Investment, as applicable, plus up to an additional aggregate of 500,000 ordinary shares of
the Company held by our sponsor or CB Co-Investment, as applicable, with such number of additional ordinary shares of the Company to be
determined based upon the date of the consummation of the Company's initial business combination. Such transfer of ordinary shares
of the Company shall be effected immediately following the consummation of the Company's business combination if such third party
or third parties continued to hold such shares through the Special Meeting. In connection with such shareholder vote, the holders of an
aggregate of 18,848,866 Class A Shares of the Company exercised their right to redeem their shares for an aggregate of approximately $197,854,025
in cash held in the trust account.

 At the Special Meeting, the
shareholders of the Company approved the amendment to the Company's amended and restated memorandum and articles of incorporation,
which extended the date to consummate an initial business combination from May 15, 2023 to November 15, 2023, and allowed the Board, without
another shareholder vote, to elect to further extend the date to consummate an initial business combination after November 15, 2023 up
to three times, by an additional month each time, up to February 15, 2024. The Company's Board elected to extend the date in each
of those additional three months until February 15, 2024.

 On December 29, 2023 (the
"Closing Date"), the Company, CBG, CB Co-Investment and Fulton AC, consummated the transactions contemplated by that certain
Securities Purchase Agreement (the "Securities Purchase Agreement"), dated December 8, 2023, pursuant to which Fulton AC acquired
from the CBG and CB Co-Investment an aggregate of (i) 3,035,000 Class B Ordinary Shares and (ii) warrants to purchase 7,385,000 Class
A Ordinary Shares exercisable 30 days after the consummation of the Company's initial business combination.

 As of the Closing Date, and
in connection with the consummation of the transactions contemplated by the Securities Purchase Agreement:

 (1) CB Co-Investment irrevocably
agreed to convert the $1.15 million CB Co-Investment loan into Loan Conversion Warrants (as contemplated and defined in that certain Warrant
Agreement, dated November 9, 2021 by and between the Company and our transfer agent (the "Warrant Agreement")), upon consummation
of the Company's initial business combination. Pursuant to its terms, if we do not consummate an initial business combination, the
CB Co-Investment Loan will not be repaid, and 805,000, 273,431 and 71,569 of the Loan Conversion Warrants will be issued to Fulton AC,
CBG and CB Co-Investment, respectively. All other existing indebtedness of the Company was terminated as of the Closing Date.

 (2) CBG, CB Co-Investment
and Roger Lazarus, our Chief Financial Officer, entered into voting agreements (the "Voting Agreements") pursuant to which
they agreed to vote all of the voting securities of the Company that each of them is entitled to vote as of the date thereof or thereafter
in favor of a proposal to amend and restate its Amended and Restated Memorandum and Articles of Association (the "Amendment Proposal")
to among other things: (i) extend from February 15, 2024 to November 15, 2024 the date by which, if the Company has not consummated its
initial business combination, the Company must (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the Class A ordinary shares sold in the Company's Initial Public
Offering; and (c) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining
shareholders and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for
claims of creditors and in all cases subject to the other requirements of applicable law; and (ii) provide for the right of the holders
of our Class B Shares, to convert such shares into shares of our Class A Shares, on a one-to-one basis at the election of such holders.
Class A Shares issued upon conversion of Class B Shares will not be entitled to receive funds from the trust account through redemptions
or otherwise. Pursuant to the Voting Agreements, each of CBG, CB Co-Investment and Roger Lazarus have also agreed to irrevocably exercise
such right to convert all of their Class B Ordinary Shares immediately upon such approval.

 (3) Fulton AC and the parties
to that certain letter agreement (the "Letter Agreement"), dated November 9, 2021, by and among CBG, CB Co-Investment, and
certain individuals, entered into an amendment to the Letter Agreement (the "Letter Agreement Amendment"), pursuant to which
Fulton AC agreed to become a party to the Letter Agreement and be bound by, and subject to, all of the terms and conditions of the Letter
Agreement and agreed that it will be liable to the Company if and to the extent any claims by a third party (excluding our independent
registered public accounting firm) for services rendered or products sold to us, or a prospective partner business with which we have
discussed entering into a transaction agreement, reduce the amounts in the trust account to below the lesser of (i) $10.20 per public
share and (ii) the actual amount per share held in the trust account as of the date of the liquidation of the trust account if less than
$10.20 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to
pay our tax obligations, provided that such liability will not apply to any claims by a third party or prospective partner business who
executed a waiver of any and all rights to seek access to the trust account nor will it apply to any claims under our indemnity of the
underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in
the event that an executed waiver is deemed to be unenforceable against a third party, Fulton AC will not be responsible to the extent
of any liability for such third party claims.

 (4) That certain services
agreement, dated November 9, 2021, by and between the Company and CBG pursuant to which CBG provided office space, administrative and
support services, was terminated.

 On December 29, 2023,
Fulton AC also agreed to loan the Company up to $1.5 million pursuant to an unsecured non-interest bearing convertible promissory
note (the "Fulton AC Note") at no interest in the same form and on the same terms as the CBG note which was terminated
on December 29, 2023. The Fulton AC Note will not be repaid in the event that the Company is unable to close a Business Combination
unless there are funds available outside the trust account to do so. The Fulton AC Note will either be paid upon consummation of the
Company's initial business combination, or, at the discretion Fulton AC, converted into additional warrants at a price of
$1.00 per warrant, which warrants will be identical to the Private Placement Warrants. Fulton AC also entered into a Services
Agreement with the Company on December 29, 2023 (the "Fulton Services Agreement") pursuant to which the Company will pay
Fulton AC up to $30,000 per month for the cost of the use of the Company's office space, administrative and support services.
Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. As of December 31,
2024, there is no outstanding balance under the Fulton AC Note.

 At an extraordinary general
meeting of its shareholders held on February 7, 2024 (the "February Extraordinary Meeting"), the shareholders of the Company
approved the second amended and restated memorandum and articles of incorporation, which (i) extended the date to consummate an initial
business combination from February 15, 2024 to November 15, 2024, which is a total of up to 36 months from the closing of the Initial
Public Offering to complete an initial business combination, (ii) provided for the right of the holders of our Class B Shares to convert
such shares into Class A Shares, on a one-to-one basis at the election of such holders, which Class A Shares issued upon conversion of
our Class B Shares are not entitled to receive funds from the trust account through redemptions or otherwise; and (iii) removed a statement
that there are no limits on the number of ordinary shares which may be issued by the Company and clarified that the Company may, but are
not required, to issue certificates to evidence ownership of ordinary shares. In connection with such shareholder vote, the holders of
an aggregate of 3,144,451 Class A Shares of the Company exercised their right to redeem their shares for an aggregate of approximately
$34.5 million in cash held in the trust account. Effective upon our adoption of the second amended and restated memorandum and articles
of association, our sponsor and CB Co-Investment converted 1,983,335 and 575,665 Class B Shares, respectively, into Class A Shares, on
an one-for-one basis.

 In connection with the February
Extraordinary Meeting, Fulton AC has agreed to contribute to the Company (i) the lesser of (x) an aggregate of $22,500 or (y) $0.03 for
each Public Share that is not redeemed in connection February Extraordinary Meeting plus (ii) the lesser of (x) $5,000 per month or (y)
$0.01 per Public Share that remains outstanding and is not redeemed in connection with February Extraordinary Meeting on the 16th of each
calendar month, commencing on May 16, 2024, until the earliest to occur of November 15, 2024, the consummation of an initial business
combination or the winding up of the Company (collectively, the "Contribution"), which amount will be deposited into the trust
account. Accordingly, the amount deposited per share will depend on the number of public shares that remain outstanding after the redemption
and length of time until the consummation of an initial business combination or winding up of the Company. The Company deposited the initial
Contribution amount of $22,500 into the trust account following the February Extraordinary Meeting. Each additional $5,000 monthly Contribution
will be deposited in the trust account within seven calendar days from the 16th day of such calendar month. Our Board will have the sole
discretion whether to wind up the Company and if our Board determines to wind up the Company, Fulton AC or its designees will not make
any additional Contributions following such determination.

 On February 21, 2024, the
Board of Directors appointed Oliver Wiener as a director. In connection with Mr. Wiener's appointment, the Board increased its size
to five (5) directors. Mr. Wiener will not receive compensation of any kind for service to the Board prior to the consummation of an initial
Business Combination. On February 21, 2024, Mr. Wiener become a party to the Letter Agreement, and became bound by, and subject to, all
of the terms and conditions of the Letter Agreement, including certain transfer restrictions with respect to the Company's securities.

 On February 21, 2024, the
Company also entered into a letter agreement with Mr. Wiener, pursuant to which, among other things, the Company agreed to grant Mr. Wiener
50,000 RSUs, to be issued after the consummation of an initial Business Combination and approval of an equity incentive plan by the Company's
shareholders, subject to the terms and conditions set forth therein.

 On April 1, 2024, Roger.
Lazarus, the Chief Financial Officer of the Company notified the Board of his resignation, effective immediately. Mr. Lazarus served as
an advisor to the Company through the end of April 2024 to ensure a smooth transition. Andrew Kucharchuk, succeeded Mr. Lazarus as the
Company's Chief Financial Officer, effective April 1, 2024. As consideration for Mr. Lazarus serving as an advisor through the end
of April 2024, the Company entered into a letter agreement with Mr. Lazarus, dated April 18, 2024, pursuant to which, among other things,
the Company agreed to grant him 30,000 RSUs in the target company, subject to the terms and conditions set forth therein, including consummation
of the Business Combination.

 On April 4, 2024, Mr. Kucharchuk
become a party to the Letter Agreement, and became bound by, and subject to, all of the terms and conditions of the Letter Agreement,
including certain transfer restrictions with respect to the Company's securities. Mr. Kucharchuk also entered into an Indemnification
Agreement in the form previously disclosed by the Company providing him contractual rights to indemnification in addition to the indemnification
provided for in the Company's third amended and restated memorandum and articles of association.

 On May 9, 2024, the Company
entered into the Exchange Agreement with Fulton AC, pursuant to which Fulton AC and the Company agreed to Exchange the Fulton AC Note
for the Exchange Note. The Exchange Note is substantially similar to the Fulton AC Note, except that (i) the governing law and jurisdiction
was changed from New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation
of the Company's initial business combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy
the purchase price of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35%. At this
time the Company does not have any agreements, written or oral, for any subsequent offering of Company securities. No new consideration
was paid in conjunction with the Exchange. As of December 31, 2024, the Company has an outstanding balance of $296,942 under the Exchange
Note.

 On June 26, 2024, Phytanix
Bio, a Nevada corporation ("Phytanix") agreed to loan the Company $1,590,995.12, pursuant to an unsecured non-interest bearing
promissory note (the "Bridge Financing Note"). The maturity date of the Bridge Financing Note is the later of (x) June 29,
2025 and (y) the consummation of the Company's initial business combination. The Bridge Financing Note may not be repaid with funds
from the trust account that the Company established for the benefit of its public holders. The proceeds from the Bridge Financing Note
will be used (i) to pay off certain working capital loans issued by the Company to Fulton AC, (ii) to pay for certain fees and expenses
incurred in connection with the transactions contemplated in the Bridge Financing Note and the Company's initial business combination
and (iii) for other general corporate purposes.

 As of December 31, 2024, the outstanding principal balance under the
Bridge Financing Note was $1,063,235.

 On July 22, 2024, the Company,
CB Holdings, Inc., a Nevada corporation ("HoldCo"), CB Merger Sub 1, a Cayman Islands exempted company ("CBRG Merger
Sub"), Phytanix Bio, and CB Merger Sub 2, Inc., a Nevada corporation ("Phytanix Merger Sub"), entered into a Business
Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the "Business Combination Agreement").
As used herein, "New Phytanix" refers to HoldCo after giving effect to the consummation of the transactions contemplated by
the Business Combination Agreement. Capitalized terms used but not otherwise defined herein have the meanings set forth in the Business
Combination Agreement.

 The Business Combination
Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Phytanix. The
Business Combination Agreement provides for, among other things, the consummation of the following transactions (the transactions contemplated
by the Business Combination Agreement, collectively, the "Business Combination"):

 (i) CBRG
Merger Sub will merge with and into the Company (the "CBRG Merger") and Phytanix Merger Sub will merge with and into Phytanix
(the "Phytanix Merger" and, together with the CBRG Merger, the "Mergers"), with the Company and Phytanix surviving
the Mergers and, after giving effect to such Mergers, each of the Company and Phytanix becoming a wholly owned subsidiary of HoldCo, on
the terms and subject to the conditions in the Business Combination Agreement;

 (ii) (A)
each issued and outstanding Class A ordinary share, par value $0.0001 per share, of the Company (the "CBRG Class A Shares")
will be automatically cancelled, extinguished and converted into the right to receive one share of common stock, par value $0.0001 per
share, of HoldCo (the "HoldCo Shares"); and (B) each issued and outstanding Class B ordinary share, par value $0.0001 per
share, of the Company (the "CBRG Class B Shares" and together with the CBRG Class A Shares, the CBRG Shares), will be automatically
cancelled, extinguished and converted into the right to receive one HoldCo Share;

 (iii) each
outstanding warrant to purchase one CBRG Class A Share will be automatically exchanged for a warrant to purchase one HoldCo Share; and

 (iv) (A)
each warrant of Phytanix to purchase Phytanix common stock will be exchanged for a warrant to purchase HoldCo Shares; (B) each warrant
of Phytanix to purchase Phytanix preferred stock will be exchanged for a warrant to purchase HoldCo preferred stock; (C) all promissory
notes of Phytanix issued in connection with its June 2024 financing will be exchanged for HoldCo Series A convertible preferred stock,
and any remaining issued and outstanding promissory notes of Phytanix will be automatically and fully cancelled; (D) each share of preferred
stock, par value $0.000000001 per share, of Phytanix (the "Phytanix Preferred Stock") that is issued and outstanding will
be automatically converted into shares of HoldCo preferred stock; and (E) all issued and outstanding shares of Phytanix Common Stock (other
than treasury shares and shares with respect to which appraisal rights under the Delaware General Corporation Law, as amended, are properly
exercised and not withdrawn) will be automatically cancelled, extinguished and converted into the right to receive HoldCo Shares based
on the exchange ratio set forth in the Business Combination Agreement.

 Prior to the closing of the
Business Combination (the "Closing"), (A) HoldCo will file with the Secretary of State of the State of Nevada an amended and
restated certificate of incorporation of HoldCo, and (B) the board of directors of HoldCo will approve and adopt amended and restated
bylaws of HoldCo, each in a form to be mutually agreed between the Company and Phytanix. Following the Business Combination, HoldCo will
change its name to Phytanix, Inc. and will be a publicly listed holding company which is expected to be listed on the Nasdaq Capital Market
under the ticker symbol "PHYX."

 Under the terms of the Business
Combination Agreement, the aggregate consideration to be paid in the Business Combination is derived from an equity value of $58 million.
In addition, HoldCo will issue 17,000 shares of HoldCo Series A convertible preferred stock and issue additional shares of HoldCo preferred
stock in exchange for certain short term debt obligations of Phytanix.

 The Business Combination
Agreement contains representations, warranties and covenants of each of the parties thereto that are customary for transactions of this
type. HoldCo has agreed to take all action as may be necessary or appropriate such that, immediately after the Closing, HoldCo's
board of directors will consist of up to seven directors, which shall be divided into three classes and be comprised of seven individuals
determined by the Company, Fulton AC and Phytanix prior to the effectiveness of the Registration Statement on Form S-4 (the "Registration
Statement"), two of which directors shall be designated by Phytanix, in consultation with the Company and Fulton AC, two of which
directors shall be designated by Fulton AC, in consultation with the Company, and three of which directors shall be mutually agreed upon
by Fulton AC and Phytanix. In addition, the board of directors of HoldCo will adopt an equity incentive plan and an employee stock purchase
plan prior to the closing of the Business Combination.

 The obligation of the Company,
HoldCo, CBRG Merger Sub, Phytanix Merger Sub and Phytanix to consummate the Business Combination is subject to certain customary closing
conditions, including, but not limited to, (i) the absence of any order, law or other legal restraint or prohibition issued by any court
of competent jurisdiction or other governmental entity of competent jurisdiction prohibiting or preventing the consummation of the transactions
contemplated by the Business Combination Agreement, (ii) the effectiveness of the Registration Statement to be filed by HoldCo, in accordance
with the provisions of the Securities Act, registering certain shares of HoldCo to be issued in the Business Combination, (iii) the required
approval of Phytanix's stockholders, (iv) the required approval of the Company's shareholders, (v) HoldCo having at least
$5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) after giving effect to the
transactions contemplated by the Business Combination Agreement (provided such limitation has not been validly removed from the Second
Amended and Restated Memorandum and Articles of Association prior to the Closing Date), (vi) the approval by Nasdaq of HoldCo's
initial listing application in connection with the Business Combination, (vii) entry into employment agreements with certain key Company
executives, (viii) formation of a capital markets and financing advisory committee made up of certain CBRG directors, (ix) assumption
or cancellation of certain existing Phytanix and Company notes, and (x) entry into an agreement providing for a $100 million equity line
of credit with Keystone Capital Partners, LLC or its affiliates.

 The Business Combination
Agreement may be terminated under certain customary and limited circumstances prior to the closing of the Business Combination, including,
but not limited to, (i) by mutual written consent of the Company and Phytanix, (ii) by the Company if the representations and warranties
of Phytanix are not true and correct or if Phytanix fails to perform any covenant or agreement set forth in the Business Combination Agreement
(including an obligation to consummate the Closing), in each case such that certain conditions to closing cannot be satisfied and the
breach or breaches of such representations or warranties or the failure to perform such covenant or agreement, as applicable, are not
cured or cannot be cured within certain specified time periods, (iii) by Phytanix if the representations and warranties of the Company
are not true and correct or if the Company fails to perform any covenant or agreement set forth in the Business Combination Agreement
(including an obligation to consummate the Closing), in each case such that certain conditions to closing cannot be satisfied and the
breach or breaches of such representations or warranties or the failure to perform such covenant or agreement, as applicable, are not
cured or cannot be cured within certain specified time periods, (iv) by either the Company or Phytanix if the required approvals are not
obtained from the Company's shareholders after the conclusion of a meeting of the Company's shareholders held for such purpose
at which such shareholders voted on such approvals, (v) by either the Company or Phytanix, if any governmental entity of competent jurisdiction
shall have issued an order permanently enjoining, restraining or otherwise prohibiting the transactions contemplated under the Business
Combination Agreement and such order shall have become final and nonappealable, (vi) by the Company if Phytanix does not deliver, or cause
to be delivered to the Company the written consent of the requisite shareholders of Phytanix adopting and approving the Business Combination
and such failure is not cured within specified time periods, and (vii) by either the Company or Phytanix if the transactions contemplated
by the Business Combination Agreement have not been consummated on or prior to the last deadline for the Company to consummate its initial
business combination pursuant to the third amended and restated memorandum and articles of association.

 Upon the valid termination
of the Business Combination Agreement, none of the parties to the Business Combination Agreement will have any liability or any further
obligation under the Business Combination Agreement, except in the case of a willful and material breach or fraud and for customary obligations
that survive the termination thereof (such as confidentiality obligations).

 Concurrently with the execution
of the Business Combination Agreement, the Company and Fulton AC, entered into a letter agreement (the "Sponsor Letter Agreement"),
pursuant to which, among other things, (i) Fulton AC agreed to vote its Class B Ordinary Shares in favor of each of the transaction proposals
to be voted upon at the meeting of the Company's shareholders, including approval of the Business Combination Agreement and the
transactions contemplated thereby, (ii) Fulton AC agreed to waive any adjustment to the conversion ratio set forth in the governing documents
of the Company or any other anti-dilution or similar protection with respect to the Class B Ordinary Shares (whether resulting from the
transactions contemplated by the Subscription Agreements (as defined below) or otherwise), and (iii) Fulton AC agreed to be bound by certain
transfer restrictions with respect to his, her or its shares in the Company prior to the Closing.

 Pursuant to the Business
Combination Agreement, certain stockholders of Phytanix entered into transaction support agreements (collectively, the "Company
Transaction Support Agreements") with the Company and Phytanix, pursuant to which such stockholders of Phytanix agreed to, among
other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby and (ii) be bound by certain
covenants and agreements related to the Business Combination.

 Concurrently with the execution
of the Business Combination Agreement, the Company, HoldCo, Fulton AC, and certain Phytanix stockholders entered into an investor rights
agreement (the "Investor Rights Agreement") pursuant to which, among other things, Fulton AC, and certain Phytanix stockholders
will be granted certain customary registration rights. Further, subject to customary exceptions set forth in the Investor Rights Agreement,
the shares of HoldCo beneficially owned or owned of record by Fulton AC, certain officers and directors of the Company and HoldCo (including
any shares of HoldCo issued pursuant to the Business Combination Agreement) will be subject to a lock-up period beginning on the date
the Closing occurs (the "Closing Date") until the date that is the earlier of (i) 365 days following the Closing Date (or
six months after the Closing Date if a lock up party is an independent director) or (ii) the first date subsequent to the Closing Date
with respect to which the closing price of HoldCo Shares equals or exceeds $12.00 per share for any 20 trading days within any 30-trading
day period commencing at least 150 days after the Closing Date.

 On April 7, 2025, the Company
and Phytanix mutually agreed to terminate the Business Combination Agreement.

 On October 29, 2024, the
Company and Fulton AC entered into an agreement (the "Dissolution Expense Reimbursement Agreement") pursuant to which Fulton
agreed to reimburse the Trust Account up to $100,000 to pay dissolution expenses if and when the Company is dissolved. The amount of such
reimbursements will be included in the amount distributable holders of Class A ordinary shares of the Company entitled to participate
the liquidation of the Trust Account.

 On November 11, 2024, the
Company entered into non-redemption agreements (the "Non-Redemption Agreements") with one or more investors named therein
(each, a "Backstop Investor"), pursuant to which the Backstop Investors agreed to rescind or reverse previous elections to
redeem up to an aggregate of 429,180 Class A ordinary shares of the Company, which redemption requests were made in connection with the
General Meeting to consider and vote on, among other proposals, a proposal to amend and restate, by way of a special resolution, the Company's
2nd amended and restated memorandum and articles of association, to extend from November 15, 2024 to November 15, 2025, the date by which,
if the Company has not consummated a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
involving the Company, with one or more businesses or entities (a "De-Spac Transaction"), the Company must (a) cease all operations
except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the
Class A ordinary shares sold in the Company's initial public offering; and (c) as promptly as reasonably possible following such
redemption, subject to the approval of the Company's remaining shareholders and the directors, liquidate and dissolve, subject in
each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements
of applicable law (the "Amendment Proposal"). The Amendment Proposal is described in more detail in the Company's definitive
proxy statement filed with the SEC on October 10, 2024, as amended. The Backstop Investors agree to hold, and not redeem, up to an aggregate
of 128,753 shares of the Class A ordinary shares of the Company (the "Backstop Investor Shares") at the Closing.

 In consideration for the
foregoing, upon consummation of the Company's Initial Business Combination, the Company shall pay or cause to be paid to each Backstop
Investor a payment in respect of its respective Backstop Investor Shares in cash released from the Trust Account in an amount equal to
the product of (x) the number of Backstop Investor Shares and (y) the price per share for a pro rata portion of the amount on deposit
in the Trust Account as of the Closing.

 The Backstop Investors acquired
an aggregate of 249,072 Class A ordinary shares of the Company in the open market at or below the Redemption Price (as defined in the
Non- Redemption Agreements) (the "Acquired Shares"). The Backstop Investors agreed not to redeem the Acquired Shares and will
not vote Acquired Shares in favor of the Amendment Proposal.

 On November 12, 2024, the
Company and each Backstop Investor entered into Amendment No.1 to Non-Redemption Agreement (the "Amendment") pursuant to which
the parties agreed to allow the Backstop Investors to purchase Acquired Shares (as defined in the Agreements) at any time prior to the
General Meeting.

 On November 14, 2024, the
Company held an extraordinary general meeting of its shareholders (the "November Extraordinary Meeting") at which the shareholders
voted to amend and restate, by way of a special resolution, the Company's second amended and restated memorandum and articles of
association, to extend from November 15, 2024 to November 15, 2025, the date by which, if the Company has not consummated a merger, share
exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company, with one or more businesses
or entities, the Company must (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but
not more than ten business days thereafter, redeem the Class A ordinary shares sold in the Company's initial public offering; and
(c) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining shareholders
and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors
and in all cases subject to the other requirements of applicable law.

 Additionally, pursuant to
Fulton AC's previously disclosed agreement to contribute to the Trust Account an amount of funds determined by reference to the
number of shares not redeemed in connection with the approval of the Amendment Proposal, Fulton AC contributed to the Trust $4,557 on
November 16, 2024 and will contribute to the Trust $4,557 per month on the 16th of each calendar month, commencing on December 16, 2024,
until the earliest to occur of November 15, 2025, the consummation of the Business Combination or the winding up of the Company.

 After the redemptions discussed
above, 3,014,736 shares of the Company's Class A ordinary shares are outstanding, including Class A ordinary shares included in
29,707 of the Company's outstanding units, and 3,191,000 shares of the Company's Class B ordinary shares are outstanding.

 As of June 16, 2025, a total of approximately $5,414,454 is on deposit
in a U.S.-based trust account, maintained by Continental Stock Transfer and Trust Company, acting as trustee. Funds held in the trust
account have been invested only in U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less or
in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the "Investment
Company Act"), which invest only in direct U.S. government obligations. Except with respect to interest earned on the funds in the
trust account that may be released to us to pay income taxes, if any, the proceeds from the Initial Public Offering and the sale of the
private placement warrants held in the trust account will not be released from the trust account (1) to us until the completion of its
initial business combination or (2) to our public shareholders, until the earliest of: (a) the completion of our initial business combination,
and then only in connection with those Class A ordinary shares that such shareholders properly elect to redeem, subject to certain limitations,
(b) the redemption of any public shares properly tendered in connection with a (i) shareholder vote to amend our third amended and restated
memorandum and articles of association to modify the substance or timing of its obligation to provide holders of its Class A ordinary
shares the right to have their shares redeemed in connection with its initial business combination by November 15, 2025 or (ii) with respect
to any other provisions relating to shareholders' rights of holders of our Class A ordinary shares or pre-initial business combination
activity and (c) the redemption of all of our public shares if we have not completed our initial business combination by November 15,
2025, subject to applicable law.

 Market Opportunity

 Our business combination
and value creation strategy is to identify and complete our initial business combination with a growth-oriented, market-leading company
in an industry that complements the collective investment experience and expertise of our management team, and to build long-term shareholder
value.

 Our management team and board
have significant experience investing in private and public companies across a wide range of sectors. Our business combination and value
creation strategy is to identify a target company with robust growth capability or the ability to grow inorganically through acquisition.
These characteristics should be complimented by profitability or a clear path to profitability while executing on a dynamic business plan.
Our search will span across high growth areas such as technology, software, biotechnology and digital assets as well as traditional sectors
such as industrials, business services and healthcare services.

 Competitive Advantage

 The relationship network,
sourcing, valuation, diligence and execution capabilities of our team should provide us what we believe to be a significant and attractive
pipeline of opportunities. Our competitive strengths include:

 A seasoned management team with dedication, singular focus and extensive track record working on SPAC
transactions through different market environments;

 Our ability to leverage an extensive global network of relationships to create a significant pipeline
of initial business combination opportunities that have strong fundamental growth prospects;

 Unique capabilities and approach to the process of executing an initial business combination, as well
as post-closing support to ensure company is well-received in the public markets; and

 Our understanding of global financial markets and financing as well as corporate strategy.

 Business Combination Criteria

 Consistent with our strategy,
we have identified the following general criteria and guidelines that we believe are important in evaluating prospective initial business
combinations. We will use these criteria and guidelines in evaluating business combination opportunities, but we may decide to enter into
our initial business combination with a target business that does not meet these criteria and guidelines.

 We seek to identify companies
that we believe have significant growth potential and a combination of the following characteristics. We use these criteria and guidelines
in evaluating acquisition opportunities, but we may decide to enter into our initial business combination with a target business that
does not meet these criteria and guidelines. We expect that no individual criteria will entirely determine a decision to pursue a particular
target.

 A scalable business model with strong unit economics

 Compatibility with high standards of corporate responsibility

 Leadership in specific sector with a proven track record

 Strong competitive dynamics including barriers to entry and defensibility against future competitive threats

 Development of detailed projections and a cogent business plan

 The ability to grow inorganically through acquisition

 Readiness to become a listed company

 These criteria are not intended
to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant,
on these general guidelines as well as other considerations, factors and criteria that our management may deem relevant. In the event
that we decide to enter into our initial business combination with a target business that does not meet the above criteria and guidelines,
we will disclose that the target business does not meet the above criteria in our shareholder communications related to our initial business
combination, which, as discussed in this Annual Report on Form 10-K, would be in the form of tender offer documents or proxy solicitation
materials that we would file with the SEC.

 In evaluating a prospective
target business, we expect to conduct a thorough due diligence review which will encompass, among other things, meetings with incumbent
management, document reviews, inspection of facilities as well as a review of financial, operational, legal and other information which
will be made available to us. We will also utilize our operational and capital planning experience.

 Initial Business Combination

memorandum and articles of association require that we complete one or more business combinations having an aggregate fair market value
of at least 80% of the net assets held in the trust account (excluding taxes payable on the interest earned on the trust account) at the
time of signing the agreement to enter into the initial business combination and that a majority of our independent directors approve
such initial business combination(s). If our Board is not able to independently determine the fair market value of the partner business
or businesses or we are considering an initial business combination with an affiliated entity, we will obtain an opinion from an independent
investment banking firm which is a member of the Financial Industry Regulatory Authority, Inc., or FINRA, or an independent valuation
or accounting firm with respect to the satisfaction of such criteria. Our shareholders may not be provided with a copy of such opinion
nor will they be able to rely on such opinion. While we consider it unlikely that our Board will not be able to make an independent determination
of the fair market value of a partner business or businesses, it may be unable to do so if the Board is less familiar or experienced with
the partner company's business, there is a significant amount of uncertainty as to the value of the company's assets or prospects,
including if such company is at an early stage of development, operations or growth, or if the anticipated transaction involves a complex
financial analysis or other specialized skills and the Board determines that outside expertise would be helpful or necessary in conducting
such analysis. Since any opinion, if obtained, would merely state that the fair market value of the partner business meets the 80% of
net assets threshold, unless such opinion includes material information regarding the valuation of a partner business or the consideration
to be provided, it is not anticipated that copies of such opinion would be distributed to our shareholders. However, if required under
applicable law, any proxy statement that we deliver to shareholders and file with the SEC in connection with a proposed transaction will
include such opinion.

 We anticipate
structuring our initial business combination so that the post-business combination company in which our public shareholders own
shares will own or acquire 100% of the equity interests or assets of the partner business or businesses. We may, however, structure
our initial business combination such that the post-business combination company owns or acquires less than 100% of such interests
or assets of the partner business in order to meet certain objectives of the partner management team or shareholders or for other
reasons, but we will only complete such business combination if the post-business combination company owns or acquires 50% or more
of the outstanding voting securities of the partner or otherwise acquires a controlling interest in the partner sufficient for it
not to be required to register as an investment company under the Investment Company Act. Even if the post-business combination
company owns or acquires 50% or more of the voting securities of the partner, our shareholders prior to the business combination may
collectively own a minority interest in the post-business combination company, depending on valuations ascribed to the partner and
us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new
shares in exchange for all of the outstanding capital stock of a partner. In this case, we would acquire a 100% controlling interest
in the partner. However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to
the completion of our initial business combination could own less than a majority of our issued and outstanding shares subsequent to
our initial business combination. If less than 100% of the equity interests or assets of a partner business or businesses are owned
or acquired by the post-business combination company, the portion of such business or businesses that is owned or acquired is what
will be valued for purposes of the 80% of net assets test. If the business combination involves more than one partner business, the
80% of net assets test will be based on the aggregate value of all of the partner businesses and we will treat the partner
businesses together as the initial business combination for purposes of a tender offer or for seeking shareholder approval, as
applicable. In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without
the prior consent of Fulton AC.

 We may pursue an initial
business combination opportunity jointly with Fulton AC or one or more of its affiliates and/or investors, which we refer to as an "Affiliated
Joint Acquisition." Any such parties may co-invest with us in the partner business at the time of our initial business combination,
or we could raise additional proceeds to complete the acquisition by issuing to such parties a class of equity or equity-linked securities.
Any such issuance of equity or equity-linked securities would, on a fully diluted basis, reduce the percentage ownership of our then-existing
shareholders. Notwithstanding the foregoing, pursuant to the anti-dilution provisions of our Class B ordinary shares, issuances or deemed
issuances of Class A ordinary shares or equity-linked securities would result in an adjustment to the ratio at which Class B ordinary
shares shall convert into Class A ordinary such that Fulton AC and its permitted transferees, if any, would retain its aggregate percentage
ownership at 20%, on an as-converted basis, of the sum of the total number of ordinary shares issued and outstanding upon the consummation
of the Initial Public Offering, plus the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion
or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or
in relation to the consummation of the initial business combination (net of any redemptions of Class A ordinary shares by public shareholders),
excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued,
deemed issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to Fulton
AC, our sponsor or CB Co-Investment, members of our team or any of their affiliates upon conversion of the CB Co-Investment loan, the
extension loans and working capital loans, unless the holders of a majority of the then outstanding Class B ordinary shares agree to waive
such adjustment with respect to such issuance or deemed issuance at the time thereof. In no event will the Class B ordinary shares convert
into Class A ordinary shares at a rate of less than one-to-one. Neither Fulton AC, our sponsor nor any of their respective affiliates,
have an obligation to make any such investment.

 The capital from such private
placement would be used as part of the consideration to the sellers in our initial business combination, and any excess capital from such
private placement would be used for working capital in the post-transaction company.

 Other Considerations

 We are not prohibited from
pursuing an initial business combination or subsequent transaction with a company that is affiliated with Fulton AC, our sponsor or any
of our officers or directors. In the event we seek to complete our initial business combination with a company that is affiliated with
Fulton AC, our sponsor or any of our officers or directors, we, or a committee of independent directors, will obtain an opinion from an
independent investment banking firm or an independent valuation or accounting firm that such initial business combination or transaction
is fair to our company from a financial point of view.

 There are many ongoing discussions
regarding suitability of companies on our "target" list. And we have made contact with many such companies - directly and
through intermediaries. However, we have not entered into any definitive agreements with respect to a potential business combination.
Additionally, we have not, nor has anyone on our behalf, taken any substantive measure, directly or indirectly, to select or locate any
suitable acquisition candidate for us, nor have we engaged or retained any agent or other representative to select or locate any such
acquisition candidate.

 In addition, our officers
and directors presently have, and any of them in the future may have additional, fiduciary and contractual duties to other entities. Our
officers and directors, are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of
interest in allocating management time among various business activities, including identifying potential business combinations and monitoring
the related due diligence.

 Members of our Board directly
or indirectly own Class B Shares and private placement warrants and, accordingly, may have a conflict of interest in determining whether
a particular partner business is an appropriate business with which to effectuate our initial business combination. Further, each of our
officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or
resignation of any such officers or directors were to be included by a partner business as a condition to any agreement with respect to
our initial business combination.

 In addition, Fulton AC and
our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business
or investment ventures during the period in which we are seeking an initial business combination. Any such companies, businesses or investments
may present additional conflicts of interest in pursuing an initial business combination. However, we do not believe that any such potential
conflicts would materially affect our ability to complete our initial business combination.

 Corporate Information

 Our executive offices are
located at 8 The Green # 17538, Dover, DE 19901. We maintain a corporate website at  The information contained on or
accessible through our corporate website or any other website that we may maintain is not part of this Annual Report on Form 10-K.

 We are a Cayman Islands exempted
company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted
from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption
undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (2018 Revision) of the Cayman
Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to
be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no tax to be levied on
profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on or in respect
of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other
distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture
or other obligation of us.

 We are an "emerging
growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended (the "Securities Act"), as modified
by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"). As such, we are eligible to take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies"
including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002 (the "Sarbanes-Oxley Act"), reduced disclosure obligations regarding executive compensation in our periodic reports
and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result,
there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 In addition, Section 107
of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended transition period provided
in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an "emerging
growth company" can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
We intend to take advantage of the benefits of this extended transition period.

 We will remain an emerging
growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the Initial
Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large
accelerated filer, which means the market value of our Class A ordinary shares that are held by non-affiliates exceeds $700 million as
of the prior June 30, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year
period. References herein to "emerging growth company" have the meaning associated with it in the JOBS Act.

 Additionally, we are a "smaller
reporting company" as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced
disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller
reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares held by non-affiliates is
equal to or exceeds $250 million as of the prior June 30, and (2) our annual revenues equaled or exceeded $100 million during such completed
fiscal year or the market value of our ordinary shares held by non-affiliates is equal to or exceeds $700 million as of the prior June
30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with
other public companies difficult or impossible.

 Status as a Public Company

 We believe our structure
makes us an attractive business combination partner to partner businesses. As an existing public company, we offer a partner business
an alternative to the traditional initial public offering through a merger or other business combination with us. In a business combination
transaction with us, the owners of the partner business may, for example, exchange their capital stock, shares or other equity interests
in the partner business for our Class A ordinary shares (or shares of a new holding company) or for a combination of our Class A ordinary
shares and cash, allowing us to tailor the consideration to the specific needs of the sellers. We believe partner businesses will find
this method a more expeditious and cost-effective method to becoming a public company than the typical initial public offering. The typical
initial public offering process takes a significantly longer period of time than the typical business combination transaction process,
and there are significant expenses in the initial public offering process, including underwriting discounts and commissions, that may
not be present to the same extent in connection with a business combination with us.

 Furthermore, once a proposed
business combination is completed, the partner business will have effectively become public, whereas an initial public offering is always
subject to the underwriters' ability to complete the offering, as well as general market conditions, which could delay or prevent
the offering from occurring or have negative valuation consequences. Once public, we believe the partner business would then have greater
access to capital, an additional means of providing management incentives consistent with shareholders' interests and the ability
to use its shares as currency for acquisitions.

 Being a public company can
offer further benefits by augmenting a company's profile among potential new customers and vendors and aid in attracting talented
employees.

 While we believe that our
structure and our team's backgrounds make us an attractive business partner, some potential partner businesses may view our status
as a blank check company, such as our lack of an operating history and our ability to seek shareholder approval of any proposed initial
business combination, negatively.

 Financial Position

 With funds available for
a business combination in the amount of approximately $129,598, we may need additional funds to consummate our initial business combination.
Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing,
we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the partner
business to fit its needs and desires. However, we have not taken any steps to secure third party financing and there can be no assurance
it will be available to us.

 Effecting Our Initial Business Combination
General

 We are not presently engaged
in, and we will not engage in, any operations for an indefinite period of time. We intend to effectuate our initial business combination
using cash from the proceeds of the Initial Public Offering, the sale of the private placement warrants, the Fulton AC loan, our equity,
debt or a combination of these as the consideration to be paid in our initial business combination. We may seek to complete our initial
business combination with a company or business that may be financially unstable or in its early stages of development or growth, which
would subject us to the numerous risks inherent in such companies and businesses.

 If our initial business combination
is paid for using equity or debt, or not all of the funds released from the trust account are used for payment of the consideration in
connection with our initial business combination or used for redemptions of our Class A ordinary shares, we may apply the balance of the
cash released to us from the trust account for general corporate purposes, including for maintenance or expansion of operations of the
post-business combination company, the payment of principal or interest due on indebtedness incurred in completing our initial business
combination, to fund the purchase of other companies or for working capital.

 There are many ongoing discussions
regarding suitability of companies on our "target" list. And we have made contact with many such companies - directly and
through intermediaries. However, we have not entered into any definitive agreements with respect to a potential business combination.
Accordingly, there is no current basis for investors in the Initial Public Offering to evaluate the possible merits or risks of the partner
business with which we may ultimately complete our initial business combination.

 Although our team will assess
the risks inherent in a particular partner business with which we may combine, we cannot assure you that this assessment will result in
our identifying all risks that a partner business may encounter. Furthermore, some of those risks may be outside of our control, meaning
that we can do nothing to control or reduce the chances that those risks will adversely affect a partner business.

 We will have up until November 15, 2025 to consummate an initial business
combination. We have extended the date to consummate an initial business combination twice and while the Company does not intend to seek
any further extensions, we may seek further extensions subject to shareholder approval. If we are unable to consummate an initial business
combination within such time period, we will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in
the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the
trust account and not previously released to us, divided by the number of then outstanding public shares, subject to applicable law and
as further described herein, and then seek to dissolve and liquidate. We expect that the pro rata redemption price, as of June 16, 2025,
to be approximately $11.88 per share, without taking into account any interest earned on such funds, and after taking into account taxes
owed but not paid by such date and less $100,000 of interest to pay dissolution expenses, and such amount may be increased by the Contribution,
as described herein. However, we cannot assure you that we will in fact be able to distribute such amounts as a result of claims of creditors
which may take priority over the claims of our public shareholders.

 In addition to the funds
held in the trust account and the Fulton AC loan, we may need to obtain additional financing to complete our initial business combination,
either because the transaction requires more cash than is available from the proceeds held in our trust account, or because we become
obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue
additional securities or incur debt in connection with such business combination. There are no prohibitions on our ability to issue securities
or incur debt in connection with our initial business combination. We are not currently a party to any arrangement or understanding with
any third party with respect to raising any additional funds through the sale of securities, the incurrence of debt or otherwise.

 Sources of Partner Businesses

 Our process of identifying
acquisition partners is leveraging our team's unique industry experiences, deal sourcing capabilities and broad and deep network
of relationships in numerous industries, including executives and management teams, private equity groups and other institutional investors,
large business enterprises, lenders, investment bankers and other investment market participants, restructuring advisers, consultants,
attorneys and accountants, which we believe should provide us with a number of business combination opportunities. We expect that the
collective experience, capability and network of Fulton AC and our directors and officers, combined with their individual and collective
reputations in the investment community, will help to create prospective business combination opportunities.

 In addition, we anticipate
that partner business candidates are brought to our attention from various unaffiliated sources, including investment bankers and private
investment funds. Partner businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us
through calls or mailings. These sources may also introduce us to partner businesses in which they think we may be interested on an unsolicited
basis, since many of these sources will have read this Annual Report on Form 10-K and know what types of businesses we are pursuing. Our
officers and directors, as well as their affiliates, may also bring to our attention partner business candidates of which they become
aware through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade
shows or conventions.

 While we do not presently
anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on any formal basis,
we may engage these firms or other individuals in the future, in which event we may pay a finder's fee, consulting fee or other
compensation to be determined in an arm's length negotiation based on the terms of the transaction. We will engage a finder only
to the extent our team determines that the use of a finder may bring opportunities to us that may not otherwise be available to us or
if finders approach us on an unsolicited basis with a potential transaction that our team determines is in our best interest to pursue.
Payment of a finder's fee is customarily tied to completion of a transaction, in which case any such fee will be paid out of the
funds held in the trust account. In no event, however, will Fulton AC or any of our existing officers or directors, or any entity with
which they are affiliated, be paid any finder's fee, consulting fee or other compensation by the company prior to, or for any services
they render in order to effectuate, the completion of our initial business combination (regardless of the type of transaction that it
is). None of Fulton AC or any of our executive officers or directors, or any of their respective affiliates, will be allowed to receive
any compensation, finder's fees or consulting fees from a prospective business combination partner in connection with a contemplated
acquisition of such partner by us. We have agreed to pay Fulton AC a total of up to $30,000 per month for office space, secretarial and
administrative support and to reimburse Fulton AC for any out-of-pocket expenses related to identifying, investigating and completing
an initial business combination. Some of our officers and directors may enter into employment or consulting agreements with the post-business
combination company following our initial business combination.

 In addition, Fulton AC and
our officers and directors presently have, and any of them in the future may have additional, fiduciary and contractual duties to other
entities. As a result, if Fulton AC or any our officers or directors becomes aware of a business combination opportunity, which is suitable
for an entity to which he or she has then-current fiduciary or contractual obligations, then, subject to their fiduciary duties under
applicable law, he or she will need to honor such fiduciary or contractual obligations to present such business combination opportunity
to such entity, before we can pursue such opportunity. If these funds or investment entities decide to pursue any such opportunity, we
may be precluded from pursuing the same.

 Evaluation of a Partner Business and Structuring
of Our Initial Business Combination

 In evaluating a prospective
partner business, we conduct a thorough due diligence review which may encompass, among other things, meetings with incumbent management
and employees, document reviews, interviews of customers and suppliers, inspection of facilities, as well as a review of financial, operational,
legal and other information which will be made available to us. If we determine to move forward with a particular partner, we will proceed
to structure and negotiate the terms of the business combination transaction.

 The time required to identify
and evaluate a partner business and to structure and complete our initial business combination, and the costs associated with this process,
are not currently ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of,
and negotiation with, a prospective partner business with which our initial business combination is not ultimately completed will result
in our incurring losses and will reduce the funds we can use to complete another business combination. The company will not pay any consulting
fees to members of our team, or any of their respective affiliates, for services rendered to or in connection with our initial business
combination. In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without the
prior consent of Fulton AC.

 Lack of Business Diversification

 For an indefinite period
of time after the completion of our initial business combination, the prospects for our success may depend entirely on the future performance
of a single business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or
several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in
a single line of business. By completing our initial business combination with only a single entity, our lack of diversification may:

 subject us to negative economic, competitive and regulatory developments, any or all of which may have
a substantial adverse impact on the particular industry in which we operate after our initial business combination; and

 cause us to depend on the marketing and sale of a single product or limited number of products or services.

 Limited Ability to Evaluate the Partner's
Management Team

 Although we closely scrutinize
the management of a prospective partner business when evaluating the desirability of effecting our initial business combination with that
business, our assessment of the partner business's management may not prove to be correct. In addition, the future management may
not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our
team, if any, in the partner business cannot presently be stated with any certainty. The determination as to whether any of the members
of our team will remain with the combined company will be made at the time of our initial business combination. While it is possible that
one or more of our directors will remain associated in some capacity with us following our initial business combination, it is unlikely
that any of them will devote their full efforts to our affairs subsequent to our initial business combination. Moreover, we cannot assure
you that members of our team will have significant experience or knowledge relating to the operations of the particular partner business.

 We cannot assure you that
any of our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether
any of our key personnel will remain with the combined company will be made at the time of our initial business combination. Following
a business combination, we may seek to recruit additional managers to supplement the incumbent management of the partner business. We
cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills,
knowledge or experience necessary to enhance the incumbent management.

 Shareholders May Not Have the Ability to
Approve Our Initial Business Combination

 We may conduct redemptions
without a shareholder vote pursuant to the tender offer rules of the SEC subject to the provisions of our third amended and restated memorandum
and articles of association. However, we will seek shareholder approval if it is required by applicable law or stock exchange rule, or
we may decide to seek shareholder approval for business or other reasons.

 Under our third amended and
restated memorandum and articles of association, shareholder approval would be required for our initial business combination if the Company
does not provide shareholders with the opportunity to have their ordinary shares repurchased by means of a tender offer.

 The Companies Act and Cayman
Islands law do not currently require, and we are not aware of any other applicable law that will require, shareholder approval of our
initial business combination.

 The decision as to whether
we will seek shareholder approval of a proposed business combination in those instances in which shareholder approval is not required
by law will be made by us, solely in our discretion, and will be based on business and legal reasons, which include a variety of factors,
including, but not limited to:

 the timing of the transaction, including in the event we determine shareholder approval would require
additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage
in the transaction or result in other additional burdens on the company;

 the expected cost of holding a shareholder vote;

 the risk that the shareholders would fail to approve the proposed business combination;

 other time and budget constraints of the company; and

 additional legal complexities of a proposed business combination that would be time-consuming and burdensome
to present to shareholders.

 Permitted Purchases and Other Transactions
with Respect to Our Securities

 If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, Fulton AC or our directors, executive officers, advisors or their affiliates may purchase public shares or warrants
in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination.
Additionally, at any time at or prior to our initial business combination, subject to applicable securities laws (including with respect
to material nonpublic information), Fulton AC and our directors, executive officers, advisors or their affiliates may enter into transactions
with investors and others to provide them with incentives to acquire public shares, vote their public shares in favor of our initial business
combination or not redeem their public shares. However, they have no current commitments, plans or intentions to engage in such transactions
and have not formulated any terms or conditions for any such transactions. None of the funds in the trust account will be used to purchase
public shares or warrants in such transactions. If they engage in such transactions, they will be restricted from making any such purchases
when they are in possession of any material non-public information not disclosed to the seller or if such purchases are prohibited by
Regulation M under the Exchange Act.

 In the event that Fulton
AC or any our directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from public shareholders
who have already elected to exercise their redemption rights or submitted a proxy to vote against our initial business combination, such
selling shareholders would be required to revoke their prior elections to redeem their shares and any proxy to vote against our initial
business combination. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender
offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however,
if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will be required
to comply with such rules.

 The purpose of any such transactions
could be to (i) vote such shares in favor of the business combination and thereby increase the likelihood of obtaining shareholder approval
of the business combination, (ii) to satisfy a closing condition in an agreement with a partner that requires us to have a minimum net
worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise
not be met or (iii) reduce the number of public warrants outstanding or vote such warrants or any matter submitted to the warrant holders
for approval in connection with our initial business combination. Any such purchases of our securities may result in the completion of
our initial business combination that may not otherwise have been possible.

 In addition, if such purchases
are made, the public "float" of our Class A ordinary shares or public warrants may be reduced and the number of beneficial
holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities
on OTCQB.

 Fulton AC or our
officers, directors and/or their affiliates anticipate that they may identify the shareholders with whom Fulton AC or our officers,
directors or their affiliates may pursue privately negotiated transactions by either the shareholders contacting us directly or by
our receipt of redemption requests submitted by shareholders (in the case of Class A ordinary shares) following our mailing of
tender offer or proxy materials in connection with our initial business combination. To the extent that Fulton AC or our officers,
directors, advisors or their affiliates enter into a private transaction, they would identify and contact only potential selling or
redeeming shareholders who have expressed their election to redeem their shares for a pro rata share of the trust account or vote
against our initial business combination, whether or not such shareholder has already submitted a proxy with respect to our initial
business combination but only if such shares have not already been voted at the general meeting related to our initial business
combination. Fulton AC or our executive officers, directors, advisors or their affiliates will select which shareholders to purchase
shares from based on the negotiated price and number of shares and any other factors that they may deem relevant, and will be
restricted from purchasing shares if such purchases do not comply with Regulation M under the Exchange Act and the other federal
securities laws.

 Fulton AC and our officers,
directors and/or their affiliates will be restricted from making purchases of shares if the purchases would violate Section 9(a)(2) or
Rule 10b-5 of the Exchange Act. Any such purchases will be reported by such person pursuant to Section 13 and Section 16 of the Exchange
Act to the extent such purchasers are subject to such reporting requirements.

 Redemption Rights for Public Shareholders
upon Completion of Our Initial Business Combination

 We will provide our public
shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business
combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of
two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust
account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares,
subject to the limitations described herein. The amount in the trust account is anticipated to be $11.62 per public share. The redemption
rights may include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be
no redemption rights upon the completion of our initial business combination with respect to our warrants. Further, we will not proceed
with redeeming our public shares, even if a public shareholder has properly elected to redeem its shares, if a business combination does
not close. Fulton AC, CBG, CB-Co Investment and our current and former directors and officers have entered into an agreement with us,
pursuant to which they have agreed to waive their redemption rights with respect to their Class B Shares, private placement warrants and
any public shares purchased during or after the Initial Public Offering in connection with (i) the completion of our initial business
combination and (ii) a shareholder vote to approve an amendment to our third amended and restated memorandum and articles of association
(A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their
shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial
business combination by November 15, 2025 or (B) with respect to any other provision relating to the rights of holders of our Class A
ordinary shares or pre-initial business combination activity. Further, Fulton AC has agreed to contribute to the Company the Contribution,
which amount will be deposited into the trust account. Accordingly, the amount deposited per share will depend on the number of public
shares that remain outstanding after the redemption and length of time until the consummation of an initial business combination or winding
up of the Company.

 Limitations on Redemptions

memorandum and articles of association provides that in no event will we redeem our public shares in an amount that would cause our net
tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC's "penny stock" rules).
However, the proposed business combination may require: (i) cash consideration to be paid to the partner or its owners, (ii) cash to be
transferred to the partner for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions
in accordance with the terms of the proposed business combination. In the event the aggregate cash consideration we would be required
to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant
to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business
combination or redeem any shares, and all Class A ordinary shares submitted for redemption will be returned to the holders thereof.

 Manner of Conducting Redemptions

 We will provide our public
shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business
combination either (i) in connection with a general meeting called to approve the business combination or (ii) by means of a tender offer.
The decision as to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer will be made
by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms
of the transaction would require us to seek shareholder approval under applicable law or stock exchange listing requirements or whether
we were deemed to be a foreign private issuer (which would require a tender offer rather than seeking shareholder approval under SEC rules).
Asset acquisitions and share purchases would not typically require shareholder approval while direct mergers with our company where we
do not survive and any transactions where we issue more than 20% of our issued and outstanding ordinary shares or seek to amend our third
amended and restated memorandum and articles of association would typically require shareholder approval. We currently intend to conduct
redemptions in connection with a shareholder vote unless shareholder approval is not required by applicable law or stock exchange rule
or we choose to conduct redemptions pursuant to the tender offer rules of the SEC for business or other reasons.

 If we held a shareholder
vote to approve our initial business combination, we will, pursuant to our third amended and restated memorandum and articles of association:

 conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the
Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and

 file proxy materials with the SEC.

 In the event that we seek
shareholder approval of our initial business combination, we will distribute proxy materials and, in connection therewith, provide our
public shareholders with the redemption rights described above upon completion of the initial business combination.

 If we seek shareholder approval,
we will complete our initial business combination only if we receive approval pursuant to an ordinary resolution under Cayman Islands
law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. In
such case, Fulton AC, CBG, CB-Co Investment and our current and former directors and officers have agreed to vote their Class B Shares
and public shares purchased during or after the Initial Public Offering in favor of our initial business combination. As a result, we
will not need any additional public shares to vote in favor of an initial business combination in order to have our initial business combination
approved (assuming all issued and outstanding shares are voted). Each public shareholder may elect to redeem their public shares irrespective
of whether they vote for or against the proposed transaction or vote at all. In addition, our sponsor and our team have entered into an
agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their Class B Shares and any public
shares purchased during or after the Initial Public Offering in connection with (i) the completion of our initial business combination
and (ii) a shareholder vote to approve an amendment to our third amended and restated memorandum and articles of association (A) that
would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares
redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial
business combination by November 15, 2025 or (B) with respect to any other provision relating to the rights of holders of our Class A
ordinary shares or pre-initial business combination activity. Further, Fulton AC has agreed to contribute to the Company the Contribution,
which amount will be deposited into the trust account. Accordingly, the amount deposited per share will depend on the number of public
shares that remain outstanding after the redemption and length of time until the consummation of an initial business combination or winding
up of the Company.

 If we conduct redemptions
pursuant to the tender offer rules of the SEC, we will, pursuant to our third amended and restated memorandum and articles of association:

 conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate
issuer tender offers; and

 file tender offer documents with the SEC prior to completing our initial business combination which contain
substantially the same financial and other information about the initial business combination and the redemption rights as is required
under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.

 Upon the public announcement
of our initial business combination, we or Fulton AC will terminate any plan established in accordance with Rule 10b5-1 to purchase Class
A ordinary shares in the open market if we elect to redeem our public shares through a tender offer, to comply with Rule 14e-5 under the
Exchange Act.

 In the event we conduct redemptions
pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a)
under the Exchange Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer
period. In addition, the tender offer will be conditioned on public shareholders not tendering more than the number of public shares we
are permitted to redeem. If public shareholders tender more shares than we have offered to purchase, we will withdraw the tender offer
and not complete the initial business combination.

 Limitation on Redemption upon Completion
of Our Initial Business Combination If We Seek Shareholder Approval

 If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, our third amended and restated memorandum and articles of association provides that a public shareholder, together
with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a "group"
(as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate
of 15% of the shares old in our Initial Public Offering, which we refer to as the "Excess Shares," without our prior consent.
We believe this restriction will discourage shareholders from accumulating large blocks of shares, and subsequent attempts by such holders
to use their ability to exercise their redemption rights against a proposed business combination as a means to force us or our founding
to purchase their shares at a significant premium to the then-current market price or on other undesirable terms. Absent this provision,
a public shareholder holding more than an aggregate of 15% of the shares sold in the Initial Public Offering could threaten to exercise
its redemption rights if such holder's shares are not purchased by us, Fulton AC or our team at a premium to the then-current market
price or on other undesirable terms. By limiting our shareholders' ability to redeem no more than 15% of the shares sold in the
Initial Public Offering without our prior consent, we believe we will limit the ability of a small group of shareholders to unreasonably
attempt to block our ability to complete our initial business combination, particularly in connection with a business combination with
a partner that requires as a closing condition that we have a minimum net worth or a certain amount of cash. However, we would not be
restricting our shareholders' ability to vote all of their shares (including Excess Shares) for or against our initial business

 Tendering Share Certificates in Connection
with a Tender Offer or Redemption Rights

 Public shareholders seeking
to exercise their redemption rights, whether they are record holders or hold their shares in "street name," will be required
to either tender their certificates (if any) to our transfer agent prior to the date set forth in the proxy solicitation or tender offer
materials, as applicable, mailed to such holders, or to deliver their shares to the transfer agent electronically using The Depository
Trust Company's DWAC (Deposit/Withdrawal At Custodian) System, at the holder's option, in each case up to two business days
prior to the initially scheduled vote to approve the business combination. The proxy solicitation or tender offer materials, as applicable,
that we will furnish to holders of our public shares in connection with our initial business combination will indicate the applicable
delivery requirements, which will include the requirement that a beneficial holder must identify itself in order to validly redeem its
shares. Accordingly, a public shareholder would have from the time we send out our tender offer materials until the close of the tender
offer period, or up to two business days prior to the initially scheduled vote on the proposal to approve the business combination if
we distribute proxy materials, as applicable, to tender its shares if it wishes to seek to exercise its redemption rights.

 Given the relatively short
period in which to exercise redemption rights, it is advisable for shareholders to use electronic delivery of their public shares. There
is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through
the DWAC System. The transfer agent will typically charge the tendering broker a fee of approximately $80.00 and it would be up to the
broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not we
require holders seeking to exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising
redemption rights regardless of the timing of when such delivery must be effectuated.

 The foregoing is different
from the procedures used by many blank check companies. In order to perfect redemption rights in connection with their business combinations,
many blank check companies would distribute proxy materials for the shareholders' vote on an initial business combination, and a
holder could simply vote against a proposed business combination and check a box on the proxy card indicating such holder was seeking
to exercise his or her redemption rights. After the business combination was approved, the company would contact such shareholder to arrange
for him or her to deliver his or her certificate to verify ownership. As a result, the shareholder then had an "option window"
after the completion of the business combination during which he or she could monitor the price of the company's shares in the market.
If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering his
or her shares to the company for cancellation. As a result, the redemption rights, to which shareholders were aware they needed to commit
before the general meeting, would become "option" rights surviving past the completion of the business combination until the
redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the meeting ensures that a redeeming
shareholder's election to redeem is irrevocable once the business combination is approved.

 Any request to redeem such
shares, once made, may be withdrawn at any time up to two business days prior to the initially scheduled vote on the proposal to approve
the business combination, unless otherwise agreed to by us.

 Furthermore, if a holder
of a public share delivered its certificate in connection with an election of redemption rights and subsequently decides prior to the
applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically
or electronically). It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares
will be distributed promptly after the completion of our initial business combination.

 If our initial business combination
is not approved or completed for any reason, then our public shareholders who elected to exercise their redemption rights would not be
entitled to redeem their shares for the applicable pro rata share of the trust account. In such case, we will promptly return any certificates
delivered by public holders who elected to redeem their shares.

 If any proposed initial business
combination is not completed, we may continue to try to complete a business combination with a different partner until November 15, 2025.

 Redemption of Public Shares and Liquidation If No Initial Business
Combination

memorandum and articles of association provides that we have only up until November 15, 2025 to consummate an initial business combination.
If we do not consummate an initial business combination by November 15, 2025, we will: (i) cease all operations except for the purpose
of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the
funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to
pay dissolution expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish public
shareholders' rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board, liquidate and dissolve,
subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the requirements
of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire
worthless if we fail to consummate an initial business combination by November 15, 2025. Our third amended and restated memorandum and
articles of association provides that, if we wind up for any other reason prior to the consummation of our initial business combination,
we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not
more than ten business days thereafter, subject to applicable Cayman Islands law.

 Fulton AC, CBG, CB Co-Investment
and each member of our team have entered into an agreement with us, pursuant to which they have agreed to waive their rights to liquidating
distributions from the trust account with respect to any Class B Shares they hold if we fail to consummate an initial business combination
by November 15, 2025 (although they will be entitled to liquidating distributions from the trust account with respect to any public shares
they hold if we fail to complete our initial business combination by November 15, 2025).

 Fulton AC and our executive
officers and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our third amended
and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders
of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem
100% of our public shares if we do not complete our initial business combination by November 15, 2025 or (B) with respect to any other
provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity, unless we provide
our public shareholders with the opportunity to redeem their public shares upon approval of any such amendment at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust
account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares.
However, we may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that
we do not then become subject to the SEC's "penny stock" rules). If this optional redemption right is exercised with
respect to an excessive number of public shares such that we cannot satisfy the net tangible asset requirement, we would not proceed with
the amendment or the related redemption of our public shares at such time. This redemption right shall apply in the event of the approval
of any such amendment, whether proposed by Fulton AC or any executive officer, director or any other person.

 We expect that all costs
and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be funded from proceeds
from the unsecured convertible promissory note, plus up to $100,000 of funds from the trust account available to us to pay dissolution
expenses, although we cannot assure you that there will be sufficient funds for such purpose.

 If we were to expend all
of the net proceeds of the Fulton AC loan through November 15, 2025, other than the proceeds deposited in the trust account, and without
taking into account interest, if any, earned on the trust account, the per-share redemption amount received by shareholders upon our dissolution
would be approximately $11.90 (less up to $100,000 of interest to pay dissolution expenses). The proceeds deposited in the trust account
could, however, become subject to the claims of our creditors which would have higher priority than the claims of our public shareholders.
We cannot assure you that the actual per-share redemption amount received by shareholders will not be less than $11.90. While we intend
to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors' claims.

 Although we will seek to
have all vendors, service providers (excluding our independent registered public accounting firm), prospective partner businesses and
other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any
monies held in the trust account for the benefit of our public shareholders, there is no guarantee that they will execute such agreements
or even if they execute such agreements that they would be prevented from bringing claims against the trust account including but not
limited to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability
of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the
trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our team
will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed
a waiver if our team believes that such third party's engagement would be significantly more beneficial to us than any alternative.
Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party
consultant whose particular expertise or skills are believed by our team to be significantly superior to those of other consultants that
would agree to execute a waiver or in cases where our team is unable to find a service provider willing to execute a waiver. The underwriters
will not execute agreements with us waiving such claims to the monies held in the trust account. In addition, there is no guarantee that
such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts
or agreements with us and will not seek recourse against the trust account for any reason. In order to protect the amounts held in the
trust account, Fulton AC has agreed that it will be liable to us if and to the extent any claims by a vendor for services rendered or
products sold to us, or a prospective partner business with which we have discussed entering into a transaction agreement, reduce the
amounts in the trust account to below the lesser of (i) $11.90 per public share and (ii) the actual amount per public share held in the
trust account as of the date of the liquidation of the trust account if less than $11.90 per public share due to reductions in the value
of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided that such liability will
not apply to any claims by a third party or prospective partner business who executed a waiver of any and all rights to seek access to
the trust account nor will it apply to any claims under our indemnity of the underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against
a third party, Fulton AC will not be responsible to the extent of any liability for such third party claims. However, we have not asked
Fulton AC to reserve for such indemnification obligations, nor have we independently verified whether Fulton AC has sufficient funds to
satisfy its indemnity obligations and we believe that Fulton AC's only assets are securities of our company. Fulton AC may not be
able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without
limitation, claims by vendors and prospective partner businesses.

 In the event that the proceeds
in the trust account are reduced below the lesser of (i) $11.90 per public share and the actual amount per public share held in the trust
account as of the date of the liquidation of the trust account if less than $11.90 per public share due to reductions in the value of
the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, and Fulton AC asserts that it is
unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent
directors would determine whether to take legal action against Fulton AC to enforce its indemnification obligations. While we currently
expect that our independent directors would take legal action on our behalf against Fulton AC to enforce its indemnification obligations
to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance.
Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemption price will not be less
than $11.90 per public share.

 We will seek to reduce the
possibility that Fulton AC will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service
providers (excluding our independent registered public accounting firm), prospective partner businesses or other entities with which we
do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account.
Fulton AC will also not be liable as to any claims under our indemnity of the underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act. We will have access to up to $1,500,000 from the Fulton AC loan with which
to pay any such potential claims (including costs and expenses incurred in connection with our liquidation, currently estimated to be
no more than approximately $100,000). In the event that we liquidate and it is subsequently determined that the reserve for claims and
liabilities is insufficient, shareholders who received funds from our trust account could be liable for claims made by creditors; however
such liability will not be greater than the amount of funds from our trust account received by any such shareholder.

 If we file a bankruptcy or
insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, the proceeds held in
the trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims
of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, we
cannot assure you we will be able to return $11.90 per public share to our public shareholders. Additionally, if we file a bankruptcy
or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, any distributions
received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a "preferential transfer"
or a "fraudulent conveyance."

 As a result, a bankruptcy
or insolvency court could seek to recover some or all amounts received by our shareholders. Furthermore, our Board may be viewed as having
breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims
of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure
you that claims will not be brought against us for these reasons.

 Our public shareholders will
be entitled to receive funds from the trust account only (i) in the event of the redemption of our public shares if we do not consummate
an initial business combination by November 15, 2025, (ii) in connection with a shareholder vote to amend our third amended and restated
memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary
shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares
if we do not complete our initial business combination by November 15, 2025 or (B) with respect to any other provision relating to the
rights of holders of our Class A ordinary shares or pre-initial business combination activity, and (iii) if they redeem their respective
shares for cash upon the completion of the initial business combination. Public shareholders who redeem their Class A ordinary shares
in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the trust
account upon the subsequent completion of an initial business combination or liquidation if we have not consummated an initial business
combination by November 15, 2025, with respect to such Class A ordinary shares so redeemed. In no other circumstances will a shareholder
have any right or interest of any kind to or in the trust account. In the event we seek shareholder approval in connection with our initial
business combination, a shareholder's voting in connection with the business combination alone will not result in a shareholder's
redeeming its shares to us for an applicable pro rata share of the trust account. Such shareholder must have also exercised its redemption
rights described above. These provisions of our third amended and restated memorandum and articles of association, like all provisions
of our third amended and restated memorandum and articles of association, may be amended with a shareholder vote.

 Competition

 In identifying, evaluating
and selecting a partner business for our initial business combination, we may encounter intense competition from other entities having
a business objective similar to ours, including other blank check companies, private equity groups and leveraged buyout funds, public
companies, operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive experience
identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess greater financial,
technical, human and other resources than us. Our ability to acquire larger partner businesses will be limited by our available financial
resources. This inherent limitation gives others an advantage in pursuing the acquisition of a partner business. Furthermore, our obligation
to pay cash in connection with our public shareholders who properly exercise their redemption rights may reduce the resources available
to us for our initial business combination and our outstanding warrants, and the future dilution they potentially represent, may not be
viewed favorably by certain partner businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating
an initial business combination.

 Facilities

 We currently maintain our
principal offices at 8 The Green # 17538 Dover, DE 19901. The cost for our use of this space is included in the up to $30,000 per month
fee we pay to Fulton AC for office space, administrative and support services. We consider our current office space adequate for our current
operations.

 Employees

 We currently have two
executive officers. These individuals are not obligated to devote any specific number of hours to our matters but they intend to
devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination. The
amount of time they will devote in any time period will vary based on whether a partner business has been selected for our initial
business combination and the stage of the business combination process we are in. We do not intend to have any full time employees
prior to the completion of our initial business combination.

 Periodic Reporting and Financial Information

 We registered our units,
Class A ordinary shares and warrants under the Exchange Act and have reporting obligations, including the requirement that we file annual,
quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports will contain financial
statements audited and reported on by our independent registered public accountants.

 We will provide shareholders
with audited financial statements of the prospective partner business as part of the proxy solicitation or tender offer materials, as
applicable, sent to shareholders. These financial statements may be required to be prepared in accordance with, or reconciled to, GAAP,
or IFRS, depending on the circumstances, and the historical financial statements may be required to be audited in accordance with the
standards of the PCAOB. These financial statement requirements may limit the pool of potential partner businesses we may acquire because
some partners may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules
and complete our initial business combination by November 15, 2025. We cannot assure you that any particular partner business identified
by us as a potential acquisition candidate will have financial statements prepared in accordance with the requirements outlined above,
or that the potential partner business will be able to prepare its financial statements in accordance with the requirements outlined above.
To the extent that these requirements cannot be met, we may not be able to acquire the proposed partner business. While this may limit
the pool of potential acquisition candidates, we do not believe that this limitation will be material.

 We are required by the Sarbanes-Oxley
Act to evaluate our internal control procedures for the fiscal year ending December 31, 2024. Only in the event that we are deemed to
be a large accelerated filer or an accelerated filer and no longer qualify as an emerging growth company would we be required to comply
with the independent registered public accounting firm attestation requirement on internal control over financial reporting. A partner
business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development
of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary
to complete any such acquisition.

 We are a Cayman Islands exempted
company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted
from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption
undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (2018 Revision) of the Cayman
Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to
be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no tax to be levied on
profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on or in respect
of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other
distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture
or other obligation of us.

 We are an "emerging
growth company," as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging
growth companies" including, but not limited to, not being required to comply with the auditor attestation requirements of Section
404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less
active trading market for our securities and the prices of our securities may be more volatile.

 In addition, Section 107
of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended transition period provided
in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an "emerging
growth company" can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
We intend to take advantage of the benefits of this extended transition period.

 We will remain an emerging
growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the Initial
Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large
accelerated filer, which means the market value of our Class A ordinary shares that are held by non-affiliates exceeds $700 million as
of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year
period.

 Additionally, we are a "smaller
reporting company" as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced
disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller
reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares held by non-affiliates is
equal to or exceeds $250 million as of the prior June 30, and (2) our annual revenues equaled or exceeded $100 million during such completed
fiscal year and the market value of our ordinary shares held by non-affiliates is equal to or exceeds $700 million as of the prior June
30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with
other public companies difficult or impossible.

 Legal Proceedings

 There is no material litigation,
arbitration or governmental proceeding currently pending against us or any members of our team in their capacity as such.

 Item
1A. Risk Factors

 An investment in our securities
involves a high degree of risk. You should consider carefully all of the risks described below, together with the other information contained
in this Annual Report on Form 10-K, before making a decision to invest in our securities. If any of the following events occur, our business,
financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could
decline, and you could lose all or part of your investment.

 Risks Related to Our Business and Financial
Position

 We are a recently incorporated company
with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.

 We are a recently incorporated
company established under the laws of the Cayman Islands with no operating results. Because we lack an operating history, you have no
basis upon which to evaluate our ability to achieve our business objective of completing our initial business combination with one or
more partner businesses. We have no plans, arrangements or understandings with any prospective partner business concerning a business
combination and may be unable to complete our initial business combination. If we fail to complete our initial business combination, we
will never generate any operating revenues.

 Past performance by our team or their
affiliates may not be indicative of future performance of an investment in us.

 Information regarding performance
by, or businesses associated with, our team or their affiliates is presented for informational purposes only. Any past experience of and
performance by our team or their affiliates, is not a guarantee either: (1) that we will be able to successfully identify a suitable
candidate for our initial business combination; or (2) of any results with respect to any initial business combination we may consummate.
You should not rely on the historical record of our team or any of their affiliates' as indicative of the future performance of
an investment in us or the returns we will, or are likely to, generate going forward.

 The ability of our public shareholders
to redeem their shares for cash may make our financial condition unattractive to potential business combination partners, which may make
it difficult for us to enter into a business combination with a partner.

 We may seek to enter into
a business combination transaction agreement with a prospective partner that requires as a closing condition that we have a minimum net
worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not be able to meet such
closing condition and, as a result, would not be able to proceed with the business combination.

 Furthermore, in no event
will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then
become subject to the SEC's "penny stock" rules). Consequently, if accepting all properly submitted redemption requests
would cause our net tangible assets to be less than $5,000,001 or such greater amount necessary to satisfy a closing condition as described
above, we would not proceed with such redemption and the related business combination and may instead search for an alternate business
combination. Prospective partners will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction
with us.

 Adverse developments affecting
the financial services industry, such as actual events or concerns involving liquidity, defaults or nonperformance by financial institutions
or transactional counterparties, could adversely affect our ability to raise sufficient funds to finance our initial business combination
or our ability to raise capital to fund our operations following our initial business combination, in each case, on reasonable terms,
or at all.

 Actual events involving limited
liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or
other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events
of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. During the week
of March 10, 2023, two banks were placed into receivership by the Federal Deposit Insurance Corporation. Similar adverse developments
affecting financial institutions in 2008 led to widespread declines in confidence in the banking system and reduced availability of credit.
Investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including
higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity
sources, thereby making it more difficult for us to acquire sufficient funds to finance our initial business combination or to fund our
operations following our initial business combination, in each case, on acceptable terms, or at all.

 Risks Related to Our Proposed Initial Business
Combination

 Our shareholders may not be afforded
an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even
though a majority of our shareholders do not support such a combination.

 We may not hold a shareholder
vote to approve our initial business combination unless the business combination would require shareholder approval under applicable Cayman
Islands law, our third amended and restated memorandum and articles of association, or stock exchange listing requirements or if we decide
to hold a shareholder vote for business or other reasons.

 Except as required by applicable
law or stock exchange rule, the decision as to whether we will seek shareholder approval of a proposed business combination or will allow
shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety
of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder
approval. Accordingly, we may consummate our initial business combination even if holders of a majority of the outstanding ordinary shares
do not approve of the business combination we consummate.

 If we seek shareholder approval of
our initial business combination, Fulton AC, CBG, CB-Co Investment and our current and former directors and officers have agreed to vote
in favor of such initial business combination, regardless of how our public shareholders vote.

memorandum and articles of association provides that, if we seek shareholder approval, we will complete our initial business combination
only if we receive approval pursuant to an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority
of the shareholders who are entitled to attend and vote at a general meeting of the Company. Fulton AC, CBG, CB Co-Investment and our
current and former directors and officers have agreed to vote their Class B Shares and Class A Shares and any public shares purchased
during or after the Initial Public Offering in favor of our initial business combination, together constituting 83.84% of the Ordinary
Shares currently outstanding. Accordingly, if we seek shareholder approval of our initial business combination, the agreement by Fulton
AC, CBG, CB-Co Investment and our current and former directors and officers to vote in favor of our initial business combination will
result in the requisite shareholder approval for such initial business combination.

 Your only opportunity to affect the
investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from
us for cash.

 At the time of your investment in
us, you will not be provided with an opportunity to evaluate the specific merits or risks of any partner businesses. Since our Board may
complete a business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote
on the business combination, unless we seek such shareholder approval. Accordingly, your only opportunity to affect the investment decision
regarding a potential business combination may be limited to exercising your redemption rights within the period of time (which will be
at least 20 business days) set forth in our tender offer documents mailed to our public shareholders in which we describe our initial
business combination. The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares
may not allow us to complete the most desirable business combination or optimize our capital structure.

 At the time we enter into
an agreement for our initial business combination, we will not know how many shareholders may exercise their redemption rights, and therefore
will need to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. If
a large number of shares are submitted for redemption, we may need to restructure the transaction to reserve a greater portion of the
cash in the trust account or arrange for additional third party financing. Raising additional third party financing may involve dilutive
equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may limit our ability to
complete the most desirable business combination available to us or optimize our capital structure.

 The ability of our public shareholders
to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination
would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.

 If our initial business combination
agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount
of cash at closing, the probability that our initial business combination would be unsuccessful is increased. If our initial business
combination is unsuccessful, you would not receive your pro rata portion of the funds in the trust account until we liquidate the
trust account. If you are in need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such time
our shares may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material
loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to
sell your shares in the open market.

 The requirement that we consummate
an initial business combination by November 15, 2025 may give potential partner businesses leverage over us in negotiating a business
combination and may limit the time we have in which to conduct due diligence on potential business combination partners, in particular
as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that
would produce value for our shareholders.

 Any potential partner
business with which we enter into negotiations concerning a business combination will be aware that we must consummate an initial
business combination by November 15, 2025. Consequently, such partner business may obtain leverage over us in negotiating a business
combination, knowing that if we do not complete our initial business combination within the required time period with that
particular partner business, we may be unable to complete our initial business combination with any partner business. This risk will
increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence and may
enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.

 Our search for a business combination,
and any target business with which we ultimately consummate a business combination, may be materially adversely affected by current or
anticipated military conflict, including between Russia and Ukraine and the conflict between Israel and Hamas, terrorism, sanctions, changes
to foreign trade policies or other geopolitical events globally, a pandemic, including new variant strains of the COVID-19 virus, and
the status of debt and equity markets.

 Our ability to consummate
a business combination may be dependent on our ability to raise equity and debt financing which may be impacted by current or anticipated
military conflict, including between Russia and Ukraine and the conflict between Israel and Hamas, terrorism, sanctions, the pandemics
and other events, including as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable
on terms acceptable to us or at all. Economic uncertainty in various global markets caused by political instability may result in weakened
demand for products sold by potential target businesses and difficulty in forecasting financial results on which we rely in the evaluation
of potential target businesses. Global conflicts, including the military conflict between Russia and Ukraine, as well as economic sanctions
implemented by the United States and European Union against Russia in response thereto, may negatively impact markets, increase energy
and transportation costs and cause weaker macro-economic conditions. Political developments impacting government spending and international
trade, including inflation, raising interest rates, recently enacted and threatened tariffs, may also negatively impact markets and cause
weaker macro-economic conditions. The effect of any or all of these events could adversely impact our ability to find a suitable business
combination, as it may affect demand for potential target companies' products or the cost of manufacturing thereof, harm their operations
and weaken their financial results.

 The current economic environment
may lead to increased difficulty in completing our initial business combination.

 Our ability to consummate
our initial business combination may depend, in part, on worldwide economic conditions. In recent months, we have observed increased economic
uncertainty in the United States and abroad. Impacts of such economic weakness include:

 falling overall demand for goods and services, leading to reduced profitability;

 reduced credit availability;

 higher borrowing costs;

 increased interest rates;

 reduced liquidity;

 volatility in credit, equity and foreign exchange markets; and

 bankruptcies.

 These developments could
lead to inflation, higher interest rates, and uncertainty about business continuity, which may adversely affect the business of our potential
target businesses and create difficulties in obtaining debt or equity financing for our initial business combination, as well as leading
to an increase in the number of public stockholders exercising redemption rights in connection therewith.

 As the number of special purpose acquisition
companies evaluating targets has experienced a resurgence, attractive targets may become scarcer and there may be more competition for
attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a
target or to consummate an initial business combination.

 After a slow down in recent
years, over the past year there has been a resurgence in the number of special purpose acquisition companies that have been formed and/or
announced business combinations. As a result, many potential targets for special purpose acquisition companies have already entered into
an initial business combination, and there are still many special purpose acquisition companies preparing for an initial public offering,
as well as many such companies currently in registration. As a result, at times, fewer attractive targets may be available to consummate
an initial business combination.

 In addition, because there
are more special purpose acquisition companies seeking to enter into an initial business combination with available targets, the competition
for available targets with attractive fundamentals or business models may increase, which could cause targets companies to demand improved
financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry sector downturns, geopolitical
tensions, or increases in the cost of additional capital needed to close business combinations or operate targets post-business combination.
This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and consummate an initial business combination,
and may result in our inability to consummate an initial business combination on terms favorable to our investors altogether.

 We may not be able to consummate an
initial business combination by November 15, 2025, in which case we would cease all operations except for the purpose of winding up and
we would redeem our public shares and liquidate.

 We may not be able to find
a suitable partner business and consummate an initial business combination by November 15, 2025. Our ability to complete our initial business
combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and the other risks described
herein. If we have not consummated an initial business combination within such applicable time period, we will: (i) cease all operations
except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the
public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of
interest to pay dissolution expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish
public shareholders' rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board, liquidate
and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law. Our third amended and restated memorandum and articles of association provides that, if
we wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing procedures
with respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter,
subject to applicable Cayman Islands law. In either such case, our public shareholders may receive only $11.90 per public share, or less
than $11.90 per public share, on the redemption of their shares, and our warrants will expire worthless. See "— If third parties
bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders
may be less than $11.90 per public share" and other risk factors herein.

 If we seek shareholder approval of
our initial business combination, Fulton AC and our directors, executive officers, advisors and their affiliates may elect to purchase
public shares or warrants, which may influence a vote on a proposed business combination and reduce the public "float" of
our Class A ordinary shares or public warrants.

 If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, Fulton AC and our directors, executive officers, advisors or their affiliates may purchase public shares or warrants
in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination,
although they are under no obligation to do so. However, other than as expressly stated herein, they have no current commitments, plans
or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. None of the funds
in the trust account will be used to purchase public shares or warrants in such transactions.

 In the event that Fulton
AC or our directors, executive officers, advisors or their affiliates purchase shares in privately negotiated transactions from public
shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their
prior elections to redeem their shares. The purpose of any such transaction could be to (1) vote in favor of the business combination
and thereby increase the likelihood of obtaining shareholder approval of the business combination, (2) reduce the number of public
warrants outstanding or vote such warrants on any matters submitted to the warrant holders for approval in connection with our initial
business combination or (3) satisfy a closing condition in an agreement with a partner that requires us to have a minimum net worth
or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise
not be met. Any such purchases of our securities may result in the completion of our initial business combination that may not otherwise
have been possible. In addition, if such purchases are made, the public "float" of our Class A ordinary shares or public
warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain
or obtain the quotation, listing or trading of our securities on a national securities exchange.

 Any such purchases will be
reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting
requirements. See "Proposed Business — Permitted Purchases and Other Transactions with Respect to Our Securities"
for a description of how Fulton AC and our directors, executive officers, advisors or their affiliates will select which shareholders
to purchase securities from in any private transaction.

 Changes in the market for directors
and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business

 In recent months, the market
for directors and officers liability insurance for special purpose acquisition companies has changed in ways adverse to us and our management
team. Fewer insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies
have generally increased and the terms of such policies have generally become less favorable. These trends may continue into the future.
The increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive
for us to negotiate an initial business combination. In order to obtain directors and officers liability insurance or modify its coverage
as a result of becoming a public company, the post-business combination entity might need to incur greater expense, accept less favorable
terms or both. However, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the
post-business combination's ability to attract and retain qualified officers and directors.

 In addition, even after we
were to complete an initial business combination, our directors and officers could still be subject to potential liability from claims
arising from conduct alleged to have occurred prior to the initial business combination. As a result, in order to protect our directors
and officers, the post-business combination entity may need to purchase additional insurance with respect to any such claims ("run-off
insurance"). The need for run-off insurance would be an added expense for the post-business combination entity, and could interfere
with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.

 If a shareholder fails to receive
notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures
for tendering its shares, such shares may not be redeemed.

 We will comply with the proxy
rules or tender offer rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our
compliance with these rules, if a shareholder fails to receive our proxy solicitation or tender offer materials, as applicable, such shareholder
may not become aware of the opportunity to redeem its shares. In addition, the proxy solicitation or tender offer materials, as applicable,
that we will furnish to holders of our public shares in connection with our initial business combination will describe the various procedures
that must be complied with in order to validly redeem or tender public shares. In the event that a shareholder fails to comply with these
procedures, its shares may not be redeemed. See "Proposed Business — Effecting Our Initial Business Combination — Tendering
Share Certificates in Connection with a Tender Offer or Redemption Rights."

 You will not have any rights or interests
in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced
to sell your public shares or warrants, potentially at a loss.

 Our public shareholders will
be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination,
and then only in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations
described herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our third
amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders
of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem
100% of our public shares if we do not complete our initial business combination by November 15, 2025 or (B) with respect to any other
provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity, and (iii) the
redemption of our public shares if we have not consummated an initial business by November 15, 2025, subject to applicable law and as
further described herein. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described
in clause (ii) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial
business combination or liquidation if we have not consummated an initial business combination by November 15, 2025, with respect to such
Class A ordinary shares so redeemed. In no other circumstances will a shareholder have any right or interest of any kind to or in the
trust account. Holders of warrants will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly,
to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.

 If we instruct the trustee
to liquidate the securities held in the trust account and instead to hold the funds in the trust account in cash in order to seek to mitigate
the risk that we could be deemed to be an investment company for purposes of the Investment Company Act, we would likely receive minimal
interest, if any, on the funds held in the trust account, which would reduce the dollar amount the public shareholders would receive upon
any redemption or liquidation of the Company.

 The funds in the trust account
have, since the IPO, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds
investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act.

 The longer that the funds
in the trust account are held in short-term U.S. government treasury obligations or in money market funds invested exclusively in such
securities, the greater the risk that we may be considered an unregistered investment company. To mitigate the risk of us being deemed
to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and
thus subject to regulation under the Investment Company Act, we may, at any time, instruct the trustee with respect to the trust account
to liquidate the U.S. government treasury obligations or money market funds held in the trust account and thereafter to hold all funds
in the trust account in cash until the earlier of consummation of an initial business combination or liquidation of the Company. Following
such liquidation of the securities held in the trust account, we would likely receive minimal interest, if any, on the funds held in the
trust account. However, interest previously earned on the funds held in the trust account still may be released to us to pay our taxes,
if any, and certain other expenses as permitted. As a result, any decision to liquidate the securities held in the trust account and thereafter
to hold all funds in the trust account in cash would reduce the dollar amount the public shareholders would receive upon any redemption
or liquidation of the Company. As of the date of this proxy statement, we have not yet made any such determination to liquidate the securities
held in the trust account.

 If we liquidate the securities held
in the trust account and instead to hold the funds in the trust account in cash, the cash balances of the trust account's bank accounts
may exceed the FDIC insurance limitations.

 If we liquidate the securities
held in the trust account, the cash balances of one or more of the trust account's bank accounts may exceed of the Federal Deposit
Insurance Corporation insurance limit of $250,000. In the event of a failure at a commercial bank where the trust account maintains such
cash, the trust account may incur a loss to the extent such loss exceeds the insurance limitation, which would reduce the dollar amount
the public shareholders would receive upon any redemption or liquidation of the Company.

 The Company's securities have been
delisted from trading on Nasdaq and currently trade on the OTC Markets, which may adversely affect the flexibility of investors'
to resell their securities in the secondary market.

 As previously disclosed,
on November 12, 2024, the Company received a letter from the Listing Qualifications Department of Nasdaq stating that, pursuant to Nasdaq
Listing Rule IM-5101-2 ("Rule IM-5101-2"), the staff of Nasdaq ("Staff") had determined that (i) the Company's
securities would be delisted from Nasdaq, (ii) trading of the Company's Class A common stock and units would be suspended at the
opening of business on November 19, 2024 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission, which will
remove the Company's securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company
must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement.
Since the Company failed to complete its initial business combination by November 4, 2024, the Staff concluded that the Company did not
comply with Rule IM-5101-2 and that the Company's securities were subject to delisting. The Company's securities were subsequently
delisted from Nasdaq.

 Following the suspension
of trading on Nasdaq, the Company's Class A ordinary shares began trading on OTCQB under the symbol "CBRRF" on The Company's
warrants and units began trading on the Expert Market operated by OTC under the symbols "CBRGF" and "CBGGF," respectively.

 The OTC Expert Market and
OTCQB are significantly more limited markets than Nasdaq, and quotation on the OTC Expert Market or OTCQB will likely result in a less
liquid market for existing and potential holders of the Company's Class A ordinary shares to trade such securities and could further
depress the trading price of the Class A ordinary shares. The Company can provide no assurance that its securities will continue to trade
on this market, whether broker-dealers will continue to provide public quotes of its securities on this market, or whether the trading
volume of its Class A ordinary shares will be sufficient to provide for an efficient trading market for existing and potential holders
of its Class A ordinary shares.

 Trading on the OTC Expert
Market or OTCQB could also harm the Company's ability to raise capital through alternative financing sources on terms acceptable
to us, or at all, and may result in the loss of confidence in the Company's financial stability by suppliers, customers and employees.
Investors would likely find it more difficult to dispose of, or to obtain accurate market quotations for, the Class A ordinary shares,
as the liquidity that Nasdaq provides would no longer be available to investors.

 You will not be entitled to protections
normally afforded to investors of many other blank check companies.

 Since the net proceeds of
the Initial Public Offering, the sale of the private placement warrants and the CB Co-Investment loan are intended to be used to complete
an initial business combination with a partner business that has not been selected, we may be deemed to be a "blank check"
company under the United States securities laws. However, we are exempt from rules promulgated by the SEC to protect investors in blank
check companies, such as Rule 419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other
things, this means our units will be immediately tradable and we will have a longer period of time to complete our initial business combination
than do companies subject to Rule 419. Moreover, if the Initial Public Offering were subject to Rule 419, that rule would prohibit the
release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were released
to us in connection with our completion of an initial business combination.

 If we seek shareholder approval of
our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a "group"
of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares
in excess of 15% of our Class A ordinary shares.

 If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, our third amended and restated memorandum and articles of association provides that a public shareholder, together
with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a "group"
(as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an
aggregate of 15% of the shares sold in the Initial Public Offering, which we refer to as the "Excess Shares," without our
prior consent. However, we would not be restricting our shareholders' ability to vote all of their shares (including Excess Shares)
for or against our initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability
to complete our initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in
open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete
our initial business combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose
of such shares, would be required to sell your shares in open market transactions, potentially at a loss.

 Because of our limited resources and the increased competition for
business combination opportunities, it may be more difficult for us to complete our initial business combination. If we do not complete
our initial business combination within the required time period, our public shareholders may, as of June 16, 2025, receive only approximately
$11.88 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.

 We expect to encounter increased competition from other entities having
a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check
companies and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals
and entities are well-established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of
companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and other
resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with those
of many of these competitors. While we believe there are numerous partner businesses we could potentially acquire with the net proceeds
of the Initial Public Offering and the sale of the private placement warrants and the proceeds from the CB Co-Investment loan, our ability
to compete with respect to the acquisition of certain partner businesses that are sizable will be limited by our available financial resources.
This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain partner businesses. Furthermore,
we are obligated to offer holders of our public shares the right to redeem their shares for cash at the time of our initial business combination
in conjunction with a shareholder vote or via a tender offer. Partner companies will be aware that this may reduce the resources available
to us for our initial business combination. Any of these obligations may place us at a competitive disadvantage in successfully negotiating
a business combination. If we have not consummated our initial business combination within the required time period, our public shareholders
may receive only approximately $11.88 per public share, or less in certain circumstances, on the liquidation of our trust account and
our warrants will expire worthless. See "— If third parties bring claims against us, the proceeds held in the trust account
could be reduced and the per-share redemption amount received by shareholders may be less than $11.88 per public share" and other
risk factors herein.

 If the funds not being held in the
trust account are insufficient to allow us to operate until November 15, 2025, it could limit the amount available to fund our search
for a partner business or businesses and complete our initial business combination, and we will depend on loans from Fulton AC to fund
our search and to complete our initial business combination.

 Only up to $1,500,000 from
the Fulton AC loan is available to us outside the trust account to fund our working capital requirements. We believe that these funds
will be sufficient to allow us to operate for at least until November 15, 2025; however, our estimate may not be accurate. If we are required
to seek additional capital, we would need to borrow funds from Fulton AC, members of our team or any of their affiliates or other third
parties to operate or may be forced to liquidate. Fulton AC, our directors and officers or any of their affiliates are under no obligation
to advance funds to us in such circumstances. Of the funds available to us, we expect to use a portion of the funds available to us to
pay fees to consultants to assist us with our search for a partner business. We could also use a portion of the funds as a down payment
or to fund a "no-shop" provision (a provision in letters of intent designed to keep partner businesses from "shopping"
around for transactions with other companies or investors on terms more favorable to such partner businesses) with respect to a particular
proposed business combination, although we do not have any current intention to do so. If we entered into a letter of intent where we
paid for the right to receive exclusivity from a partner business and were subsequently required to forfeit such funds (whether as a result
of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a
partner business.

 Any advances of funds to us by Fulton AC, our directors or officers
or their affiliates, may be repaid only from funds held outside the trust account or from funds released to us upon completion of our
initial business combination. The Fulton AC loan of $1,500,000 may be convertible into warrants of the post-business combination entity
at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants. Prior
to the completion of our initial business combination, we do not expect to seek loans from parties other than Fulton AC, or our officers
or directors or any of their affiliates as we do not believe third parties will be willing to loan such funds and provide a waiver against
any and all rights to seek access to funds in our trust account. If we do not complete our initial business combination within the required
time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account.
Consequently, our public shareholders may, as of June 16, 2025 only receive an estimated $11.88 per public share, or possibly less, on
our redemption of our public shares, and our warrants will expire worthless. See "— If third parties bring claims against
us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than
$11.88 per public share" and other risk factors herein.

 Subsequent to our completion of our
initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that
could have a significant negative effect on our financial condition, results of operations and the share price of our securities, which
could cause you to lose some or all of your investment.

 Even if we conduct due
diligence on a partner business with which we combine, this diligence may not surface all material issues with a particular partner
business. In addition, factors outside of the partner business and outside of our control may later arise. As a result of these
factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges
that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may
arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these
charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature
could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to
violate net worth or other covenants to which we may be subject as a result of assuming pre- existing debt held by a partner
business or by virtue of our obtaining post-combination debt financing.

 Accordingly, any holders
who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such
holders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due
to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully
bring a private claim under securities laws that the proxy solicitation or tender offer materials, as applicable, relating to the business
combination contained an actionable material misstatement or material omission.

 If third parties bring claims against
us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than
$11.88 per public share.

 Our placing of funds in the
trust account may not protect those funds from third party claims against us. Although we will seek to have all vendors, service providers
(excluding our independent registered public accounting firm), prospective partner businesses and other entities with which we do business
execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the
benefit of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements, they may not
be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary
responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain
advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute
an agreement waiving such claims to the monies held in the trust account, Fulton AC will perform an analysis of the alternatives available
to it and will only enter into an agreement with a third party that has not executed a waiver if our team believes that such third party's
engagement would be significantly more beneficial to us than any alternative.

 Examples of possible instances
where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular
expertise or skills are believed by our team to be significantly superior to those of other consultants that would agree to execute a
waiver or in cases where our team is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee
that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts
or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we
have not consummated an initial business combination by November 15, 2025, or upon the exercise of a redemption right in connection with
our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought
against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by public shareholders could
be less than the $11.88 per public share held in the trust account, due to claims of such creditors. Pursuant to the Amended Letter Agreement
(as defined below) which is filed as an exhibit to this Annual Report on Form 10-K, Fulton AC has agreed that it will be liable to us
if and to the extent any claims by a third party (excluding our independent registered public accounting firm) for services rendered or
products sold to us, or a prospective partner business with which we have discussed entering into a transaction agreement, reduce the
amounts in the trust account to below the lesser of (i) $11.88 per public share and (ii) the actual amount per share held in the trust
account as of the date of the liquidation of the trust account if less than $11.88 per public share due to reductions in the value of
the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided that such liability will
not apply to any claims by a third party or prospective partner business who executed a waiver of any and all rights to seek access to
the trust account nor will it apply to any claims under our indemnity of the underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, Fulton AC will not be responsible to the extent of any liability for such third party claims.

 However, we have not asked
Fulton AC to reserve for such indemnification obligations, nor have we independently verified whether Fulton AC has sufficient funds to
satisfy its indemnity obligations and we believe that Fulton AC's only assets are securities of our company. Fulton AC may not be
able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without
limitation, claims by vendors and prospective partner businesses.

 Our directors may decide not to enforce
the indemnification obligations of Fulton AC, resulting in a reduction in the amount of funds in the trust account available for distribution
to our public shareholders.

 In the event that the proceeds
in the trust account are reduced below the lesser of (i) $11.88 per public share and (ii) the actual amount per share held in the trust
account as of the date of the liquidation of the trust account if less than $11.88 per public share due to reductions in the value of
the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, and Fulton AC asserts that it is
unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent
directors would determine whether to take legal action against Fulton AC to enforce its indemnification obligations. While we currently
expect that our independent directors would take legal action on our behalf against Fulton AC to enforce its indemnification obligations
to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary duties may choose
not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount
of funds in the trust account available for distribution to our public shareholders may be reduced below $11.88 per public share.

 We may issue our shares to investors
in connection with our initial business combination at a price which is less than the prevailing market price of our shares at that time.

 In connection with our initial
business combination, we may issue shares to investors in private placement transactions (so-called PIPE transactions) at a price of $10.00
per share. A purpose of such issuances may be to enable us to provide sufficient liquidity to the post-business combination entity. The
price of the shares we issue may therefore be less, and potentially significantly less, than the market price for our shares at such time.

 If, after we distribute the proceeds
in the trust account to our public shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency
petition is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such proceeds, and the members
of our Board may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our Board and us
to claims of punitive damages.

 If, after we distribute the
proceeds in the trust account to our public shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or
insolvency petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable
debtor/creditor and/or bankruptcy laws as either a "preferential transfer" or a "fraudulent conveyance." As a
result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders.

 In addition, our Board may
be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims
of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors.

 If, before distributing the proceeds
in the trust account to our public shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency
petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our
shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

 If, before distributing the
proceeds in the trust account to our public shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or
insolvency petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy
law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders.
To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise be received by our shareholders
in connection with our liquidation may be reduced.

 If we are deemed to be an investment
company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be
restricted, which may make it difficult for us to complete our initial business combination.

 There is currently uncertainty
concerning the applicability of the Investment Company Act to a SPAC, including a company like ours. As indicated above, our IPO Registration
Statement became effective on November 9, 2021 and have operated as a blank check company searching for a partner business with which
to consummate a business combination since such time. We have not completed an initial business combination, and it is possible that a
claim could be made that we have been operating as an unregistered investment company. This risk may be increased if we continue to hold
the funds in the trust account in short-term U.S. government treasury obligations or in money market funds invested exclusively in such
securities, rather than instructing the trustee to liquidate the securities in the trust account and hold the funds in the trust account
in cash.

 If we are deemed to be an
investment company under the Investment Company Act, our activities would be severely restricted. In addition, we would be subject to
burdensome compliance requirements. We do not believe that our principal activities will subject us to regulation as an investment company
under the Investment Company Act. However, if we are deemed to be an investment company and subject to compliance with and regulation
under the Investment Company Act, we would be subject to additional regulatory burdens and expenses for which we have not allotted funds.
As a result, unless we are able to modify our activities so that we would not be deemed an investment company, we would expect to abandon
our efforts to complete an initial business combination and instead to liquidate. If we are required to liquidate, our shareholders would
not be able to realize the benefits of owning stock in a successor operating business, including the potential appreciation in the value
of our stock and warrants following such a transaction, and our warrants would expire worthless.

 Changes in laws or regulations, or
a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete
our initial business combination, and results of operations.

 We are subject to laws and
regulations enacted by national, regional and local governments. In particular, we will be required to comply with certain SEC and other
legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those
laws and regulations and their interpretation and application may also change from time to time and those changes could have a material
adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations,
as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our
initial business combination, and results of operations.

 If we do not consummate an initial
business combination by November 15, 2025, our public shareholders may be forced to wait beyond November 15, 2025 before redemption from
our trust account.

 If we do not consummate an
initial business combination by November 15, 2025, the proceeds then on deposit in the trust account, including interest earned on the
funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to
pay dissolution expenses), will be used to fund the redemption of our public shares, as further described herein. Any redemption of public
shareholders from the trust account will be effected automatically by function of our third amended and restated memorandum and articles
of association prior to any voluntary winding up. If we are required to wind up, liquidate the trust account and distribute such amount
therein, pro rata, to our public shareholders, as part of any liquidation process, such winding up, liquidation and distribution must
comply with the applicable provisions of the Companies Act. In that case, investors may be forced to wait beyond November 15, 2025 before
the redemption proceeds of our trust account become available to them, and they receive the return of their pro rata portion of the proceeds
from our trust account. We have no obligation to return funds to investors prior to the date of our redemption or liquidation unless,
prior thereto, we consummate our initial business combination or amend certain provisions of our third amended and restated memorandum
and articles of association, and only then in cases where investors have sought to redeem their Class A ordinary shares. Only upon our
redemption or any liquidation will public shareholders be entitled to distributions if we do not complete our initial business combination
and do not amend certain provisions of our third amended and restated memorandum and articles of association. Our third amended and restated
memorandum and articles of association provides that, if we wind up for any other reason prior to the consummation of our initial business
combination, we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible
but not more than ten business days thereafter, subject to applicable Cayman Islands law.

 Our shareholders may be held liable
for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.

 If we are forced to enter
into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment if it was proved that
immediately following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course
of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our directors
may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby exposing themselves
and our company to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. Claims may
be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted any distribution
to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business
would be guilty of an offence and may be liable for a fine of $18,292.68 and imprisonment for five years in the Cayman Islands.

 We may not hold an annual general
meeting until after the consummation of our initial business combination.

 In accordance with OTCQB
corporate governance requirements and our third amended and restated memorandum and articles of association, we are not required to hold
an annual general meeting until no later than one year after our first fiscal year end following our listing on OTCQB. As an exempted
company, there is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors.
Until we hold an annual general meeting, public shareholders may not be afforded the opportunity to appoint directors and to discuss company
affairs with our team. Our Board is divided into three classes with only one class of directors being appointed in each year and each
class (except for those directors appointed prior to our first annual general meeting) serving a three-year term.

 Holders of Class A ordinary shares
will not be entitled to vote on any appointment of directors we hold prior to the completion of our initial business combination.

 Prior to the completion of
our initial business combination, only holders of our Class B Shares will have the right to vote on the appointment of directors. Holders
of our public shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion
of an initial business combination, holders of a majority of our Class B Shares may remove a member of the Board for any reason.

 Fulton AC, as the majority
holder of our Class B Shares, controls the ability to elect and remove members of our Board. Accordingly, you may not have any say in
the management of our company prior to the consummation of an initial business combination.

 We are not registering the Class A
ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration
may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants
and causing such warrants to expire worthless.

 We are not registering the
Class A ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. However,
under the terms of the warrant agreement, we have agreed to use our commercially reasonable efforts to file a registration statement under
the Securities Act covering such shares and to maintain the effectiveness of such registration statement and a current prospectus relating
to the Class A ordinary shares issuable upon exercise of the warrants until the expiration or redemption of the warrants in accordance
with the provisions of the warrant agreement. We may not able to do so if, for example, any facts or events arise which represent a fundamental
change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by
reference therein are not current, complete or correct or the SEC issues a stop order. If the shares issuable upon exercise of the warrants
are not registered under the Securities Act, we will be required to permit holders to exercise their warrants on a cashless basis. However,
no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to
exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of
the state of the exercising holder, unless an exemption is available. Notwithstanding the above, if our Class A shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a "covered security"
under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to
do so on a "cashless basis" in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will
not be required to file or maintain in effect a registration statement, but we will use our reasonable best efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available. In no event will we be required to net cash settle
any warrant, or issue securities or other compensation in exchange for the warrants in the event that we are unable to register or qualify
the shares underlying the warrants under the Securities Act or applicable state securities laws. If the issuance of the shares upon exercise
of the warrants is not so registered or qualified or exempt from registration or qualification, the holder of such warrant will not be
entitled to exercise such warrant and such warrant may have no value and expire worthless. In such event, holders who acquired their warrants
as part of a purchase of units will have paid the full unit purchase price solely for the Class A ordinary shares included in the units.
There may be a circumstance where an exemption from registration exists for holders of our private placement warrants to exercise their
warrants while a corresponding exemption does not exist for holders of the warrants included as part of units sold in the Initial Public
Offering. In such an instance, Fulton AC, CBG, CB Co-Investment, their affiliates and their respective transferees (which may include
our team) would be able to exercise their warrants and sell the ordinary shares underlying their warrants while holders of our public
warrants would not be able to exercise their warrants and sell the underlying ordinary shares. If and when the warrants become redeemable
by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all
applicable state securities laws.

 Our ability to require holders of
our warrants to exercise such warrants on a cashless basis after we call the warrants for redemption or if there is no effective registration
statement covering the Class A ordinary shares issuable upon exercise of these warrants will cause holders to receive fewer Class A
ordinary shares upon their exercise of the warrants than they would have received had they been able to pay the exercise price of their
warrants in cash.

 If we call the warrants for
redemption for cash, we will have the option, in our sole discretion, to require all holders that wish to exercise warrants to do so on
a cashless basis. If we choose to require holders to exercise their warrants on a cashless basis or if holders elect to do so when there
is no effective registration statement, the number of Class A ordinary shares received by a holder upon exercise will be fewer than
it would have been had such holder exercised his or her warrant for cash.

 For example, if the holder
is exercising 875 public warrants at $11.50 per share through a cashless exercise when the Class A ordinary shares have a fair market
value of $17.50 per share, then upon the cashless exercise, the holder will receive 300 Class A ordinary shares. The holder would
have received 875 Class A ordinary shares if the exercise price was paid in cash. This will have the effect of reducing the potential
"upside" of the holder's investment in our company because the warrant holder will hold a smaller number of Class A
ordinary shares upon a cashless exercise of the warrants they hold.

 The warrants may become exercisable
and redeemable for a security other than the Class A ordinary shares, and you will not have any information regarding such other
security at this time.

 In certain situations, including
if we are not the surviving entity in our initial business combination, the warrants may become exercisable for a security other than
the Class A ordinary shares. As a result, if the surviving company redeems your warrants for securities pursuant to the warrant agreement,
you may receive a security in a company of which you do not have information at this time. Pursuant to the warrant agreement, the surviving
company will be required to use commercially reasonable efforts to register the issuance of the security underlying the warrants within
twenty business days of the closing of an initial business combination.

 The grant of registration rights to
CBG, CB Co-Investment and our then directors and officers may make it more difficult to complete our initial business combination, and
the future exercise of such rights may adversely affect the market price of our Class A ordinary shares.

 Pursuant to an agreement
to be entered into concurrently with the issuance and sale of the securities in the Initial Public Offering, CBG, CB Co-Investment and
our then directors and officers, and their permitted transferees can demand that we register the Class A ordinary shares into which Class
B Shares are convertible, the private placement warrants and the Class A ordinary shares issuable upon exercise of the private placement
warrants and the warrants that may be issued upon conversion of the CB Co-Investment loan, the extension loans and working capital loans.
The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect
on the market price of our Class A ordinary shares. In addition, the existence of the registration rights may make our initial business
combination more costly or difficult to conclude. This is because the shareholders of the partner business may increase the equity stake
they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our securities
that is expected when the securities owned by CBG, CB Co-Investment and our then directors and officers or their permitted transferees
are registered for resale.

 Because we are neither limited to
evaluating a partner business in a particular industry sector nor have we selected any specific partner businesses with which to pursue
our initial business combination, you will be unable to ascertain the merits or risks of any particular partner business's operations.

 We may pursue business combination
opportunities in any sector, except that we will not, under our third amended and restated memorandum and articles of association, be
permitted to effectuate our initial business combination solely with another blank check company or similar company with nominal operations.
Because we have not yet selected or approached any specific partner business with respect to a business combination, there is no basis
to evaluate the possible merits or risks of any particular partner business's operations, results of operations, cash flows, liquidity,
financial condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks inherent
in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking
an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable
or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular partner
business, we may not properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due
diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances
that those risks will adversely impact a partner business. An investment in our units may not ultimately prove to be more favorable
to investors than a direct investment, if such opportunity were available, in a business combination partner. Accordingly, any holders
who choose to retain their securities following our initial business combination could suffer a reduction in the value of their securities.
Such holders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was
due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully
bring a private claim under securities laws that the proxy solicitation or tender offer materials, as applicable, relating to the business
combination contained an actionable material misstatement or material omission.

 We may seek acquisition opportunities
in industries or sectors which may or may not be outside of our team's area of expertise.

 We will consider a business
combination outside of our team's area of expertise if a business combination partner is presented to us and we determine that such
candidate offers an attractive acquisition opportunity for our company. Although our team will endeavor to evaluate the risks inherent
in any particular business combination partner, we may not adequately ascertain or assess all of the significant risk factors. We also
cannot assure you that an investment in our units will not ultimately prove to be less favorable to investors in the Initial Public Offering
than a direct investment, if an opportunity were available, in a business combination partner. In the event we elect to pursue an acquisition
outside of the areas of our team's expertise, our team's expertise may not be directly applicable to its evaluation or operation,
and the information contained in this Annual Report on Form 10-K regarding the areas of our team's expertise would not be relevant
to an understanding of the business that we elect to acquire. As a result, our team may not be able to adequately ascertain or assess
all of the significant risk factors. Accordingly, any holders who choose to retain their securities following our initial business combination
could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value unless
they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary
duty owed to them, or if they are able to successfully bring a private claim under securities laws that the proxy solicitation or tender
offer materials, as applicable, relating to the business combination contained an actionable material misstatement or material omission.

 Although we have identified general
criteria that we believe are important in evaluating prospective partner businesses, we may enter into our initial business combination
with a partner that does not meet such criteria, and as a result, the partner business with which we enter into our initial business combination
may not have attributes entirely consistent with our general criteria.

 Although we have identified
general criteria for evaluating prospective partner businesses, it is possible that a partner business with which we enter into our initial
business combination will not have all of these positive attributes. If we complete our initial business combination with a partner that
does not meet some or all of these criteria, such combination may not be as successful as a combination with a business that does meet
all of our general criteria. In addition, if we announce a prospective business combination with a partner that does not meet our general
criteria, a greater number of shareholders may exercise their redemption rights, which may make it difficult for us to meet any closing
condition with a partner business that requires us to have a minimum net worth or a certain amount of cash. In addition, if shareholder
approval of the transaction is required by applicable law or stock exchange rule, or we decide to obtain shareholder approval for business
or other reasons, it may be more difficult for us to attain shareholder approval of our initial business combination if the partner business
does not meet our general criteria. If we do not complete our initial business combination within the required time period, our public
shareholders may receive only approximately $11.62 per public share, or less in certain circumstances, on the liquidation of our trust
account and our warrants will expire worthless.

 We are not required to obtain an opinion
from an independent accounting or investment banking firm, and consequently, you may have no assurance from an independent source that
the price we are paying for the business is fair to our shareholders from a financial point of view.

 Unless we complete our initial
business combination with an affiliated entity, we are not required to obtain an opinion from an independent accounting firm or independent
investment banking firm that the price we are paying is fair to our shareholders from a financial point of view. If no opinion is obtained,
our shareholders will be relying on the judgment of our Board, who will determine fair market value based on standards generally accepted
by the financial community. Such standards used will be disclosed in our proxy solicitation or tender offer materials, as applicable,
related to our initial business combination.

 We may issue additional Class A
ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion
of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the Class B Shares at a ratio
greater than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained in our third
amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders and likely
present other risks.

 Our third amended and restated memorandum and articles of association
authorizes the issuance of up to 479,000,000 Class A ordinary shares, par value $0.0001 per share, 20,000,000 Class B ordinary shares,
par value $0.0001 per share, and 1,000,000 preference shares, par value $0.0001 per share. As of the close of business on June 16, 2025,
there were 2,985,029 and 3,191,000 authorized but unissued Class A ordinary shares and Class B ordinary shares, respectively, available
for issuance which amount includes shares reserved for issuance upon exercise of outstanding warrants or shares issuable upon conversion
of the Class B ordinary shares, if any. The Class B ordinary shares are automatically convertible into Class A ordinary shares at the
time of our initial business combination as described herein and in our third amended and restated memorandum and articles of association.
There are no preference shares issued and outstanding. These amounts exclude any private placement warrants that may be issued upon conversion
of the CB Co-Investment loan and extension loans.

 We may issue a substantial
number of additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive
plan after completion of our initial business combination. We may also issue Class A ordinary shares to redeem the warrants as described
in the section entitled "Warrants — Public Shareholders' Warrants — Redemption of warrants
for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00" in Exhibit 4.5 of this Annual Report
on Form 10-K or upon conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our initial business
combination as a result of the anti-dilution provisions as set forth herein. However, our third amended and restated memorandum and articles
of association provides, among other things, that prior to the completion of our initial business combination, we may not issue additional
shares that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination
or on any other proposal presented to shareholders prior to or in connection with the completion of an initial business combination. These
provisions of our third amended and restated memorandum and articles of association, like all provisions of our third amended and restated
memorandum and articles of association, may be amended with a shareholder vote. The issuance of additional ordinary or preference shares:

 may significantly dilute the equity interest of investors in the Initial Public Offering, which dilution
would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares
on a greater than one-to-one basis upon conversion of the Class B ordinary shares;

 may subordinate the rights of holders of Class A ordinary shares if preference shares are issued
with rights senior to those afforded our Class A ordinary shares;

 could cause a change in control if a substantial number of our Class A ordinary shares are issued,
which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation
or removal of our present officers and directors;

 may have the effect of delaying or preventing a change of control of us by diluting the share ownership
or voting rights of a person seeking to obtain control of us;

 may adversely affect prevailing market prices for our units, Class A ordinary shares and/or
warrants; and

 may not result in adjustment to the exercise price of our warrants.

 Fulton AC, CBG, CB-Co Investment and
our current and former directors and officers may receive additional Class A ordinary shares if we issue shares to consummate an initial
business combination.

 The outstanding Class B Shares
will automatically convert into Class A ordinary shares on the first business day following the consummation of our initial business combination
at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class B Shares will equal, in the aggregate,
on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial
Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion
or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the
consummation of the initial business combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or
convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial business combination and
any private placement warrants issued to CBG or CB Co-Investment, members of our team or any of their affiliates upon conversion of the
CB Co-Investment loan, the extension loans and working capital loans. In no event will the Class B ordinary shares convert into Class
A ordinary shares at a rate of less than one to one. As of February 7, 2024, CBG and CB-Co Investment had converted all of their outstanding
Class B ordinary shares into Class A ordinary shares on a one-for-one basis. The Class A ordinary shares issued upon such conversion are
not entitled to participate in the distribution of funds held in the trust account.

 Resources could be wasted in researching
acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another
business. If we do not complete our initial business combination within the required time period, our public shareholders may receive
only approximately $11.88 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants
will expire worthless.

 We anticipate that the investigation
of each specific partner business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments
will require substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to
complete a specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be
recoverable. Furthermore, if we reach an agreement relating to a specific partner business, we may fail to complete our initial business
combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs
incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we do not
complete our initial business combination within the required time period, our public shareholders may receive only approximately $11.88
per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.

 We may reincorporate in another
jurisdiction in connection with our initial business combination and such reincorporation may result in taxes imposed on
shareholders.

 We may, in connection with
our initial business combination and subject to requisite shareholder approval under the Companies Act, reincorporate in the jurisdiction
in which the partner company or business is located or in another jurisdiction. The transaction may require a shareholder or warrant holder
to recognize taxable income in the jurisdiction in which the shareholder or warrant holder is a tax resident or in which its members are
resident if it is a tax transparent entity. We do not intend to make any cash distributions to shareholders or warrant holders to pay
such taxes. Shareholders or warrant holders may be subject to withholding taxes or other taxes with respect to their ownership of us after
the reincorporation. In addition, regardless of whether we reincorporate in another jurisdiction, we could be treated as tax resident
in the jurisdiction in which the partner company or business is located, which could result in adverse tax consequences to us (e.g., taxation
on our worldwide income in such jurisdiction) and to our shareholders or warrant holders (e.g., withholding taxes on dividends and taxation
of disposition gains).

 Risks Related to Our Operations

 Our executive officers and directors
will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote
to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.

 Our executive officers and
directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating
their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time
employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several other business
endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific
number of hours per week to our affairs. Our independent directors also serve as officers and Board members for other entities. If our
executive officers' and directors' other business affairs require them to devote substantial amounts of time to such affairs
in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative impact
on our ability to complete our initial business combination. For a complete discussion of our executive officers' and directors'
other business affairs, please see "Item 10. Directors, Executive Officers and Corporate Governance."

 Our officers and directors presently
have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities, which could include other
blank check companies, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity
should be presented.

 Until we consummate our initial
business combination, we intend to engage in the business of identifying and combining with one or more businesses. Certain of our officers
and directors presently have, and any of them in the future may have, additional fiduciary or contractual obligations to other entities,
pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity, subject
to his or her fiduciary duties under Cayman Islands law. Accordingly, they may have conflicts of interest in determining to which entity
a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential partner business
may be presented to another entity prior to its presentation to us, subject to their fiduciary duties under Cayman Islands law.

 In addition, Fulton AC and
our directors and officers expect in the future to become affiliated with other public blank check companies that may have acquisition
objectives that are similar to ours. Accordingly, they may have conflicts of interest in determining to which entity a particular business
opportunity should be presented. These conflicts may not be resolved in our favor and a potential partner business may be presented to
such other blank check companies, prior to its presentation to us, subject to our officers' and directors' fiduciary duties
under Cayman Islands law. Our third amended and restated memorandum and articles of association provides that we renounce our interest
in any business combination opportunity offered to any director or officer unless such opportunity is expressly offered to such person
solely in his or her capacity as a director or officer of the company and it is an opportunity that we are able to complete on a reasonable
basis.

 For a complete discussion
of our executive officers' and directors' business affiliations and the potential conflicts of interest that you should be
aware of, please see "Item 10. Directors, Executive Officers and Corporate Governance."

 Our executive officers, directors,
security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.

 We have not adopted a policy
that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary
or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest.
In fact, we may enter into a business combination with a partner business that is affiliated with Fulton AC or our directors or executive
officers, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their
own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their
interests and ours.

 The personal and financial
interests of our directors and officers may influence their motivation in timely identifying and selecting a partner business and completing
a business combination. Consequently, our directors' and officers' discretion in identifying and selecting a suitable partner
business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination
are appropriate and in our shareholders' best interest. If this were the case, it would be a breach of their fiduciary duties to
us as a matter of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders'
rights. See the section titled "Certain Differences in Corporate Law — Shareholders' Suits" in Exhibit
4.5 of this Annual Report on Form 10-K for further information on the ability to bring such claims. However, we might not ultimately be
successful in any claim we may make against them for such reason.

 Our ability to successfully effect
our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our executive officers
and directors, some of whom may join us following our initial business combination. The loss of our officers and directors could negatively
impact the operations and profitability of our post-combination business.

 Our operations and ability
to successfully effect our initial business combination is dependent upon the efforts of relatively small group of individuals and, in
particular, our executive officers and directors. We believe that our success depends on the continued service of our officers and directors,
at least until we have completed our initial business combination. In addition, our executive officers and directors are not required
to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest in allocating their time among
various business activities, including identifying potential business combinations and monitoring the related due diligence. We do not
have an employment agreement with, or key-man insurance on the life of, any of our directors or executive officers. The unexpected loss
of the services of one or more of our directors or executive officers could have a detrimental effect on us.

 Although some of our officers
and directors may remain with the partner business in senior management or advisory positions following our initial business combination,
it is likely that some or all of the management of the partner business will remain in place. While we intend to closely scrutinize any
individuals we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove
to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause
us to have to expend time and resources helping them become familiar with such requirements.

 Our key personnel may negotiate employment
or consulting agreements with a partner business in connection with a particular business combination, and a particular business combination
may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to receive compensation
following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular
business combination is the most advantageous.

 Our key personnel may be
able to remain with our company after the completion of our initial business combination only if they are able to negotiate employment
or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation
of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities
for services they would render to us after the completion of the business combination. Such negotiations also could make such key personnel's
retention or resignation a condition to any such agreement. The personal and financial interests of such individuals may influence their
motivation in identifying and selecting a partner business.

 We may have a limited ability to assess
the management of a prospective partner business and, as a result, may affect our initial business combination with a partner business
whose management may not have the skills, qualifications or abilities to manage a public company.

 When evaluating the desirability
of effecting our initial business combination with a prospective partner business, our ability to assess the partner business's
management may be limited due to a lack of time, resources or information. Our assessment of the capabilities of the partner business's
management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should
the partner business's management not possess the skills, qualifications or abilities necessary to manage a public company, the
operations and profitability of the post-combination business may be negatively impacted. Accordingly, any holders who choose to retain
their securities following our initial business combination could suffer a reduction in the value of their securities. Such holders are
unlikely to have a remedy for such reduction in value.

 The officers and directors of an acquisition
candidate may resign upon completion of our initial business combination. The loss of a business combination partner's key personnel
could negatively impact the operations and profitability of our post-combination business.

 The role of an acquisition
candidate's key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we
contemplate that certain members of an acquisition candidate's management team will remain associated with the acquisition candidate
following our initial business combination, it is possible that members of the management of an acquisition candidate will not wish to
remain in place.

 We may engage in a business combination
with one or more partner businesses that have relationships with entities that may be affiliated with Fulton AC, CBG, CB Co-Investment
or our team which may raise potential conflicts of interest.

 In light of the involvement
of Fulton AC and our team with other entities, we may decide to acquire one or more businesses affiliated with Fulton AC, CBG, CB Co-Investment
or our team. Our directors also serve as officers and board members for other entities, including, without limitation, those described
herein. Fulton AC and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may
pursue other business or investment ventures during the period in which we are seeking an initial business combination. Such entities
may compete with us for business combination opportunities. Fulton AC and our team are not currently aware of any specific opportunities
for us to complete our initial business combination with any entities with which they are affiliated, and there have been no substantive
discussions concerning a business combination with any such entity or entities.

 Although we will not be specifically
focusing on, or pursuing, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such
affiliated entity met our criteria for a business combination as set forth in "Item 1. Business" and such transaction was
approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion from an independent
investment banking firm or an independent valuation or accounting firm regarding the fairness to our company from a financial point of
view of a business combination with one or more domestic or international businesses affiliated with Fulton AC, CBG, CB Co-Investment
or our team, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous
to our public shareholders as they would be absent any conflicts of interest.

 Since Fulton AC will lose its entire
investment in us if our initial business combination is not completed (other than with respect to public shares that they acquire), a
conflict of interest may arise in determining whether a particular business combination partner is appropriate for our initial business

 On December 29, 2023 Fulton
AC acquired 3,035,000 Class B Shares and private placement warrants to purchase 7,385,000 Class A Shares exercisable 30 days after the
consummation of our initial business combination for a purchase price of $200,000. The Class B Shares are convertible into Class A Shares
at the option of the holder. However, the Class A Shares issued upon such conversion will not participate in the liquidation of the trust
account and may not be redeemed for a share of the trust account. In addition, Fulton AC made the Fulton AC loan of up to $1,500,000 to
the Company which cannot be repaid from the trust account. As of December 31, 2024, there is no outstanding balance on the Fulton AC loan.
The Fulton AC loan is convertible into warrants which are not exercisable until 30 days after the consummation of an initial business
combination. If we do not consummate an initial business by November 15, 2025, the all warrants held or into which the Fulton AC loan
is convertible (and the underlying securities) will expire worthless. In addition, if we do not complete our initial business combination,
we will not repay the Fulton AC loan from the trust account, and we would likely not have other available funds to repay the Fulton AC
loan. The interests of Fulton AC and its equity holders may influence their motivation in identifying and selecting a partner business
combination, completing an initial business combination and influencing the operation of the business following the initial business combination.

 We may issue notes or other debt,
or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition
and thus negatively impact the value of our shareholders' investment in us.

 Although we have no commitments
as of the date of this Annual Report on Form 10-K to issue any notes or other debt, or to otherwise incur debt, we may choose to incur
substantial debt to complete our initial business combination. We and our officers have agreed that we will not incur any indebtedness
unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust
account. As such, no issuance of debt will affect the per share amount available for redemption from the trust account.

 Nevertheless, the incurrence
of debt could have a variety of negative effects, including:

 default and foreclosure on our assets if our operating revenues after an initial business combination
are insufficient to repay our debt obligations;

 acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments
when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation
of that covenant;

 our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;

 our inability to obtain necessary additional financing if the debt contains covenants restricting our
ability to obtain such financing while the debt is outstanding;

 our inability to pay dividends on our Class A ordinary shares;

 using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce
the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other
general corporate purposes;

 limitations on our flexibility in planning for and reacting to changes in our business and in the industry
in which we operate;

 increased vulnerability to adverse changes in general economic, industry and competitive conditions and
adverse changes in government regulation; and

 limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions,
debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less
debt.

 We may only be able to complete one
business combination with the proceeds of the Initial Public Offering, the private placement warrants and the proceeds from the Fulton
AC loan, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This
lack of diversification may negatively impact our operations and profitability.

 We have funds available in
the amount of approximately $5,414,454, as of June 16, 2025, assuming no redemptions that we may use to complete our initial business

 We may effectuate our initial
business combination with a single partner business or multiple partner businesses simultaneously or within a short period of time. However,
we may not be able to effectuate our initial business combination with more than one partner business because of various factors, including
the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that
present operating results and the financial condition of several partner businesses as if they had been operated on a combined basis.
By completing our initial business combination with only a single entity, our lack of diversification may subject us to numerous economic,
competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible spreading
of risks or offsetting of losses, unlike other entities which may have the resources to complete several business combinations in different
industries or different areas of a single industry. Accordingly, the prospects for our success may be:

 solely dependent upon the performance of a single business, property or asset; or

 dependent upon the development or market acceptance of a single or limited number of products, processes
or services.

 This lack of diversification
may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon
the particular industry in which we may operate subsequent to our initial business combination.

 We may attempt to simultaneously complete
business combinations with multiple prospective partners, which may hinder our ability to complete our initial business combination and
give rise to increased costs and risks that could negatively impact our operations and profitability.

 If we determine to
simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that
our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make it more
difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we could
also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence
(if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services
or products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could
negatively impact our profitability and results of operations.

 We may attempt to complete our initial
business combination with a private company about which little information is available, which may result in a business combination with
a company that is not as profitable as we suspected, if at all.

 In pursuing our acquisition
strategy, we may seek to effectuate our initial business combination with a privately held company. Very little public information generally
exists about private companies, and we could be required to make our decision on whether to pursue a potential initial business combination
on the basis of limited information, which may result in a business combination with a company that is not as profitable as we suspected,
if at all.

 Our team may not be able to maintain
control of a partner business after our initial business combination. Upon the loss of control of a partner business, new management may
not possess the skills, qualifications or abilities necessary to profitably operate such business.

 We may structure our initial
business combination so that the post-business combination company in which our public shareholders own shares will own less than 100%
of the equity interests or assets of a partner business, but we will only complete such business combination if the post-business combination
company owns or acquires 50% or more of the outstanding voting securities of the partner or otherwise acquires a controlling interest
in the partner business sufficient for us not to be required to register as an investment company under the Investment Company Act. We
will not consider any transaction that does not meet such criteria. Even if the post-business combination company owns 50% or more of
the voting securities of the partner, our shareholders prior to the completion of our initial business combination may collectively own
a minority interest in the post-business combination company, depending on valuations ascribed to the partner and us in the business combination.
For example, we could pursue a transaction in which we issue a substantial number of new Class A ordinary shares in exchange for
all of the outstanding capital stock, shares or other equity interests of a partner. In this case, we would acquire a 100% interest in
the partner. However, as a result of the issuance of a substantial number of new Class A ordinary shares, our shareholders immediately
prior to such transaction could own less than a majority of our issued and outstanding Class A ordinary shares subsequent to such
transaction. In addition, other minority shareholders may subsequently combine their holdings resulting in a single person or group obtaining
a larger share of the company's shares than we initially acquired. Accordingly, this may make it more likely that our team will
not be able to maintain control of the partner business.

 We may seek business combination opportunities
with a high degree of complexity that require significant operational improvements, which could delay or prevent us from achieving our
desired results.

 We may seek business combination
opportunities with large, highly complex companies that we believe would benefit from operational improvements. While we intend to implement
such improvements, to the extent that our efforts are delayed or we are unable to achieve the desired improvements, the business combination
may not be as successful as we anticipate.

 To the extent we complete
our initial business combination with a large complex business or entity with a complex operating structure, we may also be affected by
numerous risks inherent in the operations of the business with which we combine, which could delay or prevent us from implementing our
strategy. Although our team will endeavor to evaluate the risks inherent in a particular partner business and its operations, we may not
be able to properly ascertain or assess all of the significant risk factors until we complete our business combination. If we are not
able to achieve our desired operational improvements, or the improvements take longer to implement than anticipated, we may not achieve
the gains that we anticipate. Furthermore, some of these risks and complexities may be outside of our control and leave us with no ability
to control or reduce the chances that those risks and complexities will adversely impact a partner business. Such combination may not
be as successful as a combination with a smaller, less complex organization.

 We do not have a specified maximum
redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our initial business combination
with which a substantial majority of our shareholders do not agree.

 Our third amended and
restated memorandum and articles of association do not provide a specified maximum redemption threshold, except that in no event
will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not
then become subject to the SEC's "penny stock" rules). As a result, we may be able to complete our initial
business combination even though a substantial majority of our public shareholders do not agree with the transaction and have
redeemed their shares or, if we seek shareholder approval of our initial business combination and do not conduct redemptions in
connection with our initial business combination pursuant to the tender offer rules, have entered into privately negotiated
agreements to sell their shares to Fulton AC or our officers, directors, advisors or any of their affiliates. In the event the
aggregate cash consideration we would be required to pay for all Class A ordinary shares that are validly submitted for redemption
plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate
amount of cash available to us, we will not complete the business combination or redeem any shares, all Class A ordinary shares
submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business

 In order to effectuate an initial
business combination, blank check companies have, in the recent past, amended various provisions of their charters and other governing
instruments, including their warrant agreements. We may seek to amend our third amended and restated memorandum and articles of association
or governing instruments in a manner that will make it easier for us to complete our initial business combination that our shareholders
may not support.

 In order to effectuate a
business combination, blank check companies have, in the recent past, amended various provisions of their charters and governing instruments,
including their warrant agreements. For example, blank check companies have amended the definition of business combination, increased
redemption thresholds, extended the time to consummate a business combination and, with respect to their warrants, amended their warrant
agreements to require the warrants to be exchanged for cash and/or other securities. Amending our third amended and restated memorandum
and articles of association will require at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning
the approval of holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and amending
our warrant agreement will require a vote of holders of at least 50% of the public warrants and, solely with respect to any amendment
to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants,
50% of the number of the then outstanding private placement warrants. In addition, our third amended and restated memorandum and articles
of association will require us to provide our public shareholders with the opportunity to redeem their public shares for cash if we propose
an amendment to our third amended and restated memorandum and articles of association (A) that would modify the substance or timing of
our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial
business combination or to redeem 100% of our public shares if we do not complete our initial business combination by November 15, 2025
or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination
activity. To the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered through
this registration statement, we would register, or seek an exemption from registration for, the affected securities.

 The provisions of our third amended
and restated memorandum and articles of association that relate to our pre-business combination activity (and corresponding provisions
of the agreement governing the release of funds from our trust account) may be amended with the approval of a special resolution which
requires the approval of the holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company,
which is a lower amendment threshold than that of some other blank check companies. It may be easier for us, therefore, to amend our third
amended and restated memorandum and articles of association to facilitate the completion of an initial business combination that some
of our shareholders may not support.

 Some other blank check companies
have a provision in their charter or constitutional documents which prohibits the amendment of certain of its provisions, including those
which relate to a company's pre-business combination activity, without approval by a certain percentage of the company's shareholders.
In those companies, amendment of these provisions typically requires approval by between 90% and 100% of the company's shareholders.
Our third amended and restated memorandum and articles of association provides that any of its provisions related to pre-business combination
activity (including the requirement to deposit proceeds of the Initial Public Offering and the sale of the private placement warrants
and the proceeds from the Fulton AC loan into the trust account and not release such amounts except in specified circumstances, and to
provide redemption rights to public shareholders as described herein) may be amended if approved by special resolution, meaning holders
of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and corresponding provisions of
the trust agreement governing the release of funds from our trust account may be amended if approved by holders of at least 65% of our
ordinary shares; provided that the provisions of our third amended and restated memorandum and articles of association governing the appointment
or removal of directors prior to our initial business combination may only be amended by a special resolution passed by holders representing
at least two-thirds of our issued and outstanding Class B ordinary shares. Fulton AC, CBG, CB Co-Investment and our current and former
directors and officers and their permitted transferees, if any, will participate in any vote to amend our third amended and restated memorandum
and articles of association and/or trust agreement and will have the discretion to vote in any manner they choose. As a result, we may
be able to amend the provisions of our third amended and restated memorandum and articles of association which govern our pre-business
combination behavior more easily than some other blank check companies, and this may increase our ability to complete a business combination
with which you do not agree. Our shareholders may pursue remedies against us for any breach of our third amended and restated memorandum
and articles of association.

 Fulton AC and our
executive officers and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to
our third amended and restated memorandum and articles of association (A) that would modify the substance or timing of our
obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial
business combination or to redeem 100% of our public shares if we do not complete our initial business combination by November 15,
2025 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial
business combination activity; unless we provide our public shareholders with the opportunity to redeem their Class A ordinary
shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in
the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our
income taxes, if any, divided by the number of the then-outstanding public shares. Our shareholders are not parties to, or third
party beneficiaries of, this agreement and, as a result, will not have the ability to pursue remedies against Fulton AC or our
executive officers or directors for any breach of this agreement. As a result, in the event of a breach, our shareholders would need
to pursue a shareholder derivative action, subject to applicable law.

 Certain agreements related to the
Initial Public Offering may be amended without shareholder approval.

 Certain agreements, including
the letter agreement, as amended, among us and Fulton AC, CBG, CB-Co Investment and certain of our current and former officers and directors
may be amended without shareholder approval. These agreements contain various provisions that our public shareholders might deem to be
material. While we do not expect our Board to approve any amendment to any of these agreements prior to our initial business combination,
it may be possible that our Board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or
more amendments to any such agreement in connection with the consummation of our initial business combination. Any such amendments would
not require approval from our shareholders, may result in the completion of our initial business combination that may not otherwise have
been possible, and may have an adverse effect on the value of an investment in our securities.

 We may be unable to obtain additional financing
to complete our initial business combination or to fund the operations and growth of a partner business, which could compel us to restructure
or abandon a particular business combination. If we are unable to complete our initial business combination, our public shareholders may
receive only approximately $11.88 per public share, or less in certain circumstances, on the liquidation of our trust account and our
warrants will expire worthless.

 Although we believe that
the net proceeds of the Initial Public Offering and the sale of the private placement warrants and the proceeds from the Fulton AC loan
will be sufficient to allow us to complete our initial business combination, because we have not yet selected any prospective partner
business we cannot ascertain the capital requirements for any particular transaction. If the net proceeds of the Initial Public Offering
and the sale of the private placement warrants and the proceeds from the Fulton AC loan prove to be insufficient, either because of the
size of our initial business combination, the depletion of the available net proceeds in search of a partner business, the obligation
to redeem for cash a significant number of shares from shareholders who elect redemption in connection with our initial business combination
or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to
seek additional financing or to abandon the proposed business combination. Such financing may not be available on acceptable terms, if
at all. The current economic environment may make difficult for companies to obtain acquisition financing. To the extent that additional
financing proves to be unavailable when needed to complete our initial business combination, we would be compelled to either restructure
the transaction or abandon that particular business combination and seek an alternative partner business candidate. If we do not complete
our initial business combination within the required time period, our public shareholders may, as of June 16, 2025, receive only approximately
$11.88 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
In addition, even if we do not need additional financing to complete our initial business combination, we may require such financing to
fund the operations or growth of the partner business. The failure to secure additional financing could have a material adverse effect
on the continued development or growth of the partner business. None of Fulton AC or our executive officers, directors or shareholders
is required to provide any financing to us in connection with or after our initial business combination.

 Fulton AC holds a substantial interest
in us and thus may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support.

 As of the close of business on June 16, 2025, Fulton AC owned, on an
as-converted basis, an aggregate of approximately 95.11% of our issued and outstanding ordinary shares. Accordingly, they may exert a
substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support, including amendments to
our third amended and restated memorandum and articles of association. If Fulton AC purchases any Class A ordinary shares in the open
market or in privately negotiated transactions, this would increase their control. Neither Fulton AC nor, to our knowledge, any of our
executive officers or directors, have any current intention to purchase additional securities, other than as disclosed in this Annual
Report on Form 10-K. Factors that would be considered in making such additional purchases would include consideration of the current trading
price of our Class A ordinary shares. In addition, our Board, whose members were elected by Fulton AC as the majority holder of our Class
B shares, is and will be divided into three classes, each of which will generally serve for a term of three years with only one class
of directors being elected in each year. We may not hold an annual general meeting to appoint new directors prior to the completion of
our initial business combination, in which case all of the current directors will continue in office until at least the completion of
the business combination. If there is an annual general meeting, as a consequence of our "staggered" Board, only a minority
of the Board will be considered for election and Fulton AC, because of its ownership position, will control the outcome, as only holders
of our Class B ordinary shares will have the right to vote on the election of directors and to remove directors prior to our initial business
combination. Accordingly, Fulton AC will continue to exert control at least until the completion of our initial business combination.
In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without the prior consent
of Fulton AC.

 We may amend the terms of the warrants
in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding
public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number
of our Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.

 Our warrants will be issued
in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant
agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any
defective provision or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms
of the warrants and the warrant agreement set forth in this Annual Report on Form 10-K, but requires the approval by the holders of at
least 50% of the then-outstanding public warrants to make any change that adversely affects the interests of the registered holders of
public warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 50%
of the then-outstanding public warrants approve of such amendment and, solely with respect to any amendment to the terms of the private
placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the
then outstanding private placement warrants. Although our ability to amend the terms of the public warrants with the consent of at least
50% of the then-outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase
the exercise price of the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of Class A
ordinary shares purchasable upon exercise of a warrant. We may redeem your unexpired warrants prior to their exercise at a time that is
disadvantageous to you, thereby making your warrants worthless.

 A provision of our warrant agreement
may make it more difficult for us to consummate an initial business combination.

 If (x) we issue additional
Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of our initial business
combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective
issue price to be determined in good faith by Board and, in the case of any such issuance to Franklin, CBG, CB Co-Investment and our former
directors and officers or their affiliates, without taking into account any Class B Shares held by CBG, CB Co-Investment and our former
directors or officers or such affiliates, as applicable, prior to such issuance including any transfer or reissuance of such shares),
(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of our initial business combination, and (z) the volume-weighted average trading price of our Class A ordinary shares
during the 20 trading day period starting on the trading day after the day on which we consummate our initial business combination (such
price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent)
to be equal to 115% of the Market Value, and the $10.00 and $18.00 per share redemption trigger prices of the warrants will be adjusted
(to the nearest cent) to be equal to 100% and 180% of the Market Value, respectively. This may make it more difficult for us to consummate
an initial business combination with a partner business.

 Our warrants are accounted for as
a warrant liability and will be recorded at fair value upon issuance with changes in fair value each period reported in earnings, which
may have an adverse effect on the market price of our Class A ordinary shares or may make it more difficult for us to consummate an initial
business combination.

 Following the consummation
of the Initial Public Offering and the concurrent private placement of warrants, we issued an aggregate of 22,050,000 warrants in connection
with the Initial Public Offering (comprised of the 11,500,000 warrants included in the units and the 10,550,000 private placement warrants).
We will also issue private placement warrants upon the conversion of the CB Co-Investment loan upon consummation of our initial business
combination. We account for these as a warrant liability and record them at fair value upon issuance with any changes in fair value each
period reported in earnings as determined by us based upon a valuation report obtained from an independent third party valuation firm.
The impact of changes in fair value on earnings may have an adverse effect on the market price of our Class A ordinary shares. In addition,
potential targets may seek a SPAC that does not have warrants that are accounted for as a warrant liability, which may make it more difficult
for us to consummate an initial business combination with a target business.

 Our warrant agreement designates the
courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum
for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant
holders to obtain a favorable judicial forum for disputes with our company.

 Our warrant agreement
provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way
to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or
the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such
jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We have waived any objection
to such exclusive jurisdiction and that such courts represent an inconvenient forum.

 Notwithstanding the foregoing,
these provisions of the warrant agreement do not apply to suits brought to enforce any liability or duty created by the Exchange Act or
any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or
entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to
the forum provisions in our warrant agreement. If any action, the subject matter of which is within the scope of the forum provisions
of the warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the
Southern District of New York (a "foreign action") in the name of any holder of our warrants, such holder shall be deemed
to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection
with any action brought in any such court to enforce the forum provisions (an "enforcement action"), and (y) having service
of process made upon such warrant holder in any such enforcement action by service upon such warrant holder's counsel in the foreign
action as agent for such warrant holder.

 This choice-of-forum provision
may limit a warrant holder's ability to bring a claim in a judicial forum that it finds favorable for disputes with our company,
which may discourage such lawsuits. In addition, this choice-of-forum provision may result in our warrant holders incurring increased
costs to bring an action, proceeding or claim due to, but not limited to, the warrant holder's physical location or knowledge of
the applicable laws, when the courts of the State of New York or the United States District Court for the Southern District of New York
is the exclusive forum. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with
respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such
matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations
and result in a diversion of the time and resources of our team and Board.

 We may redeem your unexpired warrants
prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.

 We have the ability to redeem
the outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, if,
among other things, the Reference Value equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, rights issuances,
subdivisions, reorganizations, recapitalizations and the like). Please see "Warrants — Public Shareholders'
Warrants — Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $18.00"
in Exhibit 4.5 of this Annual Report on Form 10-K. If and when the warrants become redeemable by us, we may exercise our redemption right
even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption
of the outstanding warrants as described above could force you to (i) exercise your warrants and pay the exercise price therefor at a
time when it may be disadvantageous for you to do so, (ii) sell your warrants at the then-current market price when you might otherwise
wish to hold your warrants or (iii) accept the nominal redemption price which, at the time the outstanding warrants are called for redemption,
we expect would be substantially less than the Market Value of your warrants. None of the private placement warrants will be redeemable
by us so long as they are held by CBG, CB Co-Investment or their respective permitted transferees.

 In addition, we have the
ability to redeem the outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.10
per warrant if, among other things, the Reference Value equals or exceeds $10.00 per share (as adjusted for share splits, shared dividends,
rights issuances, subdivisions, reorganizations, recapitalizations and the like). In such a case, the holders will be able to exercise
their warrants prior to redemption for a number of shares of our Class A ordinary shares determined based on the redemption date
and the fair market value of our Class A ordinary shares. The value received upon exercise of the warrants (1) may be less than
the value the holders would have received if they had exercised their warrants at a later time where the underlying share price is higher
and (2) may not compensate the holders for the value of the warrants, including because the number of ordinary shares received is
capped at 0.361 shares of our Class A ordinary shares per warrant (subject to adjustment) irrespective of the remaining life of the
warrants.

 Our warrants may have an adverse effect
on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.

 We issued public
warrants to purchase 11,500,000 of our Class A ordinary shares as part of the units offered in the Initial Public Offering and,
simultaneously with the closing of the Initial Public Offering, we issued in a private placement 10,550,000 private placement
warrants at $1.00 per warrant. In addition, Fulton AC may convert up to $1,500,000 of the Fulton AC loan into up to an additional
1,500,000 private placement warrants, at the price of $1.00 per warrant. Our public warrants are also redeemable by us for Class A
ordinary shares as described in "Warrants — Public Shareholders' Warrants
 — Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds
$10.00" in Exhibit 4.5 of this Annual Report on Form 10-K. To the extent we issue ordinary shares to effectuate a business
transaction, the potential for the issuance of a substantial number of additional Class A ordinary shares upon exercise of these
warrants could make us a less attractive acquisition vehicle to a partner business. Such warrants, when exercised, will increase the
number of issued and outstanding Class A ordinary shares and reduce the value of the Class A ordinary shares issued to complete the
business transaction. Therefore, our warrants may make it more difficult to effectuate a business transaction or increase the cost
of acquiring the partner business.

 Because each unit contains one-half
of one warrant and only a whole warrant may be exercised, the units may be worth less than units of other blank check companies.

 Each unit contains one-half
of one warrant. Pursuant to the warrant agreement, no fractional warrants will be issued upon separation of the units, and only whole units
will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise,
round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder. This is different
from other offerings similar to ours whose units include one ordinary share and one warrant to purchase one whole share. We have
established the components of the units in this way in order to reduce the dilutive effect of the warrants upon completion of a business
combination since the warrants will be exercisable in the aggregate for one-half of the number of shares compared to units that each
contain a whole warrant to purchase one share, thus making us, we believe, a more attractive merger partner for partner businesses. Nevertheless,
this unit structure may cause our units to be worth less than if it included a warrant to purchase one whole share.

 There is currently no market for our
securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities.

 There is currently no market
for our securities. Shareholders therefore have no access to information about prior market history on which to base their investment
decision. The price of our securities may vary significantly due to one or more potential business combinations and general market or
economic conditions. Furthermore, an active trading market for our securities may never develop or, if developed, it may not be sustained.
You may be unable to sell your securities unless a market can be established and sustained.

 Because we must furnish our shareholders
with partner business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination
with some prospective partner businesses.

 The federal proxy rules require
that a proxy statement with respect to a vote on our proposed business combination include historical and/or pro forma financial
statement disclosure. We will include the same financial statement disclosure in connection with our tender offer documents, whether or
not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be
reconciled to, accounting principles generally accepted in the United States of America, or GAAP, or international financial reporting
standards as issued by the International Accounting Standards Board, or IFRS, depending on the circumstances and the historical financial
statements may be required to be audited in accordance with the standards of the Public Company Accounting Oversight Board (United States),
or PCAOB. These financial statement requirements may limit the pool of potential partner businesses we may acquire because some partners
may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete
our initial business combination by November 15, 2025.

 We are an emerging growth company
and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure
requirements available to "emerging growth companies" or "smaller reporting companies," this could make our securities
less attractive to investors and may make it more difficult to compare our performance with other public companies.

 We are an "emerging
growth company" within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not "emerging growth companies"
including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments
not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We could be
an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if
the market value of our Class A ordinary shares held by non-affiliates exceeds $700 million as of any June 30 before that
time, in which case we would no longer be an emerging growth company as of the following December 31. We cannot predict whether investors
will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive
as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there
may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

 Further, Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period
which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an
emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may
make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.

 Additionally, we are a "smaller
reporting company" as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain
reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will
remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares held
by non-affiliates exceeds $250 million as of the prior June 30, and (2) our annual revenues exceeded $100 million
during such completed fiscal year or the market value of our ordinary shares held by non-affiliates exceeds $700 million as of the
prior June 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial
statements with other public companies difficult or impossible.

 Our third amended and restated memorandum
and articles of association designates the courts of the Cayman Islands or the federal district courts of the United States as the sole
and exclusive forum for certain actions or proceedings that may be initiated by our shareholders, which could discourage claims or limit
shareholders' ability to make a claim against the Company, our directors, officers and employees.

memorandum and articles of association provides that, all internal corporate claims, including (i) any claim of (or based upon) a breach
of fiduciary duty owed by any current or former director, officer or other employee of the Company to the Company or its shareholders;
and (ii) any action asserting a claim arising pursuant to any provision of Cayman Islands law, the second amended and restated memorandum,
or the second amended and restated articles of association, shall be governed by the laws of the Cayman Islands and unless we consent
in writing to the selection of an alternative forum, the courts of the Cayman Islands are the sole and exclusive forum for any such internal
corporate claims brought by any shareholder against, or on behalf of, the Company and its affiliates or any of its current or former directors,
officers, or employees. Our third amended and restated memorandum and articles of association will further provide that, unless the Company
consents in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive
forum for any causes of actions or suits asserting a claim arising under the U.S. Securities Act of 1933, as amended or the rules and
regulations promulgated thereunder. These exclusive forum provisions would not apply to (i) suits brought to enforce a duty or liability
created by the Exchange Act, which provides for exclusive jurisdiction of the United States federal courts; (ii) any other claim for which
the federal district courts of the United States of America are the sole and exclusive forum; or (iii) any action, proceeding or claim
against the Company arising out of or relating in any way to the warrant agreement, which will be brought and enforced in the courts of
the State of New York or the United States District Court for the Southern District of New York. These exclusive forum provisions may
limit the ability of our shareholders to bring a claim in a judicial forum that such shareholders find favorable for disputes with us
or our directors, officers, or employees, which may discourage such lawsuits against us and our directors, officers and employees. In
addition, these exclusive forum provisions may result in our shareholders incurring increased costs to bring a claim or action due to,
but not limited to, the shareholder's physical location or knowledge of the applicable laws, when the courts of the Cayman Islands,
the federal district courts of the United States, the courts of the State of New York or the United States District Court for the Southern
District of New York, or an alternative forum, with our consent, is the sole and exclusive forum. Alternatively, if a court were to find
the choice of forum provisions contained in our third amended and restated memorandum and articles of association to be inapplicable or
unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially
adversely affect our business, financial condition, and operating results.

 Compliance obligations under the Sarbanes-Oxley
Act may make it more difficult for us to effectuate a business combination, require substantial financial and management resources, and
increase the time and costs of completing an acquisition.

 Section 404 of the Sarbanes-Oxley
Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on Form 10-K for the year
ending December 31, 2023. Only in the event we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify
as an emerging growth company, will we be required to comply with the independent registered public accounting firm attestation requirement
on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of
the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a partner business with which we seek
to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy
of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act
may increase the time and costs necessary to complete any such acquisition.

 Because we are incorporated under
the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through
the U.S. federal courts may be limited.

 We are an exempted company
incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within
the United States upon our directors or executive officers, or enforce judgments obtained in the United States courts against our directors
or officers.

 Our corporate affairs and
the rights of shareholders are governed by our third amended and restated memorandum and articles of association, the Companies Act (as
the same may be supplemented or amended from time to time) and the laws of the Cayman Islands. We are also subject to the federal securities
laws of the United States. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary
responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the laws of the Cayman Islands. The
laws of the Cayman Islands are derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English
common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights
of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be
under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body
of securities laws as compared to the United States, and certain states, such as Delaware, may have more fully developed and judicially
interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative
action in a Federal court of the United States. For a more detailed discussion of the principal differences between the provisions of
the Companies Act applicable to us and, for example, the laws applicable to companies incorporated in the United States and their shareholders,
see the section of Exhibit 4.5 of this Annual Report on Form 10-K captioned "Certain Differences in Corporate Law."

 Shareholders of Cayman Islands
exempted companies like the Company have no general rights under Cayman Islands law to inspect corporate records or to obtain copies of
the register of members of these companies. Our directors have discretion under our third amended and restated memorandum and articles
of association to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but
are not obliged to make them available to our shareholders. Pursuant to the second amended and restated memorandum and articles of association
of the Company, shareholders may, by Ordinary Resolution, also resolve to make the Company's records available to the Shareholders.
This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or
to solicit proxies from other shareholders in connection with a proxy contest.

 We have been advised by
Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of
courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or
any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil
liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those
provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of
judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a
foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign
court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions
are met. For a foreign judgment to be enforced in the Cayman Islands, the foreign court must have had jurisdiction over the parties
to the dispute and such judgment must be final and conclusive, for a liquidated sum and not subject to appeal,, and must not be (i)
in respect of a public or revenue nature, taxes or a fine or penalty, (ii) inconsistent with a Cayman Islands judgment in respect of
the same matter, (iii) impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is,
contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to
be contrary to public policy) or (iv) inconsistent with section 91 or 92 of the Trusts Act (as revised) of the Cayman Islands, and
the process by which the judgment is enforced must not be barred under laws relating to the prescription and limitation of actions.
A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

 As a result of all of the
above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by our team, members of
the Board or controlling shareholders than they would as public shareholders of a United States company.

 Provisions in our third amended and
restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to
pay in the future for our Class A ordinary shares and could entrench our team.

memorandum and articles of association contains provisions that may discourage unsolicited takeover proposals that shareholders may consider
to be in their best interests. These provisions include a staggered Board, the ability of the Board to designate the terms of and issue
new series of preference shares, and the fact that prior to the completion of our initial business combination only holders of our Class
B ordinary shares, which have been issued to our sponsor, are entitled to vote on the appointment of directors, which may make more difficult
the removal of our team and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices
for our securities.

 Cyber incidents or attacks directed
at us could result in information theft, data corruption, operational disruption and/or financial loss.

 We depend on digital technologies,
including information systems, infrastructure and cloud applications and services, including those of third parties with which we may
deal. Sophisticated and deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure
of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential
data. As an early stage company without significant investments in data security protection, we may not be sufficiently protected against
such occurrences. We may not have sufficient resources to adequately protect against, or to investigate and remediate any vulnerability
to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have adverse consequences on our business
and lead to financial loss.

 Risks Associated with Acquiring and Operating
a Business in Foreign Countries

 If we pursue a partner company with
operations or opportunities outside of the United States for our initial business combination, we may face additional burdens in connection
with investigating, agreeing to and completing such initial business combination, and if we effect such initial business combination,
we would be subject to a variety of additional risks that may negatively impact our operations.

 If we pursue a partner company
with operations or opportunities outside of the United States for our initial business combination, we would be subject to risks associated
with cross-border business combinations, including in connection with investigating, agreeing to and completing our initial business combination,
conducting due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators or agencies
and changes in the purchase price based on fluctuations in foreign exchange rates.

 If we effect our initial
business combination with such a company, we would be subject to any special considerations or risks associated with companies operating
in an international setting, including any of the following:

 costs and difficulties inherent in managing cross-border business operations;

 rules and regulations regarding currency redemption;

 complex corporate withholding taxes on individuals;

 laws governing the manner in which future business combinations may be effected;

 exchange listing and/or delisting requirements;

 tariffs and trade barriers;

 regulations related to customs and import/export matters;

 local or regional economic policies and market conditions;

 unexpected changes in regulatory requirements;

 longer payment cycles;

 tax issues, such as tax law changes and variations in tax laws as compared to United States tax laws;

 currency fluctuations and exchange controls;

 rates of inflation;

 challenges in collecting accounts receivable;

 cultural and language differences;

 employment regulations;

 underdeveloped or unpredictable legal or regulatory systems;

 corruption;

 protection of intellectual property;

 social unrest, crime, strikes, riots and civil disturbances;

 regime changes and political upheaval;

 terrorist attacks, natural disasters, pandemics and wars; and

 and deterioration of political relations with the United States.

 We may not be able to adequately
address these additional risks. If we were unable to do so, we may be unable to complete such initial business combination, or, if we
complete such combination, our operations might suffer, either of which may adversely impact our business, financial condition and results
of operations.

 If our team following our initial
business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with
such laws, which could lead to various regulatory issues.

 Following our initial business
combination, our team may resign from their positions as officers or directors of the company and the management of the partner business
at the time of the business combination will remain in place. Management of the partner business may not be familiar with United States
securities laws. If new management is unfamiliar with United States securities laws, they may have to expend time and resources becoming
familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect
our operations.

 After our initial business combination,
substantially all of our assets may be located in a foreign country and substantially all of our revenue may be derived from our operations
in such country. Accordingly, our results of operations and prospects will be subject, to a significant extent, to the economic, political
and social conditions and government policies, developments and conditions in the country in which we operate.

 The economic, political and
social conditions, as well as government policies, of the country in which our operations are located could affect our business. Economic
growth could be uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future.
If in the future such country's economy experiences a downturn or grows at a slower rate than expected, there may be less demand
for spending in certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our
ability to find an attractive partner business with which to consummate our initial business combination and if we effect our initial
business combination, the ability of that partner business to become profitable.

 Exchange rate fluctuations and currency
policies may cause a partner business' ability to succeed in the international markets to be diminished.

 In the event we acquire
a non-U.S. partner, all revenues and income would likely be received in a foreign currency, and the dollar equivalent of our net
assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value of the
currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions.
Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any partner
business or, following consummation of our initial business combination, our financial condition and results of operations.
Additionally, if a currency appreciates in value against the dollar prior to the consummation of our initial business combination,
the cost of a partner business as measured in dollars will increase, which may make it less likely that we are able to consummate
such transaction.

 We may reincorporate in another jurisdiction
in connection with our initial business combination, and the laws of such jurisdiction may govern some or all of our future material agreements
and we may not be able to enforce our legal rights.

 In connection with our initial
business combination, we may relocate the home jurisdiction of our business from the Cayman Islands to another jurisdiction. If we determine
to do this, the laws of such jurisdiction may govern some or all of our future material agreements. The system of laws and the enforcement
of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability
to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities
or capital.

 We are subject to changing law and
regulations regarding regulatory matters, corporate governance and public disclosure that have increased both our costs and the risk of
non-compliance.

 We are subject to rules and
regulations by various governing bodies, including, for example, the SEC, which are charged with the protection of investors and the oversight
of companies whose securities are publicly traded, and to new and evolving regulatory measures under applicable law. Our efforts to comply
with new and changing laws and regulations have resulted in and are likely to continue to result in, increased general and administrative
expenses and a diversion of management time and attention from seeking a business combination partner.

 Moreover, because these laws,
regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes
available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing
revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes,
we may be subject to penalty and our business may be harmed.

 Social unrest, acts of
terrorism, regime changes, changes in laws and regulations, political upheaval, or policy changes or enactments may occur in a country
in which we may operate after we effect our initial business combination.

 Political events in another
country, current or anticipated military conflict, including between Russia and Ukraine and the conflict between Israel and Hamas, terrorism,
sanctions or other geopolitical events globally, may significantly affect our business, assets or operations. Social unrest, acts of terrorism,
regime changes, changes in laws and regulations, political upheaval, pandemics and policy changes or enactments could negatively impact
our business in a particular country.

 If relations between the
United States and foreign governments deteriorate, it could cause potential target businesses or their goods and services to become less
attractive.

 The relationship between
the United States and foreign governments could be subject to sudden fluctuation and periodic tension. For instance, the United States
may announce its intention to impose quotas or other restrictions on certain imports, such as the sanctions placed against Russia in connection
with the military conflict between Russia and Ukraine and the conflict between Israel and Hamas. Such import quotas may adversely affect
political relations between the two countries and result in retaliatory countermeasures by the foreign government in industries that may
affect our ultimate target business. Changes in political conditions in foreign countries and changes in the state of U.S. relations with
such countries are difficult to predict and could adversely affect our operations or cause potential target businesses or their goods
and services to become less attractive. Because we are not limited to any specific industry, there is no basis for investors in this offering
to evaluate the possible extent of any impact on our ultimate operations if relations are strained between the United States and a foreign
country in which we acquire a target business or move our principal manufacturing or service operations.

 We may be a passive foreign investment
company, or "PFIC," which could result in adverse U.S. federal income tax consequences to U.S. investors.

 If we are a PFIC for any
taxable year (or portion thereof) that is included in the holding period of a U.S. Holder (as defined in the section of our final prospectus
captioned "Taxation — United States Federal Income Tax Considerations — General") of our
Class A ordinary shares or warrants, the U.S. Holder may be subject to adverse U.S. federal income tax consequences and may be subject
to additional reporting requirements. Accordingly, there can be no assurances with respect to our status as a PFIC for our current taxable
year or any subsequent taxable year. Our actual PFIC status for any taxable year will not be determinable until after the end of such
taxable year. Moreover, if we determine we are a PFIC for any taxable year, upon written request, we will endeavor to provide to a U.S.
Holder such information as the Internal Revenue Service (the "IRS") may require, including a PFIC Annual Information Statement,
in order to enable the U.S. Holder to make and maintain a "qualified electing fund" election, but there can be no assurance
that we will timely provide such required information, and such election would be unavailable with respect to our warrants in all cases.
We urge U.S. investors to consult their tax advisors regarding the possible application of the PFIC rules. For a more detailed discussion
of the tax consequences of PFIC classification to U.S. Holders, see the section of our final prospectus captioned "Taxation — United
States Federal Income Tax Considerations — U.S. Holders — Passive Foreign Investment Company Rules."

 After our initial business combination,
it is possible that a majority of our directors and officers will live outside the United States and all of our assets will be located
outside the United States; therefore investors may not be able to enforce federal securities laws or their other legal rights.

 It is possible that after
our initial business combination, a majority of our directors and officers will reside outside of the United States and all of our assets
will be located outside of the United States. As a result, it may be difficult, or in some cases not possible, for investors in the United
States to enforce their legal rights, to effect service of process upon all of our directors or officers or to enforce judgments of United
States courts predicated upon civil liabilities and criminal penalties on our directors and officers under United States laws.

 In particular, there is uncertainty
as to whether the courts of the Cayman Islands or any other applicable jurisdictions would recognize and enforce judgments of U.S. courts
obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States
or any state in the United States or entertain original actions brought in the Cayman Islands or any other applicable jurisdiction's
courts against us or our directors or officers predicated upon the securities laws of the United States or any state in the United States.

 For a more detailed discussion,
see the section of Exhibit 4.5 of this Annual Report on Form 10-K captioned "Certain Differences in Corporate Law."

 Item
1B. Unresolved Staff Comments

 None.

 Item
1C. Cybersecurity

 We are a special purpose
acquisition company with no business operations. Since our IPO, our sole business activity has been identifying and evaluating suitable
acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any
cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our Board is generally responsible for the
oversight of risks from cybersecurity threats, if any. We have not encountered any cybersecurity incidents since our IPO.

 Item
2. Properties

 We currently maintain our
executive offices at 8 The Green # 17538 Dover, DE 19901. The cost for our use of this space is included in the up to $30,000 per month
fee we pay to Fulton AC for office space, administrative and support services. We consider our current office space adequate for our current
operations.

 Item
3. Legal Proceedings

 To the knowledge of our management,
there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against
any of our property.

 Item
4. Mine Safety Disclosures

 Item
5. Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

 (a) Market Information

 On November 12, 2024, the
Company received a letter from the Listing Qualifications Department of Nasdaq stating that, pursuant to Rule IM-5101-2, the Staff had
determined that (i) the Company's securities would be delisted from Nasdaq, (ii) trading of the Company's Class A ordinary
shares and units would be suspended at the opening of business on November 19, 2024 and (iii) a Form 25-NSE will be filed with the SEC,
which will remove the Company's securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition
company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration
statement. Since the Company failed to complete its initial business combination by November 4, 2024, the Staff concluded that the Company
did not comply with Rule IM-5101-2 and that the Company's securities were subject to delisting.

 Nasdaq suspended that trading
of the Company's Class A ordinary shares and units at the opening of business on November 19, 2024 and subsequently delisted such
securities.

 Following the suspension
of trading, the Company's Class A ordinary shares began trading on OTCQB operated on OTC under the symbol "CBRRF." The
Company's warrants and units began trading on the Expert Market operated by OTC under the symbols "CBRGF" and "CBGGF,"
respectively. There is no assurance that a broker will continue to make a market in the Company's securities or that trading of
the ordinary shares will continue on an over-the-counter market or elsewhere.

 (b) Holders

 On June 16, 2025, there were
1 holder of record of our units, 3 holders of record of our Class A ordinary shares, 7 holders of record of our Class B ordinary shares
and 4 holders of record of our warrants.

 (c) Dividends

 We have not paid any cash
dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination.
The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general
financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our
initial business combination will be within the discretion of our Board at such time, and we will only pay such dividend out of our profits
or share premium (subject to solvency requirements) as permitted under Cayman Islands law. If we incur any indebtedness in connection
with our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection
therewith.

 (d) Securities Authorized for Issuance Under Equity Compensation Plans

 None.

 (e) Performance Graph

 (f) Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings

 None.

 (g) Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 None.

 Item
6. Reserved.

 Item
7. Management's Discussion and Analysis of Financial Condition and Results of Operations

 The following discussion and analysis of the Company's
financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related
thereto which are included in "Item 8. Financial Statements and Supplementary Data" of this Annual Report on Form 10-K. Certain
information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ
materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under "Cautionary
Note Regarding Forward-Looking Statements and Risk Factor Summary," "Item 1A. Risk Factors" and elsewhere in this Annual
Report on Form 10-K.

 References to "we", "us", "our"
or the "Company" are to Chain Bridge I., except where the context requires otherwise. The following discussion should be read
in conjunction with our financial statements and related notes thereto included elsewhere in this report.

 Liquidity and Going Concern

 As of December 31, 2024, we had cash of $129,598 and a working capital
deficit of $884,195.

 Our liquidity needs up to
December 29, 2023 had been satisfied through the cash receipt of $25,000 from CBG and CB Co-Investment to cover for certain expenses on
behalf of the Company in exchange for issuance of founder shares, a loan from the related party of approximately $244,000 under the Note
(as defined herein) which was repaid in full on November 17, 2021, the net proceeds from the consummation of the Initial Public Offering,
over-allotment, the Private Placement held outside of the trust account and the issuance of the convertible notes. In addition, in order
to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the
Company's officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5).
In connection with the consummation of the transactions contemplated by the Securities Purchase Agreement, CB Co-Investment irrevocably
agreed to convert the $1.15 million loan (the "Conversion Amount") by CB Co-Investment to the Company at a conversion price
of $1.00 per warrant, or 1,150,000 warrants. As of December 31, 2024, the fair value of converted loan was $4,600 which is included in
contingently issuable private placement warrants on the accompanying balance sheet as of December 31, 2024.

 The Company has until November
15, 2025 to consummate an initial Business Combination. If the Company has not consummated a Business Combination, the Company must (a)
cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days
thereafter, redeem Public Shares; and (c) as promptly as reasonably possible following such redemption, subject to the approval of the
Company's remaining shareholders and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman
Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.

 In connection with our assessment
of going concern considerations in accordance with ASU 2014-15, "Disclosures of Uncertainties about an Entity's Ability to
Continue as a Going Concern," the Company has determined that the liquidity condition and the date for mandatory liquidation and
subsequent dissolution raises substantial doubt about the Company's ability to continue as a going concern. No adjustments have
been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 15, 2025. The financial
statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

 Results of Operations

 Our entire activity since
inception up to December 31, 2024 was in preparation for our Initial Public Offering and since the closing of the Initial Public Offering,
the search for a prospective Business Combination. We will not generate any operating revenues until the closing and completion of our
initial Business Combination, at the earliest.

 For the year ended December 31, 2024, we had a net loss of approximately
$1.4 million, which consisted of general and administrative expenses of approximately $2.1 million and general and administrative expenses
to related party of $120,000, offset by investment income on the Trust Account of approximately $734,000, gain from the change in fair
value of derivative liabilities of approximately $24,000, and gain from change in fair value of contingently issuable private placement
warrants of approximately $1,300.

 For the year ended December
31, 2023, we had a net income of approximately $7.6 million, which consisted of investment income on the Trust Account of approximately
$5.4 million, gain from the change in fair value of derivative liabilities of approximately $2.1 million, gain from change in fair value
of contingently issuable private placement warrants of approximately $1.1 million, gain on extinguishment of forward purchase agreement
of approximately $0.3 million, gain on forgiveness of legal fees of approximately $19,000, and gain from the change in fair value of convertible
note to related party of approximately $800, partially offset by general and administrative expenses of approximately $969,000, general
and administrative expenses to related party of $350,000 and loss on conversion of note to contingently issuable private placement warrants
of approximately $69,000.

 Contractual Obligations

 Registration Rights and Shareholder Rights

 The holders of Class B ordinary
shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of ordinary
shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and
upon conversion of the Class B ordinary shares), were entitled to registration rights pursuant to a registration and shareholder rights
agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and "piggyback"
registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 Critical Accounting Policies

 Derivative Financial Instruments

 We do not use derivative
instruments to hedge exposures to cash flow, market or foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, and forward purchase agreements, to determine if such instruments are derivatives or contain features
that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Topic 815. The classification of derivative instruments, including
whether such instruments should be recorded as liabilities or as equity, will be re-assessed at the end of each reporting period. Derivative
warrant liabilities will be classified as non-current liabilities as their liquidation is not reasonably expected to require the use of
current assets or require the creation of current liabilities.

 The 22,050,000 warrants that
were issued in connection with the Initial Public Offering (including the 11,500,000 warrants included in the Units and the 10,550,000
Private Placement Warrants) and the 4,000,000 Forward Purchase Securities, were recognized as derivative liabilities in accordance with
ASC Topic 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and adjust the instruments to
fair value at each reporting period. The liabilities will be subject to re-measurement at each balance sheet date until exercised. The
fair value of the Forward Purchase Securities, Public Warrants and the Private Placement Warrants were initially measured using a Monte
Carlo simulation. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured
based on the listed market price of such Public Warrants. On December 26, 2023, in connection with the Securities Purchase Agreement,
the Forward Purchase Securities were terminated and the Convertible Note was converted into contingently issuable private placement warrants.
As of December 31, 2024 and 2023, the fair value of Private Placement Warrants was determined based on the quoted price of the Public
Warrants.

 Class A Ordinary Shares Subject to Possible
Redemption

 We account for our Class
A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to
mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A
ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or
subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all
other times, Class A ordinary shares are classified as shareholders' equity. Our Class A ordinary shares feature certain redemption
rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of December
31, 2024 and 2023, 455,736 and 4,151,134, respectively, Class A ordinary shares subject to possible redemption are presented at redemption
value as temporary equity, outside of the shareholders' deficit section of our balance sheets, respectively.

 We recognize changes in redemption
value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal
the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the
redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment
option), we recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in
capital (to the extent available) and accumulated deficit.

 Net Income (Loss) Per Share

 We comply with accounting
and disclosure requirements of ASC Topic 260. We have two classes of shares, which are referred to as Class A ordinary shares and Class
B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated
by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period.

 The calculation of diluted net income does not consider the effect
of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private
Placement Warrants to purchase an aggregate of 23,200,000 Class A ordinary shares in the calculation of diluted income per share, because
their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic
net income per share for the year ended December 31, 2024 and 2023. Accretion associated with the redeemable Class A ordinary shares is
excluded from earnings per share as the redemption value approximates fair value.

 We have considered the effect
of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option
by the underwriters. Since the contingency was satisfied, we have included these shares in the weighted average number as of the beginning
of the period to determine the dilutive impact of these shares.

 Recent Accounting Pronouncements

 In June 2022, the FASB issued
ASU 2022-03, ASC Topic 820 "Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions". The ASU
amends ASC Topic 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and
to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value.
The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU
are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early
adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The
adoption of ASU 2023-09 did not have a material impact on the Company's financial statements and disclosures.

 In December 2023, the FASB
issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental
income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements.
ASU 2023-09 is effective for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company's management
does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures.

 In November 2023, the FASB
issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments
in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating officer decision maker ("CODM"), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the
CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding
how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in
interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments
in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after
December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company
adopted ASU 2023-07 on January 1, 2024. The amendments will be applied retrospectively to all prior period presented in the financial
statements.

 Management does not believe
that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying
financial statements.

 Off-Balance Sheet Arrangements

 As of December 31, 2024 and
2023, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

 JOBS Act

 The JOBS Act contains provisions
that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an "emerging growth
company" and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date
for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result,
we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-
emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.

 Additionally, we are in the
process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain
conditions set forth in the JOBS Act, if, as an "emerging growth company," we choose to rely on such exemptions we may not
be required to, among other things, (i) provide an auditor's attestation report on our system of internal controls over financial
reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public
companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by
the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's report providing additional information about
the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items
such as the correlation between executive compensation and performance and comparisons of the CEO's compensation to median employee
compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until
we are no longer an "emerging growth company," whichever is earlier.

 Item 7A. Quantitative and Qualitative Disclosure
About Market Risk.

 Not required for smaller reporting companies.

 Item 8. Financial Statements and Supplementary
Data

 This information appears following Item 15 of
this Report and is included herein by reference.

 Item 9. Changes in and Disagreements With Accountants
on Accounting and Financial Disclosure.

 None.

 Item 9A. Controls and Procedures.

 Evaluation of Disclosure Controls and Procedures

 Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our
management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.

 Under the supervision and with the participation
of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation
of the effectiveness of our disclosure controls and procedures as of December 31, 2024, as such term is defined in Rules 13a-15(e) and
15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer
have concluded that as of December 31, 2024, our disclosure controls and procedures were not effective due to the material weaknesses
in internal controls over financial reporting discussed below.

 Internal Control over Financial Reporting

 Management is responsible for establishing and
maintaining adequate internal control over financial reporting for the Company. Management assessed the effectiveness of our internal
control over financial reporting as of December 31, 2024 based on the framework in Internal Control – Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on its assessment, management concluded that our
internal control over financial reporting was not effective as of December 31, 2024, due to the material weaknesses in internal controls
over financial reporting discussed below.

 Management's Report on Internal Controls
Over Financial Reporting

 As required by SEC rules and regulations implementing
Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial
reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Our internal control
over financial reporting includes those policies and procedures that:

 (1)

 pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,

 (2)

 provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

 (3)

 provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 Because of its inherent limitations, internal
control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal
control over financial reporting at December 31, 2024. In making these assessments, management used the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessments
and those criteria, management determined that our internal control over financial reporting as of December 31, 2024 were not effective
because of the previously disclosed material weakness in the Company's internal control over financial reporting related to the
adequate review and reconciliation of its liabilities.

 The material weakness is due to an error understating
the liability of the Bridge Financing Note by $200,000 in the unaudited consolidated balance sheet as of September 30, 2024, that was
previously included in our Quarterly Report on Form 10-Q filed on November 19, 2024, which the Audit Committee determined should be restated.
As a result, the Bridge Financing Note and total general and administrative expenses were understated and net income was overstated. The
impact of the error affects the unaudited condensed statements of operations, changes in shareholders' deficit, and cash flows for
the periods ended September 30, 2024.

 Remediation

 Management has implemented remediation steps to
improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities
and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification
of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with
the requisite experience and training to supplement existing accounting professionals.

 This Annual Report on Form 10-K does not include
an attestation report of our independent registered public accounting firm due to our status as an emerging growth company under the JOBS
Act.

 Changes in Internal Control over Financial Reporting

 Except as described above, there were no changes
to our internal control over financial reporting that occurred during our fiscal quarter ended December 31, 2024 that have materially
affected or are reasonably likely to materially affect, our internal control over financial reporting.

 Item
9B. Other Information

 (a)

 (b)
 None of our directors or officers adopted or terminated any contract, instruction or written plan for
the purchase or sale of company securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or any non-Rule
10b5-1 trading arrangement during the quarter ending December 31, 2024.

 (c)

 Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 Item
10. Directors, Executive Officers and Corporate Governance

 As of the date of this Annual
Report on Form 10-K, our officers and directors are as follows:

 Name

 Age

 Position

 Daniel Wainstein

 Chairman of the Board

 Chief Executive Officer and Director

 Andrew Kucharchuk

 Chief Financial Officer

 Oliver Wiener

 Our Executive Officers

 Andrew Cohen, Chief Executive Officer and Director

 Andrew Cohen has served as
our Chief Executive Officer and a Board member since December 2023. From January 2019 to September 2023 Mr. Cohen was a Founder and the
CIO of Difesa Capital Management, a special situations fund focused on convertible bonds, SPAC securities, PIPEs, warrants and public
equities. Prior to launching Difesa, Mr. Cohen worked at Ramius from 2001 to 2018. Ramius was a $13 billion multi-strategy hedge fund
that ultimately merged with the investment bank Cowen in 2009. While at Ramius Mr. Cohen worked across a range of investment strategies
including merger arbitrage, event driven, small cap equity activism, and distressed debt. Most recently, Mr. Cohen was one of two partners
overseeing the Ramius Event Driven and Merger Arbitrage business within Cowen Investment Management. From 2011 to 2018, Mr. Cohen co-founded
and operated a nine-person team investing Cowen proprietary capital and fiduciary assets in merger arbitrage and event driven strategies.
During his time with the firm the Ramius Merger Fund LLC had peak assets of $500 million and the Merrill Lynch Investment Solutions /
Ramius Merger Arbitrage UCITS Fund had peak assets of $250 million. Prior to joining Ramius, Mr. Cohen worked as an analyst in the investment
banking and private equity groups at Thomas Weisel Partners. Andrew Cohen also serves as a Managing Partner of two private investment
vehicles Kitty Hawk Capital LLC and Kitty Hawk Capital II LLC. Mr. Cohen received a B.A. in Public Policy from the Terry Sanford Institute
at Duke University and an MBA from Columbia Business School.

 Mr. Cohen has deep industry
experience, including specific experience with SPACs and a proven record of leadership and growth. His business insights and leadership
will provide significant value to the Company and make him well qualified to serve on our Board.

 Andrew Kucharchuk, Chief Financial Officer

 Andrew Kucharchuk has served
as our Chief Financial Officer since April 2024. Mr. Kucharchuk serves as Chief Financial Officer of Cero Therapeutics, Inc (Nasdaq: CERO).
Previously, he has served as the Chief Financial Officer of Theralink Technologies, Inc. ("Theralink") (OTCMKTS: THER) from
May 2023 until May 2024 also served as President and Chief Financial Officer of Theralink from February 2016 until June 2020, as Chief
Executive Officer of Theralink from November 2019 until June 2020 and as Acting Chief Financial Officer of Theralink from June 2020 to
September 2020. He has served on the Board of Directors of Theralink since June 2020. Mr. Kucharchuk also served as Chief Executive Officer
and Chief Financial Officer of OncBioMune, Inc. ("OBMP") prior to Theralink's acquisition of OBMP. Mr. Kucharchuk served
as the Chairman and Chief Operating Officer Adhera Therapeutics, Inc. (OTCMKTS: ATRX) from July 2020 until September 2022 and its Chief
Operations Officer from October 2022 to September 2024. Mr. Kucharchuk is a graduate of Louisiana State University and Tulane University's
Freeman School of Business, where he earned an MBA with a Finance Concentration.

 Directors

 Andrew Cohen, Chief Executive Officer and Director

 Andrew Cohen's business
background information is set forth under "Our Executive Officers" above.

 Daniel Wainstein, Chairman

 Daniel Wainstein has served
as a director and the Chairman of our Board since December 2023. Mr. Wainstein co-Founded, Keystone Capital Partners in 2019. Mr. Wainstein
focuses on both identifying and structuring Keystone's equity and debt investments for both public and private companies. Prior
to Keystone, he co-founded a private investment firm with offices in New York that focuses on strategic real estate acquisitions, asset
acquisitions and investments. Keystone has been the principal investor and general partner in a significant number of transactions including
alternative public offering transactions, PIPE financings, and various structured finance transactions in both the public and private
sectors. Mr. Wainstein earned his bachelor's degree from Hofstra University and his Juris Doctorate from Hofstra University School
of Law.

 Mr. Wainstein's 22
years of experience in and ties to financial markets and his proven record of growth and leadership will provide significant value and
opportunities for acquisitions to the Company and make him well qualified to lead our Board as Chairman.

 Lewis Silberman, Director

 Lewis Silberman has served
as a director since December 2023. Mr. Silberman currently serves as Co-Chief Executive Officer and Director of GSR III Acquisition Corp.,
a blank check company in the process of completing its initial business combination with Terra Innovatum Global S.R.L. Mr. Silberman formerly
served as Co-Chief Executive Officer and Director of GSR II Meteora Acquisition Corp, a blank check company that completed its initial
business combination with Bitcoin Depot Inc. (NASDAQ: BTM) in Q2 2023. Mr. Silberman is Co-Founder and Managing Member of SPAC Advisory
Partners, a boutique M&A and Capital Markets Advisory firm focused on the Special Purpose Acquisition Company market. Previously,
from 2021 to 2022, Mr. Silberman served as Co-President & Director at Graf Acquisition Corp. IV, which successfully closed a SPAC
transaction with NKGen Biotech Inc. (NASDAQ: NKGN) in September 2023. Mr. Silberman has also served as a registered representative of
Kingswood Capital Partners LLC, which is a financial services firm engaged in wealth management, investment banking and other associated
services, since July 2022. From 1998 to 2021, Mr. Silberman served in several roles at Oppenheimer including as head of SPAC Equity Capital
Markets at Oppenheimer prior to Graf Acquisition Corp. IV and led financings for Oppenheimer's SPAC IPOs and business combination
clients and managed all SPAC IPO clients, including a number of sponsor formation processes. Mr. Silberman has acted in an advisory or
placement agent role for transactions multiple business combinations. Before joining Oppenheimer, he spent three years at CIBC World Markets,
working in a special situations client-coverage group focused on strategies including merger-arbitrage, ADR-arbitrage, and closed-end
fund arbitrage. Prior to CIBC World Markets, he worked at PaineWebber. Mr. Silberman has a Bachelor of Science from the Leonard N. Stern
School of Business at New York University and an MBA from the Stern School at New York University. 1

 Mr. Silberman's deep
expertise with SPACs will be invaluable to our Board and makes him qualified to serve as a member of the Company's Board.

 Paul Baron, Director

 Paul Baron is the
former Director of Macro trading for Ben Melkman a Senior Portfolio Manager at Schonfeld Asset Management. In this role he was
responsible for trading management across a team of 4 portfolios managers globally from Syndney to New York. His responsibilities
also included COO for the group which had 10 investment professionals. The team invested globally in rates, FX, equity, commodities,
and credit. The portfolio consisted of macro and relative value positions expressed through options. Prior joining Schonfeld, Mr.
Baron was the Co-CIO for Michael Ovitz's family office of which he has recently rejoined. His primary responsibility is
consulting on the public markets portfolio. Mr. Baron is also Head of Business Development at Enhanced Digital Group
("EDG"). EDG is a whole sale derivatives solutions firm focusing on providing derivatives-based solutions on BTC / ETH
& SOL to institutional based clients. EDG is onshore and adheres to Dodd Frank regulations. Mr. Baron had previously been on EDG
advisory board in 2021 before joining in this role in July 2024. Prior to working in money management, Mr. Baron worked for 23 years
in public markets with industry leaders such as Bank of America, Deutsche Bank and Goldman Sachs; providing coverage and solutions
to institutional clients in equity derivative products. Mr. Baron was a founding member of Big Blind Consulting LLC in October 2006,
which works with various clients consulting on matters related to the financial services industry, and currently serves as its
Manager. Mr. Baron holds a BS from State University of New York at Plattsburgh. Among his non-profit initiatives and work, he is
most proud of his role as Treasurer with Children in Conflict. Children in Conflict, a sister organization to War Child UK, focuses
on targeted global relief programs for children whose lives have been displaced by conflict. Mr. Baron is a proud New Yorker for the
past twenty years, calling it home with his wife and daughter.

 Mr. Baron's experience
in money and portfolio management and leadership provide him with an understanding of acquisition transactions and financial decision
making and make him qualified to serve as a member of our Board.

 Oliver Wiener, Director

 Oliver Wiener has served
as a director since February 2024. He is currently the Founder and Managing Member of Kensington Merchant Partners ("KMP"),
a merchant bank and independent sponsor focused on Financials, Fintech, Insurance and Blockchain verticals. Prior to founding KMP, Oliver
was a Portfolio Manager at Standard Investments. From 2003-2021, Oliver was a founding partner and Senior Managing Director of BTIG LLC,
a global investment bank, with a broad range of activity across multiple business lines including SPACs. In 2018, he was a founding board
member and Board President of The Association for Digital Asset Markets, a self-regulatory organization of digital asset market participants.
Mr. Wiener has served as the Principal General Partner of Tower Street I LP, which is a single asset fund under KMP, since October 2024.
He is currently on the University of Wisconsin-Madison, Technology Entrepreneurship Office Advisor Board and a board advisor to Figment
Inc.

 Mr. Wiener's experience
across financials, investing, experience in structuring, sourcing and board work, makes him qualified to serve as a member of our Board.

 Family Relationships

 No family relationships exist
between any of our directors or executive officers.

 Involvement in Certain Legal Proceedings

 There are no material proceedings
to which any director or executive officer or any associate of any such director or officer is a party adverse to our Company or has a
material interest adverse to our Company.

 Number and Terms of Office of Officers and
Directors

 Our Board is divided into
three classes, with only one class of directors being appointed in each year, and with each class (except for those directors appointed
prior to our first annual general meeting) serving a three-year term. The term of office of the first class of directors, consisting of
Mr. Wainstein, will expire at our first annual general meeting. The term of office of the second class of directors, consisting of Mr.
Cohen, will expire at our second annual general meeting. The term of office of the third class of directors, consisting of Messrs. Silberman,
Baron and Wiener, will expire at our third annual general meeting.

 Prior to the completion of
an initial business combination, any vacancy on the Board may be filled by a nominee chosen by holders of a majority of our Class B Shares.
In addition, prior to the completion of an initial business combination, holders of a majority of our Class B Shares may remove a member
of the Board for any reason. Without prejudice to the Company's power to appoint a person to be a director pursuant to our third
amended and restated memorandum and articles of association, the directors shall have power at any time to appoint any person who is willing
to act as a director, either to fill a vacancy or as an additional director.

 Our officers are appointed
by the Board and serve at the discretion of the Board, rather than for specific terms of office. Our Board is authorized to appoint persons
to the offices set forth in our third amended and restated memorandum and articles of association as it deems appropriate. Our third amended
and restated memorandum and articles of association provides that our officers may consist of one or more chairman of the Board, chief
executive officers, presidents, a chief financial officer, a treasurer, vice-presidents, one or more assistant vice-presidents, one or
more assistant treasurers and one or more assistant secretaries and such other offices as may be determined by the Board.

 Director Independence

 The rules of OTCQB require
that at least two members of our Board be independent. An "independent director" is defined generally as a person other than
an officer or employee of the company or its subsidiaries or any other individual having a relationship with the company which in the
opinion of the Board, could interfere with the director's exercise of independent judgment in carrying out the responsibilities
of a director. We have "independent directors" as defined in OTCQB's listing standards and applicable SEC rules. Our
Board has determined that Messrs. Wainstein, Silberman, Baron and Wiener are "independent directors" as defined in OTCQB's
listing standards and applicable SEC rules.

 Our independent directors
have regularly scheduled meetings at which only independent directors are present.

 Committees of the Board

 Our Board has three standing
committees: an audit committee, a nominating committee and a compensation committee. Subject to phase-in rules and a limited exception,
OTCQB rules require that the audit committee of a listed company be comprised of a majority of independent directors. Each committee operates
under a charter that has been approved by our Board and has the composition and responsibilities described below. The charter of each
committee is available on our website at

 Audit Committee

 We
have established an audit committee of the Board. Mr. Baron serves as the Chairman of the audit committee and Messrs. Silberman and Wiener
serve as members of the audit committee.

 The Board has determined
that each member of the audit committee is independent, and that Mr. Baron qualifies as an "audit committee financial expert"
as defined in applicable SEC rules and has accounting or related financial management expertise.

 The audit committee is responsible
for:

 meeting with our independent registered public accounting firm regarding, among other issues, audits,
and adequacy of our accounting and control systems;

 monitoring the independence of the independent registered public accounting firm;

 verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the
audit and the audit partner responsible for reviewing the audit as required by law;

 inquiring and discussing with management our compliance with applicable laws and regulations;

 pre-approving all audit services and permitted non-audit services to be performed by our independent registered
public accounting firm, including the fees and terms of the services to be performed;

 appointing or replacing the independent registered public accounting firm;

 determining the compensation and oversight of the work of the independent registered public accounting
firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose
of preparing or issuing an audit report or related work;

 establishing procedures for the receipt, retention and treatment of complaints received by us regarding
accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies;
and

 reviewing and approving all payments made to our existing shareholders, executive officers or directors
and their respective affiliates.

 Nominating Committee

 We have established a nominating
committee of our Board. The members of our nominating committee are Messrs. Wainstein and Baron. Mr. Wainstein serves as chairman of the
nominating committee. Our Board has determined that each of are independent.

 The nominating committee
is responsible for overseeing the selection of persons to be nominated to serve on our Board. The nominating committee considers persons
identified by its members, management, shareholders, investment bankers and others.

 Guidelines for Selecting Director Nominees

 The guidelines for selecting
nominees, which is specified in the charter, generally provide that persons to be nominated:

 should have demonstrated notable or significant achievements in business, education or public service;

 should possess the requisite intelligence, education and experience to make a significant contribution
to the Board and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and

 should have the highest ethical standards, a strong sense of professionalism and intense dedication to
serving the interests of the shareholders.

 The nominating committee
considers a number of qualifications relating to management and leadership experience, background and integrity and professionalism in
evaluating a person's candidacy for membership on the Board. The nominating committee may require certain skills or attributes,
such as financial or accounting experience, to meet specific Board needs that arise from time to time and will also consider the overall
experience and makeup of its members to obtain a broad and diverse mix of Board members. The nominating committee does not distinguish
among nominees recommended by shareholders and other persons.

 Compensation Committee

 We have established a compensation
committee of our Board. The members of our compensation committee are Messers. Silberman and Baron. Mr. Silberman serves as chairman of
the compensation committee.

 Our Board has determined
that each are independent. We have adopted a compensation committee charter, which details the principal functions of the compensation
committee, including:

 reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive
Officer's compensation, evaluating our Chief Executive Officer's performance in light of such goals and objectives and recommending
the remuneration (if any) of our Chief Executive Officer based on such evaluation for approval by the independent members of the Board;

 reviewing and recommending for Board approval the compensation of all of our other Section 16 executive
officers; reviewing our executive compensation policies and plans;

 implementing and administering our incentive compensation equity-based remuneration plans;

 assisting management in complying with our proxy statement and annual report disclosure requirements;

 review and report to the Board for its consideration any cash incentive compensation plans, option plans
or other equity based plans that provide for payment in the Company's shares or are based on the value of the Company's shares;
and

 producing a report on executive compensation to be included in our annual proxy statement; and reviewing,
evaluating and recommending changes, if appropriate, to the remuneration for directors.

 The charter also provides
that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or
other adviser and is directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before
engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will
consider the independence of each such adviser, including the factors required by the SEC.

 Compensation Committee Interlocks and
Insider Participation

 None of our executive officers
currently serves, and in the past year has not served, as a member of the compensation committee of any entity that has one or more executive
officers serving on our Board.

 Code of Ethics

 We have adopted a Code of
Ethics applicable to our directors, officers and employees. A copy of the Code of Ethics is available on the Company's website at
 The information contained on our website is not part of this Report. We intend to disclose any amendments to or waivers
of certain provisions of our Code of Ethics by filing a Current Report on Form 8-K.

 Insider Trading Policy

 Due to limited resources and
the small number of our management, we do not have an insider trading policy.

 Conflicts of Interest

 Under Cayman Islands law,
directors and officers owe the following fiduciary duties:

 duty to act in good faith in what the director or officer believes to be in the best interests of the
company as a whole;

 duty to exercise powers for the proper purposes for which those powers were conferred and not for a collateral
purpose;

 directors should not improperly fetter the exercise of future discretion;

 duty to exercise powers fairly as between different sections of shareholders;

 duty not to put themselves in a position in which there is a conflict between their duty to the company
and their personal interests; and

 duty to exercise independent judgment.

 In addition to the above,
directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably
diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same
functions as are carried out by that director in relation to the company and the general knowledge skill and experience of that director.

 As set out above, directors
have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit
as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized
in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of disclosure made in
accordance with the provisions of the second amended and restated memorandum and articles of association.

 Some of our officers and
directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to another entity, pursuant
to which such officer or director is or will be required to present a business combination opportunity to such entity. Furthermore, if
any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she
has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present
such business combination opportunity to such entity, and may only decide to present it to us if such entity rejects the opportunity and
consummating the same would not violate any restrictive covenants to which such officers and directors are subject. Notwithstanding the
foregoing, we may pursue an Affiliated Joint Acquisition opportunity with an entity to which an officer or director has a fiduciary or
contractual obligation. Any such entity may co-invest with us in the partner business at the time of our initial business combination,
or we could raise additional proceeds to complete the acquisition by issuing to such entity a class of equity or equity-linked securities.
Our third amended and restated memorandum and articles of association provides that we renounce our interest in any corporate opportunity
offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director
or officer of the company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable
for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal
obligation.

 In addition, Fulton AC and
our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business
or investment ventures during the period in which we are seeking an initial business combination. Any such companies, businesses or investments
may present additional conflicts of interest in pursuing an initial business combination. However, we do not believe that any such potential
conflicts would materially affect our ability to complete our initial business combination.

 Below is a table summarizing
the entities to which our executive officers and directors currently have fiduciary duties, contractual obligations or other material
management relationships:

 INDIVIDUAL

 ENTITY

 ENTITY'S BUSINESS

 AFFILIATION

 Big Blind Consulting LLC

 Consulting

 Manager

 Enhanced Digital Group

 Wholesale Crypto Derivatives Firm

 Head of Business Development

 Children in Conflict

 Non-Profit

 Treasurer

 CREO Investments LLC

 Investment Vehicle

 Managing Member

 Fulton AC I LLC

 SPAC Sponsor

 Managing Member

 Kitty Hawk Capital LLC

 Investment Vehicle

 Managing Partner

 Kitty Hawk Capital II LLC

 Investment Vehicle

 Managing Partner

 SPAC Advisory Partners, LLC

 Financial advisory firm focused on the special purpose acquisition company market

 Co-Founder, Partner

 GSR III Meteroa Acquisition Corp.

 Special purpose acquisition company

 Board Member, Co-Chief Executive Officer

 Kingswood Capital Partners LLC

 FINRA registered broker dealer

 Registered Representative

 Oliver Wiener

 Tower Street I LP

 Investment Management

 Principal General Partner

 Potential investors should also be aware of the following other potential
conflicts of interest:

 Our executive officers and directors are not required to, and will not, commit their full time to our
affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination
and their other businesses. We do not intend to have any fulltime employees prior to the completion of our initial business combination.
Each of our executive officers is engaged
in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated
to contribute any specific number of hours per week to our affairs.

 Fulton AC, CBG, CB Co-Investment and our current and former directors and officers have entered into an
agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their Class B Shares and any public
shares purchased during or after the Initial Public Offering in connection with (i) the completion of our initial business combination
and (ii) a shareholder vote to approve an amendment to our third amended and restated memorandum and articles of association (A) that
would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares
redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial
business combination by November 15, 2025 or (B) with respect to any other provision relating to the rights of holders of our Class A
ordinary shares or pre-initial business combination activity. Additionally, Fulton AC, CBG, CB Co-Investment and our current and former
directors and officers have agreed to waive their rights to liquidating distributions from the trust account with respect to their respective
Class B Shares if we fail to complete our initial business combination within the required time period. If we do not complete our initial
business combination within the required time period, the private placement warrants and the underlying securities will expire worthless.
Except as described herein, Fulton AC, CBG, CB Co-Investment and our current and former directors and officers have agreed not to transfer,
assign or sell any of their Class B Shares until the earliest of (A) one year after the completion of our initial business combination
and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00
per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we
complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders
having the right to exchange their ordinary shares for cash, securities or other property. With certain limited exceptions, private placement
warrants and the Class A ordinary shares underlying such warrants, will not be transferable until 30 days following the completion of
our initial business combination. Because each of our executive officers and directors will own ordinary shares or warrants directly or
indirectly, they may have a conflict of interest in determining whether a particular partner business is an appropriate business with
which to effectuate our initial business combination.

 Our officers and directors may have a conflict of interest with respect to evaluating a particular business
combination if the retention or resignation of any such officers and directors was included by a partner business as a condition to any
agreement with respect to our initial business combination.

 We are not prohibited from
pursuing an initial business combination or subsequent transaction with a company that is affiliated with Fulton AC or any of officers
or directors. In the event we seek to complete our initial business combination with a company that is affiliated with Fulton AC or any
of our officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking
firm or an independent valuation or accounting firm that such initial business combination or transaction is fair to our company from
a financial point of view. We are not required to obtain such an opinion in any other context. Furthermore, in no event will Fulton AC
or any of our existing officers or directors, or any of their respective affiliates, be paid by us any finder's fee, consulting
fee or other compensation prior to, or for any services they render in order to effectuate, the completion of our initial business combination.
Further, we reimburse Fulton AC for office space, secretarial and administrative services provided to us in the amount of up to $30,000
per month.

 In addition, Fulton AC of
any of its affiliates may make additional investments in the company in connection with the initial business combination, although, other
than the private placement warrants, Fulton AC and its affiliates have no obligation or current intention to do so. If Fulton AC of any
of its affiliates elects to make additional investments, such proposed investments could influence Fulton AC's motivation to complete
an initial business combination.

 We cannot assure you that
any of the above mentioned conflicts will be resolved in our favor.

 If we seek shareholder approval,
we will complete our initial business combination only if we receive approval required under Cayman Island law. The forms our initial
business combination are mostly likely to take would require approval of the shareholders pursuant to a special resolution under Cayman
Islands law, which requires the affirmative vote of the holders of 2/3s of the then outstanding ordinary shares entitled to attend and
vote at a general meeting of the company. In such case, Fulton AC, CBG, CB Co-Investment and our current and former directors and officers
have agreed to vote their Class B ordinary shares and Class A ordinary shares in favor of our initial business combination.

 Limitation on Liability and Indemnification
of Officers and Directors

 Cayman Islands law does not
limit the extent to which a company's memorandum and articles of association may provide for indemnification of officers and directors,
except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against willful default, willful neglect, civil fraud or the consequences of committing a crime. Our third amended and restated memorandum
and articles of association provides for indemnification of our officers and directors to the extent permitted by law, including for any
liability incurred in their capacities as such, except through their own actual fraud, willful default or willful neglect. We entered
into agreements with our directors and officers to provide contractual indemnification in addition to the indemnification provided for
in our third amended and restated memorandum and articles of association.

 We purchased a policy of
directors' and officers' liability insurance that insures our officers and directors against the cost of defense, settlement
or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.

 Our officers and directors
have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account, and have agreed to waive
any right, title, interest or claim of any kind they may have in the future as a result of, or arising out of, any services provided to
us and will not seek recourse against the trust account for any reason whatsoever (except to the extent they are entitled to funds from
the trust account due to their ownership of public shares). Accordingly, any indemnification provided will only be able to be satisfied
by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination.

 Our indemnification obligations
may discourage shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action,
if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder's investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.

 We believe that these provisions,
the insurance and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.

 Item 11. Executive Compensation

 None of our executive officers
or directors have received any cash compensation for services rendered to us. Commencing on the date that our shares were first listed
on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will reimburse Fulton AC for
office space, secretarial and administrative services provided to us in the amount of up to $30,000 per month. In addition, Fulton AC
and our executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred
in connection with activities on our behalf such as identifying potential partner businesses and performing due diligence on suitable
business combinations. Our audit committee will review on a quarterly basis all payments that were made by us Fulton AC or our executive
officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will be made using funds
held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional
controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred
in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. Other
than these payments and reimbursements, no compensation of any kind, including finder's and consulting fees, will be paid by the
company to Fulton AC and our executive officers and directors, or any of their respective affiliates, prior to completion of our initial
business combination.

 After the completion of
our initial business combination, directors or members of our team who remain with us may be paid consulting or management fees from
the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation
materials or tender offer materials furnished to our shareholders in connection with a proposed business combination. We have not
established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management.
It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors
of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation
to be paid to our executive officers will be determined, or recommended to the Board for determination, either by a compensation
committee constituted solely by independent directors or by a majority of the independent directors on our Board.

 We do not intend to take
any action to ensure that members of our team maintain their positions with us after the consummation of our initial business combination,
although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to
remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain
their positions with us may influence our team's motivation in identifying or selecting a partner business but we do not believe
that the ability of our team to remain with us after the consummation of our initial business combination will be a determining factor
in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers and
directors that provide for benefits upon termination of employment.

 Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

 The following table sets forth information regarding the beneficial
ownership of our ordinary shares as of June 16, 2025 based on information obtained from the persons named below, with respect to the beneficial
ownership of our ordinary shares, by:

 each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary
shares;

 each of our executive officers and directors; and

 and all our executive officers and directors as a group.

 Unless otherwise indicated,
we believe that all persons named in the table have sole voting and investment power with respect to all of our ordinary shares beneficially
owned by them.

 In the table below, percentage
ownership is based on 3,014,736 Class A ordinary shares, including Class A ordinary shares that are included in 29,707 outstanding Units,
and 3,191,000 Class B ordinary shares outstanding as of June 16, 2025. Voting power represents the combined voting power of Class A ordinary
shares and Class B ordinary shares owned beneficially by such person. On all matters to be voted upon, the holders of the Class A ordinary
shares and the Class B ordinary shares vote together as a single class. Currently, all of the Class B ordinary shares are convertible
into Class A ordinary shares on a one-for-one basis.

 Class B ordinary shares (1)(2)

 Class A ordinary shares

 Number of Shares

 Approximate

 Number of Shares

 Approximate

 Approximate

 Name of Beneficial Owners

 Beneficially Owned

 Percentage

of Class

 Beneficially

Owned

 Percentage

of Class

 Percentage of

Outstanding Shares

 Andrew Cohen (3)

 3,035,000

 95.11

 %

 —

 —

 48.91

 %

 Daniel Wainstein (3)

 —

 —

 —

 —

 —

 Andrew Kucharchuk

 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 Oliver Wiener

 —

 —

 —

 —

 —

 All officers and directors as a group (6 individuals) (3)

 3,035,000

 95.11

 %

 —

 —

 48.91

 %

 Fulton AC I LLC (3)

 3,035,000

 95.11

 %

 —

 —

 49.91

 %

 Chain Bridge Group (4)(8)

 —

 *

 1,983,335

 65.79

 %

 31.96

 %

 CB Co-Investment LLC (5)(8)

 —

 —

 575,665

 19.10

 %

 9.28

 %

 TQ Master Fund LP (6)

 —

 —

 249,072

 8.26

 %

 4.01

 %

 Sandia Investment Management LP (7)

 —

 —

 249,072

 8.26

 %

 4.01

 %

 *
 Less than one percent.

 (1)
 Unless otherwise specified, the business address of each of the entity and individual is 8 The Green #
17538 Dover, DE 19901.

 (2)
 Interests shown consist solely of founder shares, classified as Class B Shares. The Class B Shares will
automatically convert into Class A ordinary shares at the time of our initial Business Combination.

 (3)
 Fulton AC I LLC ("Fulton AC") is the record holder of the shares reported herein. Fulton AC
is managed by CREO I LLC ("CREO"). Fulton AC is owned 20% by CREO, 40% by Seven Knots, LLC ("Seven Knots") and
40% by Keystone Capital Partners, LLC ("Keystone"). Daniel Wainstein indirectly, through his ownership interest in Seven Knots
and Keystone, owns approximately 40% of the equity interests of Fulton AC. Mr. Wainstein has no control over the voting and dispositive
decisions regarding the Issuer's securities owned by Fulton AC, which are made solely by CREO or the voting or dispositive decisions
regarding Fulton AC interests owned by Keystone and Seven Knots. Accordingly, Mr. Wainstein will not be deemed to have or share beneficial
ownership of such shares and, for the avoidance of doubt, he expressly disclaims any such beneficial interest to the extent of any pecuniary
interest he may have therein, directly or indirectly.

 (4)
 The managers of Chain Bridge Group are Michael Rolnick, Stephen Bowsher and Christopher Darby. Each manager
of Chain Bridge Group has one vote, and the approval of a majority of the managers is required to approve an action of Chain Bridge Group.
Under the so-called "rule of three," if voting and dispositive decisions regarding an entity's securities are made by
three or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of
the individuals is deemed a beneficial owner of the entity's securities. Based upon the foregoing analysis, no individual manager
of Chain Bridge Group exercises voting or dispositive control over any of the securities held by Chain Bridge Group, even those in which
he directly holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such shares
and, for the avoidance of doubt, each of them expressly disclaims any such beneficial interest to the extent of any pecuniary interest
any of them may have therein, directly or indirectly. The business address of Chain Bridge Group is 330 Primrose Road, Suite 500, Burlingame,
CA 94010.

 (5)
 CB Co-Investment LLC is the record holder of the securities reported herein. As the sole member of CB
Co-Investment LLC, Cowen Investments II LLC may be deemed to beneficially own the securities owned directly by CB Co-Investment LLC. Cowen
Investments II LLC is a wholly owned indirect subsidiary of The Toronto-Dominion Bank. The business address of each of CB Co Investment
LLC and Cowen Investments II LLC is 599 Lexington Avenue, 20th Floor, New York, NY 10022.

 (6)

 The Quarry LP. ("Investment Manager") is the investment advisor to TQ Master Fund LP (the "Quarry Fund"). The Investment Manager, as the investment advisor to the Quarry Fund, may be deemed to beneficially own the shares reported herein. Peter Bremberg, the managing member of The Quarry LLC, the general partner of the Investment Manager may be considered control persons of the Quarry Fund and may be deemed to beneficially own the securities owned directly by Quarry Fund. The business address of each such entity and person is 331 Park Avenue South, 3 rd Floor, New York, NY 10010.

 (7)

 The securities are beneficially owned by Sandia Investment Management L.P. ("Sandia") in its capacity as investment manager to a private investment vehicle and separately managed accounts. Timothy J. Sichler serves as Managing Member of the general partner of Sandia, and in such capacity may be deemed to indirectly beneficially own the securities. The business address of each such entity and person is 201 Washington Street, Boston, MA 02108.

 (8)

 The Class A Shares held by Chain Bridge Group and CB Co-Investment LLC were issued upon conversion of their respective Class B Shares on a one-for-one basis upon adoption of our second amended and restated memorandum and articles of association. Chain Bridge Group and CB Co-Investment LLC each waived their rights to participate in any liquidation of our trust account or other assets with respect such Class A Shares.

 As of June 16, 2025, Fulton
AC and our officers and directors beneficially owned 3,035,000 Class B Shares representing approximately 48.91% of the Company's
issued and outstanding ordinary shares and Fulton AC has the right to elect all of our directors prior to the completion of our initial
business combination. Holders of our public shares will not have the right to elect any directors to our Board prior to the completion
of our initial business combination. Because their ownership block, Fulton AC may be able to effectively influence the outcome of all
other matters requiring approval by our shareholders, including amendments to our third amended and restated memorandum and articles of
association and approval of significant corporate transactions including our initial business combination.

 Fulton AC, our sponsor and
CB Co-Investment and our officers and directors have entered into an agreement with us, pursuant to which they have agreed to waive their
redemption rights with respect to their Class B Shares and any public shares purchased by them in connection with the completion of an
initial business combination. Our sponsor and CB Co-Investment exercised their right to convert all of their Class B Shares immediately
upon adoption of our second amended and restated memorandum and articles of association.

 Changes in Control

 The Company is not aware
of any arrangements, including by pledge by any person of securities of the Company, of any operation which may at a subsequent date result
in a change in control of the Company.

 Item
13. Certain Relationships and Related Transactions, and Director Independence

 As more fully discussed in
the section of the Company's final prospectus entitled "Management — Conflicts of Interest," if any
of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity
to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations
to present such opportunity to such entity. Our officers and directors currently have certain relevant fiduciary duties or contractual
obligations that may take priority over their duties to us.

 We currently maintain our
executive offices at 8 The Green # 17538 Dover, DE 19901. The cost for our use of this space is included in the up to $30,000 per month
fee we pay to Fulton AC for office space, administrative and support services. Upon completion of our initial business combination or
our liquidation, we will cease paying these monthly fees.

 No compensation of any kind,
including finder's and consulting fees, will be paid to Fulton AC and our officers and directors, or any of their respective affiliates,
for services rendered prior to or in connection with the completion of an initial business combination. However, these individuals will
be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential partner
businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments
that were made by us to Fulton AC and our officers, directors or our or their affiliates and will determine which expenses and the amount
of expenses that will be reimbursed.

 There is no cap or ceiling
on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 On October 29, 2024, the
Company and Fulton AC entered into the Dissolution Expense Reimbursement Agreement, pursuant to which Fulton agreed to reimburse the Trust
Account up to $100,000 to pay dissolution expenses if and when the Company is dissolved. The amount of such reimbursements will be included
in the amount distributable holders of Class A ordinary shares of the Company entitled to participate the liquidation of the Trust Account.

 In addition, in order to
finance transaction costs in connection with an intended initial business combination, Fulton AC or an affiliate of Fulton AC or certain
of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination,
we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination
does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds
from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of
$1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants, including as to exercise
price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and
no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than Fulton AC, members of our
team or any of their affiliates as we do not believe third parties will be willing to loan such funds and provide a waiver against any
and all rights to seek access to funds in our trust account.

 After our initial business
combination, members of our team who remain with us may be paid consulting, management or other fees from the combined company with any
and all amounts being fully disclosed to our shareholders, to the extent then known, in the tender offer or proxy solicitation materials,
as applicable, furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution
of such tender offer materials or at the time of a general meeting held to consider our initial business combination, as applicable,
as it will be up to the directors of the post-combination business to determine executive and director compensation.

 Policy for Approval of Related Party Transactions

 The audit committee of our
Board has adopted a charter, providing for the review, approval and/or ratification of "related party transactions," which
are those transactions required to be disclosed pursuant to Item 404 of Regulation S-K as promulgated by the SEC, by the audit committee.
At its meetings, the audit committee shall be provided with the details of each new, existing, or proposed related party transaction,
including the terms of the transaction, any contractual restrictions that the company has already committed to, the business purpose of
the transaction, and the benefits of the transaction to the company and to the relevant related party. Any member of the committee who
has an interest in the related party transaction under review by the committee shall abstain from voting on the approval of the related
party transaction, but may, if so requested by the chairman of the committee, participate in some or all of the committee's discussions
of the related party transaction. Upon completion of its review of the related party transaction, the committee may determine to permit
or to prohibit the related party transaction.

 Item
14. Principal Accountant Fees and Services

 As previously disclosed,
on April 5, 2025, our audit committee terminated the Company's engagement of Frank, Rimerman & Co. LLP as the Company's
independent registered public accounting firm for the fiscal year ending December 31, 2024 and engaged RBSM, LLP ("RBSM")
as the Company's independent public accounting firm for the fiscal year ending December 31, 2024.

 The following is a summary of the fees billed to us for professional services
rendered for the fiscal years ended December 31, 2024 and 2023.

 Audit Fees. During 2024 and 2023, the audit services were provided by Frank Rimerman
& Co LLP. The aggregate fees billed for audit fees by Frank Rimerman & Co LLP, inclusive of required filings with the SEC for
the years ended December 31, 2024 and 2023, totaled $176,390 and $119,655, respectively. The Current auditor RBSM LLP is engaged and is
providing the services in 2025, inclusive of $75,000 of audit fees billed for the audit of the Company's financial statements for
the years ended December 31, 2023 and 2024. We did not pay RBSM any audit fees in the years ended December 31, 2024 and 2023.

 Audit-Related Fees. Audit-related fees
consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our year-end
financial statements and are not reported under "Audit Fees." These services include attest services that are not required
by statute or regulation and consultation concerning financial accounting and reporting standards. We did not pay RBSM any audit-related
fees for the year ended December 31, 2024 and 2023.

 Tax Fees. Tax fees consist of fees billed
for professional services relating to tax compliance, tax planning and tax advice. We did not pay RBSM any tax fees for the year ended
December 31, 2024 and 2023.

 All Other Fees. All other fees consist
of fees billed for all other services. We did not pay RBSM any other fees for the year ended December 31, 2024 and 2023.

 Pre-Approval Policy

 Our audit committee has and
will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and
terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit
committee prior to the completion of the audit).

 Item
15. Exhibits, Financial Statement Schedules

 (a) The following documents are filed as part of this Form 10-K:

 (1)
Financial Statements:

 Page

 Report of Independent Registered Public Accounting Firm

 Balance Sheets

 Statements of Operations

 Statements of Changes in Shareholders' Deficit

 Statements of Cash Flows

 Notes to Financial Statements

 F-7 to F-33

 (2) Financial Statement Schedules:

 None.

 (3)
Exhibits

 We hereby file as part of
this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be inspected and
copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Copies of such
material can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed
rates or on the SEC website at www.sec.gov.

 Exhibit No.

 Description

 1.1

 Underwriting Agreement, dated November 9, 2021, by and among the Registrant, Cowen and Company, LLC and Wells Fargo Securities, LLC (incorporated by reference to Exhibit 1.1 to our Form 8-K filed on November 16, 2021 (File No. 001-41047)).

 1.2

 Business Combination Marketing Agreement, dated November 9, 2021, by and among the Registrant, Cowen and Company, LLC and Wells Fargo Securities, LLC (incorporated by reference to Exhibit 1.2 to our Form 8-K filed on November 16, 2021 (File No. 001-41047)).

 2.1

 Business Combination Agreement, dated as of July 22, 2024, by and among CBRG, HoldCo, CBRG Merger Sub, Company Merger Sub and the Company (incorporated by reference to Exhibit 2.1 to our Form 8-K filed on July 23, 2024 (File No. 001-41047)).

 3.1

 Third Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to our Form 8-K filed on November 19, 2024 (File No. 001-41047)).

 4.1

 Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-1/A filed on April 12, 2021 (File No. 333-254502)).

 4.2

 Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to our Registration Statement on Form S-1/A filed on April 12, 2021 (File No. 333-254502)).

 4.3

 Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to our Registration Statement on Form S-1/A filed on April 12, 2021 (File No. 333-254502)).

 4.4

 Warrant Agreement, dated November 9, 2021, between the Registrant and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.4 to our Form 8-K filed on November 16, 2021 (File No. 001-41047)).

 4.5

 Description of the Registrant's Securities (incorporated by reference to Exhibit 4.5 to our Form 10-K filed on March 29, 2024 (File No. 001-41047).

 4.6

 Form
 of Exchange Note (incorporated by reference to Exhibit 10.1 to our Form 10-Q filed on May 14, 2024 (File No. 001-41047).

 4.7

 Form of Bridge Financing Note (incorporated by reference to Exhibit 4.1 to our Form 8-K filed on July 1, 2024 (File No. 001-41047)).

 10.1

 Investment Management Trust Agreement, dated November 9, 2021, between the Registrant and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on November 16, 2021 (File No. 001-41047)).

 10.2

 Registration and Shareholder Rights Agreement, dated November 9, 2021, among the Registrant, Chain Bridge Group, CB Co-Investment LLC and certain equity holders of the Registrant (incorporated by reference to Exhibit 10.2 to our Form 8-K filed on November 16, 2021 (File No. 001-41047)).

 10.3

 Form of Indemnification Agreement (incorporated by reference to Exhibit 10.4 to our Registration Statement on Form S-1/A filed on April 12, 2021 (File No. 333-254502)).

 10.4

 Administrative Services Agreement, dated November 9, 2021, between the Registrant and Chain Bridge Group (incorporated by reference to Exhibit 10.5 in our Form 8-K filed on November 16, 2021 (File No. 333-254502)).

 10.5

 Amended and Restated Administrative Services Agreement, dated July 14, 2022, between the Registrant and Chain Bridge Group (incorporated by reference to Exhibit 10.6 in our Form 10-K filed on March 17, 2023 (File No. 333-254502)).

 10.6

 Promissory Note, dated as of February 1, 2021, issued to Chain Bridge Group (incorporated by reference to Exhibit 10.6 in our Registration Statement on Form S-1/A filed on November 1, 2021 (File No. 333-254502)).

 10.7

 Letter Agreement between the Registrant, Chain Bridge Group, CB Co-Investment LLC and each director and officer of the Registrant (incorporated by reference to Exhibit 10.9 to our Form 8-K filed on November 16, 2021 (File No. 001-41047)).

 10.8

 Forward Purchase Agreement, dated November 1, 2021, between the Registrant and Franklin Strategic Series — Franklin Growth Opportunities Fund (incorporated by reference to Exhibit 10.15 in our Registration Statement on Form S-1/A filed on November 1, 2021 (File No. 333-254502)).

 10.9

 Form of Non-Redemption Agreement (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on May 11, 2023 (File No. 001-41047)).

 10.10

 Letter Agreement, dated June 15, 2023, between the Company and Mr. Lazarus (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on June 22, 2023 (File No. 001-41047)).

 10.11

 Joinder Agreement, dated June 20, 2023, among the Company, the Sponsor and Mr. Lazarus (incorporated by reference to Exhibit 10.2 to our Form 8-K filed on June 22, 2023 (File No. 001-41047)).

 10.12

 Form of Voting Agreement (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on January 5, 2024 (File No. 0001-41047)).

 10.13

 Convertible Promissory Note, dated December 29, 2023, made by Fulton AC I, LLC (incorporated by reference to Exhibit 10.2 on our Form 8-K filed on January 5, 2024 (File No. 0001-41407)).

 10.14

 Letter Agreement Amendment, dated December 29, 2023, by and among Chain Bridge Group, CB Co-Investment LLC, Fulton AC I, LLC and certain Insiders party thereto (incorporated by reference to Exhibit 10.3 to our Form 8-K filed on January 5, 2024 (File No. 001-41047)).

 10.15

 Services Agreement, dated December 29, 2023, by and between the Company and Fulton AC I, LLC (incorporated by reference to Exhibit 10.4 to our Form 8-K filed on January 5, 2024 (File No. 001-41047)).

 10.16

 Form of RSU Agreement (incorporated by reference to Exhibit 10.5 to our Form 8-K filed on January 5, 2024 (File No. 001-41047)).

 10.17

 Sponsor Letter Agreement, dated as of July 22, 2024, by and among CBRG, the CBRG Sponsor, HoldCo, the Company and the other parties thereto (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on July 23, 2024 (File No. 001-41047)).

 10.18

 Form
 of Company Stockholder Transaction Support Agreement, dated as of July 22, 2024, by and among CBRG, CBRG Sponsor, Company and
 certain Company stockholders (incorporated by reference to Exhibi t 10.2 to our Form 8-K filed on July 23, 2024 (File No.
 001-41047)).

 10.19

 Form of Investor Rights Agreement, dated as of July 22, 2024, by and among CBRG, HoldCo, the CBRG Sponsor and the other parties thereto (incorporated by reference to Exhibit 10.3 to our Form 8-K filed on July 23, 2024 (File No. 001-41047)).

 10.20

 Agreement, dated October 29, 2024, by and between Chain Bridge I and Fulton AC I LLC (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on October 29, 2024 (File No. 001-41047)).

 10.21.1

 Form of Non-Redemption Agreement among Chain Bridge I and certain Backstop Investors signatory thereto (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on November 12, 2024 (File No. 001-41047)).

 10.21.2

 Form Amendment No. 1 to Non-Redemption Agreement among Chain Bridge I and certain Backstop Investors signatory thereto (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on November 13, 2024 (File No. 001-41047)).

 10.22

 Termination
Agreement, dated as of April 7, 2025, between Chain Bridge I and Phytanix Bio (incorporated by reference to Exhibit 10.1 to our Form
8-K filed on April 10, 2025 (File No. 001-41047).

 10.23

 Exchange Agreement by and between Chain Bridge I and Fulton AC I LLC, dated May 9, 2024(incorporated by reference to Exhibit 10.1 to our Form 10-Q filed on May 14, 2024 (File No. 001-41047).

 Code of Business Conduct and Ethics (incorporated by reference to Exhibit 14 to our Form 10-K filed on March 18, 2022 (File No. 001-41047)).

 31.1

 Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)*

 31.2

 Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)*

 32.1

 Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350*

 32.2

 Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350*

 101.INS

 101.SCH

 101.CAL

 101.DEF

 101.LAB

 101.PRE

 Indicates a management contract or compensatory plan or arrangement.

 *
 Filed or furnished herewith

 Item 16. Form 10-K Summary

 SIGNATURES

 Pursuant to the requirements
of Section 13 or 15(d) of the Securities Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its
behalf by the undersigned, thereunto duly authorized.

 Chain Bridge I

 /s/ Andrew Cohen

 Name:

 Title:

 Chief Executive Officer

 /s/ Andrew Kucharchuk

 Name:

 Andrew Kucharchuk

 Title:

 Chief Financial Officer

 POWER OF ATTORNEY

 KNOW ALL MEN BY THESE PRESENTS,
that each individual whose signature appears below hereby constitutes and appoints Andrew Cohen and Andrew Kucharchuk, and each of them
individually, his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him
or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange
Commission any and all amendments to this Report together with all schedules and exhibits thereto, (ii) act on, sign and file with the
Securities and Exchange Commission any and all exhibits to this Report and any and all exhibits and schedules thereto, (iii) act on, sign
and file any and all such certificates, notices, communications, reports, instruments, agreements and other documents as may be necessary
or appropriate in connection therewith and (iv) take any and all such actions which may be necessary or appropriate in connection therewith,
granting unto such agents, proxies and attorneys-in-fact, and each of them individually, full power and authority to do and perform each
and every act and thing necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person,
and hereby approving, ratifying and confirming all that such agents, proxies and attorneys-in-fact, any of them or any of his, her or
their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 Pursuant to the requirements
of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

 Name

 Position

 Date

 /s/ Daniel Wainstein

 Chairman of the Board

 Daniel Wainstein

 /s/ Andrew Cohen

 Chief Executive Officer, Director

 (Principal Executive Officer and the Registrant's authorized signatory in the United States)

 /s/ Andrew Kucharchuk

 Chief Financial Officer

 Andrew Kucharchuk

 (Principal Financial and Accounting Officer)

 /s/ Paul Baron

 /s/ Lewis Silberman

 /s/ Oliver Weiner

 Oliver Wiener

 INDEX TO FINANCIAL STATEMENTS

 Report of Independent Registered Public Accounting Firm (PCAOB ID #587)

 Financial Statements:

 Balance Sheets

 Statements of Operations

 Statements of Changes in Shareholders' Deficit

 Statements of Cash Flows

 Notes to Financial Statements

 F-7 to F-34

 F- 1

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM

 To the Board of Directors and Shareholders of

Chain Bridge I

 Opinion on the Financial Statements

 We have audited the accompanying balance sheets of Chain Bridge I.
(the "Company") as of December 31, 2024 and 2023, and the related statements of operations, shareholders' deficit, and
cash flows for each of the year ended December 31, 2024 and 2023, and the related notes (collectively referred to as the financial statements).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years ended December 31, 2024 and 2023, in
conformity with accounting principles generally accepted in the United States of America.

 Explanatory Paragraph - Going Concern

 The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered recurring losses
from operations, had an accumulated deficit and has a deficit working capital. Additionally, The Company has determined that the insufficient
funds to meet the operating needs of the Company through the liquidation date as well as the mandatory liquidation, should a Business
Combination not occur, and potential subsequent dissolution raise substantial doubt about its ability to continue as a going concern.
Management's plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.

 Basis for Opinion

 These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.

 We conducted our audits in accordance with the standards of the PCAOB.
Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free
of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control
over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. Accordingly, we express no such opinion.

 Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 /s/ RBSM LLP

 We have served as the Company's auditor
since 2025.

 PCAOB ID 587

 New York, NY

 F- 2

 BALANCE SHEETS

 2024

 2023

 Assets

 Current assets:

 Cash

 $
 129,598

 $
 3,898

 Prepaid expenses

 28,000

 3,148

 Total current assets

 157,598

 7,046

 Investments held in Trust Account

 5,285,060

 45,356,234

 Total Assets

 $
 5,442,658

 $
 45,363,280

 Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit:

 Current liabilities:

 Accounts payable

 $
 341,262

 $
 9,065

 Accrued expenses

 580,531

 59,430

 Accrued expenses – related party

 120,000

 —

 Total current liabilities

 1,041,793

 68,495

 Exchange Note – related party

 296,942

 —

 Bridge Financing Note

 1,063,235

 —

 Derivative liabilities

 88,200

 112,460

 Contingently issuable private placement warrants

 4,600

 5,865

 Total Liabilities

 2,494,770

 186,820

 Commitments and Contingencies (Note 6)

 Class A ordinary shares subject to possible redemption; $ 0.0001 par value; 455,736 and 4,151,134 shares at redemption value of $ 11.377 and $ 10.902 per share at December 31, 2024 and 2023, respectively

 5,185,060

 45,256,234

 Shareholders' deficit:

 Preference shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding

 —

 —

 Class A ordinary shares, $ 0.0001 par value; 479,000,000 shares authorized; 2,559,000 and no non-redeemable shares issued or outstanding as of December 31, 2024 and 2023, respectively

 —

 Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 3,191,000 and 5,750,000 shares issued and outstanding as of December 31, 2024 and 2023, respectively

 Additional paid-in capital

 129,497

 863,326

 Accumulated deficit

 ( 2,367,244
)

 ( 943,675
)

 Total shareholders' deficit

 ( 2,237,172
)

 ( 79,774
)

 Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit

 $
 5,442,658

 $
 45,363,280

 The accompanying notes are an integral part
of these financial statements.

 F- 3

 STATEMENTS OF OPERATIONS

 For the Year Ended

 2024

 2023

 General and administrative expenses

 $
 2,062,923

 $
 969,148

 General and administrative expenses - related party

 120,000

 350,323

 Loss from operations

 ( 2,182,923
)

 ( 1,319,471
)

 Other income:

 Change in fair value of derivative liabilities

 24,260

 2,103,247

 Change in fair value of convertible note - related party

 —

 Change in fair value of contingently issuable private placement warrants

 1,265

 1,144,135

 Loss on conversion of note to contingently issuable private placement warrants

 —

 ( 69,293
)

 Gain on forgiveness of legal fees

 —

 18,827

 Gain on extinguishment of FPA

 —

 331,528

 Income from investments held in Trust Account

 733,829

 5,414,145

 Net (loss) income

 $
 ( 1,423,569
)

 $
 7,623,957

 Weighted average shares outstanding of Class A ordinary shares, basic and diluted

 1,269,492

 11,225,914

 Basic and diluted net income per share, Class A ordinary shares

 $
 ( 0.20
)

 $
 0.45

 Weighted average shares outstanding of Class B ordinary shares, basic and diluted

 Basic and diluted net income per share, Class B ordinary shares

 $
 ( 0.20
)

 $
 0.45

 The accompanying notes are an integral part
of these financial statements.

 F- 4

 STATEMENTS OF CHANGES IN SHAREHOLDERS'
DEFICIT

 FOR THE YEAR ENDED DECEMBER 31, 2024 and 2023

 Ordinary Shares

 Additional

 Total

 Class A

 Class B

 Paid-in

 Accumulated

 Shareholders'

 Shares

 Amount

 Shares

 Amount

 Capital

 Deficit

 Deficit

 Balance - December 31, 2022

 —

 $
 —

 $

 $
 —

 $
 ( 3,740,653
)

 $
 ( 3,740,078
)

 Fair value of transferred Class B Shares (non-redemption agreements)

 —

 —

 —

 —

 ( 4,802,931
)

 —

 ( 4,802,931
)

 Deemed capital contribution from non-redemption agreements

 —

 —

 —

 —

 4,802,931

 —

 4,802,931

 Capital contribution from CBG

 —

 —

 —

 —

 1,201,899

 —

 1,201,899

 Net income

 —

 —

 —

 —

 —

 7,623,957

 7,623,957

 Waiver of offering costs allocated to Class A ordinary shares subject
to possible redemption

 —

 —

 —

 —

 248,593

 —

 248,593

 Deemed dividend - increase in redemption value of Class A ordinary shares subject to possible redemption

 —

 —

 —

 —

 ( 587,166
)

 ( 4,826,979
)

 ( 5,414,145
)

 Balance - December 31, 2023

 —

 $
 —

 $

 $
 863,326

 $
 ( 943,675
)

 $
 ( 79,774
)

 Conversion of Class B ordinary shares to Class A ordinary shares

 2,559,000

 ( 2,559,000
)

 ( 256
)

 —

 —

 —

 Net loss

 —

 —

 —

 —

 —

 ( 1,423,569
)

 ( 1,423,569
)

 Deemed dividend - increase in redemption value of Class A ordinary shares subject to possible redemption

 —

 —

 —

 —

 ( 733,829
)

 —

 ( 733,829
)

 Balance - December 31, 2024

 2,559,000

 $

 3,191,000

 $

 $
 129,497

 $
 ( 2,367,244
)

 $
 ( 2,237,172
)

 The accompanying notes are an integral part
of these financial statements.

 F- 5

 STATEMENTS OF CASH FLOWS

 For the Year Ended

 2024

 2023

 Cash Flows from Operating Activities:

 Net (loss) income

 $
 ( 1,423,569
)

 $
 7,623,957

 Adjustments to reconcile net income to net cash used in operating activities:

 Change in fair value of derivative liabilities

 ( 24,260
)

 ( 2,103,247
)

 Change in fair value of convertible note – related party

 —

 ( 839
)

 Change in fair value of contingently issuable private placement warrants

 ( 1,265
)

 ( 1,144,135
)

 Gain on forgiveness of legal fees

 —

 ( 18,827
)

 Gain on extinguishment of FPA

 —

 ( 331,528
)

 Loss on conversion of note to contingently issuable private placement warrants

 —

 69,293

 Income from investments held in Trust Account

 ( 733,829
)

 ( 5,414,145
)

 Changes in operating assets and liabilities:

 Prepaid expenses

 ( 24,852
)

 319,144

 Accounts payable

 641,139

 10,609

 Accrued expenses

 641,101

 53,997

 Net cash used in operating activities

 ( 925,535
)

 ( 935,721
)

 Cash Flows from Investing Activities:

 Cash deposited in Trust Account

 ( 61,615
)

 —

 Cash withdrawn from Trust Account in connection with redemption

 40,866,618

 197,854,025

 Net cash provided by investing activities

 40,805,003

 197,854,025

 Cash Flows from Financing Activities:

 Proceeds from convertible note - related party

 —

 823,299

 Proceeds from Exchange Note - related party

 188,000

 —

 Proceeds from bridge financing note

 863,235

 —

 Sponsor contribution

 61,615

 —

 Redemption of Class A ordinary shares

 ( 40,866,618
)

 ( 197,854,025
)

 Net cash used in financing activities

 ( 39,753,768
)

 ( 197,030,726
)

 Net change in cash

 125,700

 ( 112,422
)

 Cash — beginning of the year

 3,898

 116,320

 Cash — end of the year

 $
 129,598

 $
 3,898

 Supplemental disclosure of noncash financing activities:

 Deemed capital contribution from non-redemption agreements

 $
 —

 $
 4,802,931

 Fair value of transferred Class B Shares (non-redemption agreements)

 $
 —

 $
 ( 4,802,931
)

 Capital contribution from CBG

 $
 —

 $
 1,201,899

 Deemed dividend - increase in redemption value of Class A ordinary shares subject to possible redemption

 $
 733,829

 $
 5,414,144

 Forgiveness of deferred offering costs

 $
 —

 248,953

 Vendor payment made by the convertible note – related party

 $
 —

 $
 28,600

 Convertible note - related party re-classed as contingent issuable warrant

 $
 —

 $
 1,150,000

 Conversion of Class B ordinary shares to Class A ordinary shares

 $

 $
 —

 Vendor payment made by exchange note holder

 $
 108,942

 $
 —

 Vendor payment made by bridge financing note holder

 $
 200,000

 $
 —

 Exchange the Fulton AC Note for the Exchange Note

 $
 265,442

 $
 —

 The accompanying notes are an integral part
of these financial statements.

 F- 6

 DECEMBER 31, 2024 and 2023

 Note 1 — Description of Organization and Business Operations

 Chain Bridge I (the "Company") is
a blank check company incorporated as a Cayman Islands exempted company on January 21, 2021. The Company was incorporated for the purpose
of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or
more businesses ("Business Combination"). The Company is not limited to a particular industry or geographic region for purposes
of consummating a Business Combination.

 All activity for the period from January 21,
2021 (inception) through December 31, 2024 relates to the Company's formation and the initial public offering ("Initial Public
Offering"), which is described below, and since the closing of the Initial Public Offering, the search for a prospective Business
Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at
the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds
derived from the Initial Public Offering. The Company has selected a December 31st fiscal year end.

 The registration statement for the Company's
Initial Public Offering was declared effective on November 9, 2021. On November 15, 2021, the Company consummated its Initial Public
Offering of 23,000,000 units (the "Units" and, with respect to the Class A ordinary shares included in the Units being offered,
the "Public Shares"), including 3,000,000 additional Units to cover over-allotments (the "Over-Allotment Units"),
at $ 10.00 per Unit, generating gross proceeds of $ 230.0 million, and incurring offering costs of approximately $ 5.7 million, of which
approximately $ 254,000 was for offering costs allocated to derivative warrant liabilities.

 Simultaneously with the closing of the Initial
Public Offering, the Company consummated the private placement ("Private Placement") of 10,550,000 warrants (each, a "Private
Placement Warrant" and collectively, the "Private Placement Warrants"), at a price of $ 1.00 per Private Placement Warrant
to Chain Bridge Group ("CBG") and CB Co-Investment LLC ("CB Co-Investment"), generating proceeds of approximately
$ 10.6 million (Note 4).

 In addition, upon closing of the Initial Public
Offering, CB Co-Investment loaned the Company $ 1,150 thousand at no interest (the "CB Co-Investment Loan"). On November 16,
2022, CBG agreed to loan the Company up to $ 1,200 thousand pursuant to an unsecured non-interest bearing convertible promissory note
("Additional Convertible Note"). Such Additional Convertible Note will not be repaid in the event that the Company is unable
to close a Business Combination unless there are funds available outside the Trust Account (as defined below) to do so. Such Additional
Convertible Note would either be paid upon consummation of the Company's initial Business Combination, or, at the discretion of
CBG, converted into additional warrants at a price of $ 1.00 per warrant, which warrants will be identical to the Private Placement Warrants.
The Additional Convertible Note was terminated on December 29, 2023.

 Upon the closing of the Initial Public Offering,
$ 234.6 million ($ 10.20 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering, certain of the proceeds
of the Private Placement and the proceeds from the convertible promissory note issued to CB Co-Investment, were placed in a trust account
("Trust Account") with Continental Stock Transfer & Trust Company acting as trustee and invested in United States "government
securities" within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company
Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the
Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier
of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

 F- 7

2023

 On October 13, 2022, the Company approved an
agreement to grant 30,000 restricted stock units ("RSUs") to David G. Brown, then a member of the Board of Directors, upon
satisfaction of certain circumstances, including the consummation of the Business Combination and shareholder approval of an incentive
plan pursuant to which such RSUs will be issued. Such RSU grant agreement terminated effective December 29, 2023 upon Mr. Brown's
resignation from the Board. (see Note 6).On May 10, 2023, the Company, CBG, and CB Co-Investment entered into non-redemption agreements
with several unaffiliated third parties in exchange for such third parties agreeing not to redeem an aggregate of 4,000,000 ordinary
shares of the Company sold in its Initial Public Offering at an extraordinary general meeting of its shareholders held on May 12, 2023
(the "Special Meeting"). In exchange for the foregoing commitments not to redeem such shares, CBG and CB Co-Investment, as
applicable, agreed to transfer to such third parties an aggregate of 1,000,000 ordinary shares of the Company held by CBG or CB Co-Investment,
as applicable, plus up to an additional aggregate of 500,000 ordinary shares of the Company held by CBG or CB Co-Investment, as applicable,
with such number of additional ordinary shares of the Company to be determined based upon the date of the consummation of the Company's
initial Business Combination. Such transfer of ordinary shares of the Company shall be effected immediately following the consummation
of the Company's initial Business Combination if such third party or third parties continued to hold such shares through the Special
Meeting. In connection with such shareholder vote, the holders of an aggregate of 18,848,866 Class A ordinary shares of the Company exercised
their right to redeem their shares for an aggregate of approximately $ 197,854,025 in cash held in the Trust Account.

 At the Special Meeting, the shareholders of the
Company approved the amendment to the Company's amended and restated memorandum and articles of incorporation (as amended from
time to time, the "Amended and Restated Memorandum and Articles of Association"), which extended the date to consummate a
Business Combination from May 15, 2023 to November 15, 2023, and allowed the board of directors of the Company (the "Board"),
without another shareholder vote, to elect to further extend the date to consummate a Business Combination after November 15, 2023 up
to three times, by an additional month each time, up to February 15, 2024. In November and December 2023, the Company's Board elected
to extend the date through December 15, 2023 and January 15, 2024, respectively.

 On June 13, 2023, the Company received a written
notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that since the Company's
aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq
Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market
value of its outstanding warrants of at least $1 million (the "Warrant Notice"). The Warrant Notice additionally indicates
that the Company, pursuant to the Listing Rules, had until July 28, 2023 to submit a plan to regain compliance. The Company did not submit
to Nasdaq such a plan to regain compliance. Effective September 8, 2023, the Company's warrants ceased trading on the Nasdaq Global
Market.

 On June 14, 2023, the Board approved an agreement
to grant of 30,000 RSUs to Roger Lazarus as compensation for services provided to the Company, upon satisfaction of certain circumstances.
Such RSUs will be granted to Mr. Lazarus upon consummation of a Business Combination and shareholder approval of an incentive plan pursuant
to which such RSUs will be issued, subject to the 2023 RSU Letter Agreement (as defined below). Such RSU grant agreement terminated effective
April 1, 2024 upon Mr. Lazarus' resignation as Chief Financial Officer of the Company. (see Note 6).

 Effective as of December 4, 2023, the Company's
Class A ordinary shares and Units ceased trading on the Nasdaq Global Market and commenced trading on the Nasdaq Capital Market.

 On December 29, 2023 (the "Closing Date"),
the Company, CBG, CB Co-Investment and Fulton AC I LLC ("Fulton AC"), consummated the transactions contemplated by that certain
Securities Purchase Agreement (the "Securities Purchase Agreement"), dated December 8, 2023, pursuant to which Fulton AC
acquired from the CBG and CB Co-Investment an aggregate of (i) 3,035,000 Class B ordinary shares and (ii) warrants to purchase 7,385,000
Class A ordinary shares exercisable 30 days after the consummation of the Company's initial Business Combination.

 As of the Closing Date, and in connection with
the consummation of the transactions contemplated by the Securities Purchase Agreement:

 (1) CB Co-Investment irrevocably agreed to convert
the $ 1.15 million CB Co-Investment loan into contingently issuable Private Placement Warrants (as contemplated and defined in that certain
Warrant Agreement, dated November 9, 2021 by and between the Company and our transfer agent (the "Warrant Agreement")), upon
consummation of the Company's initial Business Combination. Pursuant to its terms, if we do not consummate an initial Business
Combination, the CB Co-Investment Loan will not be repaid, and 805,000, 273,431 and 71,569 of the contingently issuable Private Placement
Warrants will be issued to Fulton AC, CBG and CB Co-Investment, respectively. All other existing indebtedness of the Company was terminated
as of the Closing Date (see Note 5).

 F- 8

2023

 (2) CBG, CB Co-Investment and Mr. Lazarus, our
then Chief Financial Officer, entered into voting agreements (the "Voting Agreements") pursuant to which they agreed to vote
all of the voting securities of the Company that each of them is entitled to vote as of the date thereof or thereafter in favor of the
Amendment Proposal (as defined below). Class A ordinary shares issued upon conversion of Class B ordinary shares will not be entitled
to receive funds from the Trust Account through redemptions or otherwise. Pursuant to the Voting Agreements, each of CBG, CB Co-Investment
and Mr. Lazarus have also agreed to irrevocably exercise such right to convert all of their Class B ordinary shares immediately upon
such approval.

 (3) Fulton AC, CBG, CB Co-Investment and certain
individuals entered into an amendment (the "Letter Agreement Amendment") to that certain letter agreement, dated November
9, 2021, by and among CBG, CB Co-Investment and certain individuals (the "Letter Agreement"), pursuant to which Fulton AC
agreed to become a party to the Letter Agreement and be bound by, and subject to, all of the terms and conditions of the Letter Agreement
and agreed that it will be liable to the Company if and to the extent any claims by a third party (excluding our independent registered
public accounting firm) for services rendered or products sold to us, or a prospective partner business with which we have discussed
entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $ 10.20 per public share and
(ii) the actual amount per share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $ 10.20
per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our
tax obligations, provided that such liability will not apply to any claims by a third party or prospective partner business who executed
a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under our indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities
Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, Fulton AC will not be
responsible to the extent of any liability for such third party claims.

 (4) That certain services agreement, dated November
9, 2021, by and between the Company and CBG pursuant to which CBG provided office space, administrative and support services, was terminated.

 (5) The Company and Franklin Strategic Series
– Franklin Growth Opportunities Fund ("Franklin") entered into a Letter Agreement terminating that certain Forward
Purchase Agreement, dated November 1, 2021, by and between the Company and Franklin (the "Forward Purchase Agreement").

 (6) Additionally, CBG irrevocably agreed to terminate
all outstanding loans to the Company, which included the Additional Convertible Note.

 On December 29, 2023, Fulton AC agreed to loan
the Company up to $ 1.5 million pursuant to an unsecured non-interest bearing convertible promissory note (the "Fulton AC Note")
at no interest in the same form and on the same terms as the Additional Convertible Note. The Fulton AC Note will not be repaid in the
event that the Company is unable to close a Business Combination unless there are funds available outside the Trust Account to do so.
The Fulton AC Note will either be paid upon consummation of the Company's initial Business Combination, or, at the discretion Fulton
AC, converted into additional warrants at a price of $ 1.00 per warrant, which warrants will be identical to the Private Placement Warrants.
Fulton AC also entered into a Services Agreement with the Company on December 29, 2023 (the "Fulton Services Agreement")
pursuant to which the Company will pay Fulton AC up to $ 30,000 per month for the cost of the of the use of the Company's office
space, administrative and support services. Upon completion of our initial Business Combination or our liquidation, we will cease paying
these monthly fees.

 On May 9, 2024, the Company entered into an Exchange
Agreement (the "Exchange Agreement") with Fulton AC, pursuant to which Fulton AC and the Company agreed to exchange (the
"Exchange") the Fulton AC Note for a new unsecured non - interest bearing convertible promissory note (the "Exchange
Note"). The Exchange Note is substantially similar to the Fulton AC Note, except that (i) the governing law and jurisdiction was
changed from New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation of
the Company's initial business combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy
the purchase price of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35 %. No new
consideration was paid in conjunction with the Exchange.

 Effective as of the Closing Date, all of the
Company's officers, other than the Chief Financial Officer, and the entirety of the Board resigned. Further, the size of the Board
was decreased from five to four members. Prior to resigning, the Board appointed Andrew Cohen, Daniel Wainstein, Lewis Silberman and
Paul Baron to fill the Board vacancies and appointed Mr. Cohen as Chief Executive Officer of the Company. Mr. Lazarus, the Company's
Chief Financial Officer continued to serve as the Chief Financial Officer of the Company until his resignation on April 1, 2024. The
Board appointed Andrew Kucharchuk as Chief Financial Officer of the Company, effective April 1, 2024.

 F- 9

2023

 On December 29, 2023, the Company entered into
letter agreements with each Mr. Silberman, Mr. Baron and Mr. Lazarus, pursuant to which, among other things, the Company agreed to grant
each of them 50,000, 50,000 and 70,000 RSUs of the Company, respectively, subject to the terms and conditions set forth therein, including
consummation of a Business Combination and shareholder approval of an incentive plan pursuant to which such RSUs will be issued (each,
a "RSU Award Letter"). The RSU Award Letter issued to Mr. Lazarus terminated effective upon his resignation on April 1, 2024.
As discussed in Note 6 below, on February 21, 2024, the Board of Directors appointed Oliver Wiener as a director and agreed to grant
Mr. Wiener 50,000 RSUs, to be issued after the consummation of an initial Business Combination and approval of an equity incentive plan
by the Company's shareholders, subject to the terms and conditions set forth therein.

 On January 15, 2024, the Board approved extending
the Company's business operations for an additional month, until February 15, 2024, in accordance with the Company's Amended
and Restated Memorandum and Articles of Association.

 On February 7, 2024, the Company held an extraordinary
general meeting of shareholders (the "Meeting"). At the Meeting, the shareholders approved a proposal (the "Amendment
Proposal") to amend and restate, by way of a special resolution, the Company's Amended and Restated Memorandum and Articles
of Association (as amended, the "Second Amended and Restated Memorandum and Articles of Association"), to

 (1) extend from February 15, 2024 (the "Existing
Termination Date") to November 15, 2024 (the "Extended Termination Date"), the date (the "Termination Date")
by which, if the Company has not consummated a Business Combination, the Company must (a) cease all operations except for the purpose
of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem Public Shares; and (c) as
promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining shareholders and
the directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors
and in all cases subject to the other requirements of applicable law;

 (2) provide for the right of the holders of our
Class B ordinary shares, par value $ 0.0001 per share, to convert such shares into shares of our Class A ordinary shares, par value $ 0.0001
per share, on a one-to-one basis at the election of such holders. Class A ordinary shares issued upon conversion of Class B ordinary
shares will not be entitled to receive funds from the Trust Account through redemptions or otherwise; and

 (3) to remove a statement that there are no limits
on the number of ordinary shares which may be issued by the Company and to clarify that the Company may, but is not required to, issue
certificates to evidence ownership of ordinary shares of the Company.

 In connection with the Meeting, the holders of
an aggregate of 3,144,451 Class A ordinary shares of the Company exercised their right to redeem their shares for an aggregate of approximately
$ 34,530,234.77 in cash held in the Trust Account.

 Additionally, pursuant to Fulton AC's agreement
to contribute to the Trust Account an amount of funds determined by reference to the number of shares not redeemed in connection with
the approval of the Amendment Proposal, Fulton AC contributed to the Trust Account $ 22,500 on February 16, 2024 and will contribute $ 5,000
per month on the 16th of each calendar month, commencing on May 16, 2024, until the earliest to occur of the Extended Termination Date,
the consummation of the Business Combination or the winding up of the Company.

 Pursuant to those certain Voting Agreements,
dated December 29, 2023, entered into by each of CBG and CB Co-Investment, effective upon our adoption of the Second Amended and Restated
Memorandum and Articles of Association, CBG and CB Co-Investment exercised their right to convert all of their Class B ordinary shares
(an aggregate of 2,559,000 Class B ordinary shares) on a one-for-one basis into an aggregate of 2,559,000 Class A ordinary shares, which
are not entitled to receive funds from the Trust Account through redemptions or otherwise.

 After the redemptions and conversions discussed
above, 3,565,683 shares of Class A ordinary shares are outstanding, including Class A ordinary shares included in our units, and 3,191,000
shares of Class B ordinary shares are outstanding.

 F- 10

2023

 On November 14, 2024, the Company held an extraordinary
general meeting of its shareholders (the "General Meeting") at which the shareholders voted to amend and restate, by way
of a special resolution, the Company's 2nd amended and restated memorandum and articles of association, to extend from November
15, 2024 to November 15, 2025, the date by which, if the Company has not consummated a merger, share exchange, asset acquisition, share
purchase, reorganization or similar business combination involving the Company, with one or more businesses or entities, the Company
must (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business
days thereafter, redeem the Class A ordinary shares sold in the Company's initial public offering; and (c) as promptly as reasonably
possible following such redemption, subject to the approval of the Company's remaining shareholders and the directors, liquidate
and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject
to the other requirements of applicable law (the "Amendment Proposal").

 In connection with the General Meeting, the holders
of an aggregate of 550,947 Class A Shares of the Company exercised their right to redeem their shares for an aggregate of approximately
$ 6,336,383 in cash held in the Trust Account.

 Additionally, pursuant to Fulton AC's previously
disclosed agreement to contribute to the Trust Account an amount of funds determined by reference to the number of shares not redeemed
in connection with the approval of the Amendment Proposal, Fulton AC contributed to the Trust $ 4,557 on November 16, 2024 and will contribute
to the Trust $ 4,557 per month on the 16th of each calendar month, commencing on December 16, 2024, until the earliest to occur of the
Extended Termination Date, the consummation of the Business Combination or the winding up of the Company.

 After the redemptions discussed above, 3,014,736
shares of Class A Ordinary Shares are outstanding, including Class A Ordinary Shares included in 29,707 of the Company's outstanding
units, and 3,191,000 shares of Class B Ordinary Shares are outstanding.

 On April 1, 2024, Mr. Lazarus, the Chief Financial
Officer of the Company notified the Board of his resignation, effective immediately. Mr. Lazarus served as an advisor to the Company
through the end of April 2024 to ensure a smooth transition. Andrew Kucharchuk, succeeded Mr. Lazarus as the Company's Chief Financial
Officer, effective April 1, 2024. As consideration for Mr. Lazarus serving as an advisor through the end of April 2024, the Company entered
into a letter agreement with Mr. Lazarus, dated April 18, 2024, pursuant to which, among other things, the Company agreed to grant him
 30,000 RSUs in the target company, subject to the terms and conditions set forth therein, including consummation of the Business Combination.

 Mr. Kucharchuk will be compensated pursuant to
a consulting agreement by and between Mr. Kucharchuk and Fulton AC. Pursuant to such consulting agreement, Mr. Kucharchuk received $ 7,500
upon execution of such consulting agreement and will be entitled to receive $ 7,500 per month during the term of such consulting agreement
and Mr. Kucharchuk may be eligible (but not entitled) to special performance bonuses, in such form and amount, if any, to be determined
by Fulton AC in its sole discretion.

 On April 4, 2024, Mr. Kucharchuk become a party
to the Letter Agreement, and became bound by, and subject to, all of the terms and conditions of the Letter Agreement, including certain
transfer restrictions with respect to the Company's securities. Mr. Kucharchuk also entered into an Indemnification Agreement in
the form previously disclosed by the Company providing him contractual rights to indemnification in addition to the indemnification provided
for in the Company's Second Amended and Restated Memorandum and Articles of Association.

 On June 20, 2024, the Company received a written
notice from the Listing Qualifications Department of Nasdaq indicating that the Company no longer complies with the Nasdaq Capital Market
continued listing criteria set forth in Listing Rule 5550(a)(3), which requires the Company to maintain a minimum of 300 public holders
(the "Minimum Public Holder Notice"). The Minimum Public Holder Notice indicates that the Company, pursuant to the Listing
Rules, has 45 calendar days to submit a plan to regain compliance. If Nasdaq accepts the Company's plan, the Company will have
180 calendar days from the date of the Minimum Public Holder Notice to evidence compliance. If Nasdaq were to reject the Company's
plan, Nasdaq rules permit the Company to appeal the decision to a hearings panel.

 The Company has timely submitted a plan to regain
compliance with Rule 5550(a)(3), which contained evidence that the Company has regained compliance.

 On September 13, 2024, the Company was notified
by Nasdaq that the Company had regained compliance with Public Shareholder Rule.

 F- 11

2023

 On October 10, 2024, the Company filed a Proxy
Statement seeking to obtain shareholder approval, among other things, approval of the Amendment Proposal — to amend and restate,
by way of a special resolution, the Company's 2nd amended and restated memorandum and articles of association (the "Existing
Charter"), to extend from November 15, 2024 (the "Existing Termination Date") to November 15, 2025 (the "Extended
Termination Date"), the date (the "Termination Date") by which, if the Company has not consummated a merger, share
exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company, with one or more businesses
or entities (an "Initial Business Combination"), the Company must (a) cease all operations except for the purpose of winding
up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Class A ordinary shares sold in
the Company's initial public offering (the "Public Shares"); and (c) as promptly as reasonably possible following such
redemption, subject to the approval of the Company's remaining shareholders and the directors, liquidate and dissolve, subject
in each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements
of applicable law. The scheduled meeting of shareholders to vote on the proposals stated within the Proxy Statement will be held on November
8, 2024.

 On October 29, 2024, the Company and Fulton AC
entered into an agreement (the "Dissolution Expense Reimbursement Agreement") pursuant to which Fulton agreed to reimburse
the Trust Account up to $ 100,000 to pay dissolution expenses if and when the Company is dissolved. The amount of such reimbursements
will be included in the amount distributable holders of Class A ordinary shares of the Company entitled to participate the liquidation
of the Trust Account.

 On November 7, 2024, the Company determined to
postpone the extraordinary general meeting of shareholders (the "Postponement"), originally scheduled to be held on November
8, 2024 (the "General Meeting"), to allow additional time for the Company to engage with its shareholders. The General Meeting
was held on Thursday, November 14, 2024 at 11:00 a.m., Eastern Time. There was no change to the location or the record date of the General
Meeting. In connection with the Postponement, the right of the public shareholders of the Company to redeem their Class A ordinary shares
for their pro rata portion of the funds available in the Trust Account was extended to 5:30 p.m., Eastern Time, on November 12, 2024
(two business days before the postponed General Meeting) (the "Redemption Deadline Extension").

 On November 11, 2024, the Company entered into
non-redemption agreements (the "Non-Redemption Agreements") with one or more investors named therein (each, a "Backstop
Investor"), pursuant to which the Backstop Investors agreed to rescind or reverse previous elections to redeem up to an aggregate
of 429,180 Class A ordinary shares of the Company, which redemption requests were made in connection with the General Meeting to consider
and vote on, among other proposals, a proposal to amend and restate, by way of a special resolution, the Company's 2nd amended
and restated memorandum and articles of association, to extend from November 15, 2024 to November 15, 2025, the date by which, if the
Company has not consummated a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
involving the Company, with one or more businesses or entities (a "De-Spac Transaction"), the Company must (a) cease all
operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Class A ordinary shares sold in the Company's initial public offering; and (c) as promptly as reasonably possible following
such redemption, subject to the approval of the Company's remaining shareholders and the directors, liquidate and dissolve, subject
in each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements
of applicable law (the "Amendment Proposal"). The Amendment Proposal is described in more detail in the Company's definitive
proxy statement filed with the SEC on October 10, 2024, as amended. The Backstop Investors agree to hold, and not redeem, up to an aggregate
of 128,753 shares of the Class A ordinary shares of the Company (the "Backstop Investor Shares") at the Closing.

 In consideration for the foregoing, upon consummation
of the Company's Initial Business Combination, the Company shall pay or cause to be paid to each Backstop Investor a payment in
respect of its respective Backstop Investor Shares in cash released from the Trust Account in an amount equal to the product of (x) the
number of Backstop Investor Shares and (y) the price per share for a pro rata portion of the amount on deposit in the Trust Account as
of the Closing.

 The Backstop Investors expect to acquire up to
an aggregate of 321,984 Class A ordinary shares of the Company in the open market at or below the Redemption Price (as defined in the
Non- Redemption Agreements) (the "Acquired Shares"). The Backstop Investors agree not to redeem the Acquired Shares and will
not vote Acquired Shares in favor of the Amendment Proposal.

 On November 12, 2024, the Company and each Backstop
Investor entered into Amendment No.1 to Non-Redemption Agreement (the "Amendment") pursuant to which the parties agree to
allow the Backstop Investors to purchase Acquired Shares (as defined in the Agreements) at any time prior to the General Meeting.

 F- 12

2023

 On November 12, 2024, the Company received a
letter from the Listing Qualifications Department of Nasdaq stating that, pursuant to Nasdaq Listing Rule IM-5101-2 ("Rule IM-5101-2"),
the staff of Nasdaq ("Staff") had determined that (i) the Company's securities will be delisted from Nasdaq, (ii) trading
of the Company's Class A ordinary shares and units will be suspended at the opening of business on November 19, 2024 and (iii)
a Form 25-NSE will be filed with the SEC, which will remove the Company's securities from listing and registration on Nasdaq. Under
Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness
of its initial public offering registration statement. Since the Company failed to complete its initial business combination by November
4, 2024, the Staff concluded that the Company did not comply with Rule IM-5101-2 and that the Company's securities are now subject
to delisting.

 Nasdaq suspended that trading of the Company's
Class A ordinary shares and units at the opening of business on November 19, 2024.

 Following the suspension of trading on Nasdaq,
the Company's Class A ordinary shares began trading on the OTCQB Market operated on The OTC Market systems ("OTC")
under the symbol "CBRRF." The Company's warrants and units began trading on the Expert Market operated by OTC under
the symbols "CBRGF" and "CBGGF," respectively. There can be no assurance that a broker will continue to make
a market in the Company's securities or that trading of the common stock will continue on an over-the-counter market or elsewhere.

 Nasdaq will complete the delisting by filing
a Form 25-NSE with the U.S. Securities and Exchange Commission (the "SEC"), which will remove the Company's securities
from listing and registration on Nasdaq.

 We do not expect the delisting to impact our
ability to consummate the previously disclosed business combination with Phtytanix Bio (the "Phytanix Business Combination").
Regardless of where our securities are traded, the surviving Company will apply to list its securities on Nasdaq Capital Markets upon
consummation of the Phytanix Business Combination. However, if the Phytanix Business Combination is not consummated, the delisting will
have a material adverse impact on our ability to locate another target for an initial business combination, and would likely cause us
to enter liquidation. If we are required to liquidate, our shareholders would not be able to realize the benefits of owning stock in
a successor operating business, including the potential appreciation in the value of our stock and warrants following such a transaction,
and our warrants would expire worthless.

 On November 14, 2024, the Company held its General
Meeting at which the shareholders voted to approve the Amendment Proposal.

 In connection with the General Meeting, the holders
of an aggregate of 550,947 Class A ordinary shares of the Company exercised their right to redeem their shares for an aggregate of approximately
$ 6,336,383 in cash held in the Trust Account.

 Additionally, pursuant to Fulton AC's previously
disclosed agreement to contribute to the Trust Account an amount of funds determined by reference to the number of shares not redeemed
in connection with the approval of the Amendment Proposal, Fulton AC contributed to the Trust Account $ 4,557 on November 16, 2024 and
will contribute to the Trust Account $ 4,557 per month on the 16th of each calendar month, commencing on December 16, 2024, until the
earliest to occur of the Extended Termination Date, the consummation of the Business Combination or the winding up of the Company.

 The Company's management has broad discretion
with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants
and the proceeds from the promissory note issued to CB Co-Investment, although substantially all of the net proceeds are intended to
be applied generally toward consummating a Business Combination. The Company's initial Business Combination must be with one or
more operating businesses or assets with a fair value equal to at least 80 % of the net assets held in the Trust Account (excluding taxes
payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial
Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires
 50 % or more of the outstanding voting securities of the partner business or otherwise acquires a controlling interest in the partner
business sufficient for it not to be required to register as an investment company under the Investment Company Act.

 F- 13

2023

 The Company will provide its holders of the Public
Shares (the "Public Shareholders") with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender
offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the
amount then in the Trust Account. The Company expects the pro rata price to be at least $ 10.20 per share, plus any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). These Public Shares
will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance
with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 480 "Distinguishing
Liabilities from Equity" ("ASC Topic 480"). In such case, the Company will proceed with a Business Combination if the
Company has net tangible assets of at least $ 5,000,001 upon the consummation of such Business Combination and a majority of the shares
voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing
requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to
the Second Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of
the U.S. Securities and Exchange Commission (the "SEC"), and file tender offer documents with the SEC prior to completing
a Business Combination. If, however, a shareholder approval of the transactions is required by applicable law or stock exchange listing
requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public
Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether
they were a Public Shareholder on the record date for the general meeting held to approve the proposed transaction. If the Company seeks
shareholder approval in connection with a Business Combination, Fulton AC, CBG, CB Co-Investment and our current and former directors
and officers agreed to vote their Class B ordinary shares (as defined in Note 5) and any Public Shares purchased during or after the
Initial Public Offering in favor of a Business Combination. In addition, Fulton AC, CBG, CB Co-Investment and our current and former
directors and officers agreed to waive their redemption rights with respect to their Class B ordinary shares and Public Shares in connection
with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an
initial Business Combination without the prior consent of Fulton AC.

 Notwithstanding the foregoing, the Company's
Second Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of
such shareholder or any other person with whom such shareholder is acting in concert or as a "group" (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares
with respect to more than an aggregate of 15 % or more of the Class A ordinary shares sold in the Initial Public Offering, without the
prior consent of the Company.

 Fulton AC, CBG, CB Co-Investment and our current
and former directors and officers have agreed to waive their liquidation rights with respect Class B ordinary shares held by them if
the Company fails to complete a Business Combination by the Termination Date. However, if such shareholders acquire Public Shares, they
will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete
a Business Combination by the Termination Date. The underwriters agreed to waive their rights to the Marketing Fee (see Note 6) held
in the Trust Account in the event the Company does not complete a Business Combination by the Termination Date and, in such event, such
amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company's
Public Shares. The Marketing Fee was waived as of December 29, 2023.

 Emerging Growth
Company

 The Company is an "emerging growth company,"
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS
Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public
companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in
its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and shareholder approval of any golden parachute payments not previously approved.

 F- 14

2023

 Further, Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private
companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities
registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides
that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the
new or revised standard. This may make comparison of the Company's financial statement with another public company which is neither
an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible
because of the potential differences in accounting standards used.

 Risks and Uncertainties

 Management continues to evaluate the current
or anticipated military conflicts, including between Russia and Ukraine, and Israel and Hamas, terrorism, sanctions or other geopolitical
events as well as adverse developments in the economy and capital markets, including rising energy costs, inflation and interest rates,
in the United States and globally, on the industry and has concluded that while it is reasonably possible that these events could have
a negative effect on the Company's financial position, results of its operations and/or search for a target company, the specific
impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.

 Liquidity and Capital Resources

 As of December 31, 2024, the Company had $ 129,598 in its operating
bank account and a working capital deficit of $ 884,195.

 The Company's liquidity needs prior to
the consummation of the Initial Public Offering were satisfied through the payment of $ 25,000 from CBG and CB Co-Investment to cover
for certain expenses on behalf of the Company in exchange for issuance of Class B ordinary shares (as defined in Note 5) and a loan from
related party of approximately $ 244,000. The Company fully repaid the Note on November 17, 2021. Subsequent to the consummation of the
Initial Public Offering, the Company's liquidity has been satisfied through the net proceeds from the consummation of the Initial
Public Offering, the Private Placement held outside of the Trust Account and the issuance of the Convertible Note, the Additional Convertible
Note and the Fulton AC Note. On December 29, 2023, Fulton AC agreed to loan the Company up to $ 1.5 million pursuant to the Fulton AC
Note at no interest in the same form and on the same terms as the Additional Convertible Note with CBG which was terminated on December
29, 2023.

 On May 9, 2024, the Company entered into the
Exchange Agreement with Fulton, pursuant to which Fulton and the Company agreed to Exchange the Fulton AC Note for the Exchange Note.
The Exchange Note is substantially similar to the Fulton AC Note, except that (i) the governing law and jurisdiction was changed from
New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation of the Company's
initial business combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy the purchase price
of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35 %. At this time the Company
does not have any agreements, written or oral, for any subsequent offering of Company securities. No new consideration was paid in conjunction
with the Exchange. As of December 31, 2024, the Company has an outstanding balance of $ 296,942 under the Exchange Note.

 On June 26, 2024, Phytanix Bio ("Phytanix")
agreed to loan the Company $ 1,590,995.12, pursuant to an unsecured non - interest bearing promissory note (the "Bridge Financing
Note"). The maturity date of the Bridge Financing Note is the later of (x) June 29, 2025 and (y) the consummation of the Company's
initial business combination. The Bridge Financing Note may not be repaid with funds from the trust account that the Company established
for the benefit of its public holders. The proceeds from the Bridge Financing Note will be used (i) to pay off certain working capital
loans issued by the Company to Fulton AC, (ii) to pay for certain fees and expenses incurred in connection with the transactions contemplated
in the Bridge Financing Note and the Company's initial business combination and (iii) for other general corporate purposes. As
of December 31, 2024, the outstanding balance under the Bridge Financing Note was $ 1,063,235 in the accompanying balance sheets.

 The Company has until November 15, 2025 to consummate
an initial Business Combination. If the Company has not consummated a Business Combination by November 15, 2025, the Company must (a)
cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares; and (c) as promptly as reasonably possible following such redemption, subject to the approval of
the Company's remaining shareholders and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman
Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.

 F- 15

2023

 In connection with our assessment of going concern
considerations in accordance with FASB Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about
an Entity's Ability to Continue as a Going Concern," the Company has determined that the liquidity condition and the date
for mandatory liquidation and subsequent dissolution raises substantial doubt about the Company's ability to continue as a going
concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after
November 15, 2025. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue
as a going concern.

 Investment Company Act

 Under the current rules and regulations of the
SEC we are not deemed an investment company for purposes of the Investment Company Act; however, on March 30, 2022, the SEC proposed new
rules (the "Proposed Rules") relating, among other matters, to the circumstances in which SPACs such as the Company could
potentially be subject to the Investment Company Act and the regulations thereunder. The Proposed Rules provide a safe harbor for companies
from the definition of "investment company" under Section 3(a)(1)(A) of the Investment Company Act, provided that a SPAC satisfies
certain criteria. To comply with the duration limitation of the proposed safe harbor, a SPAC would have a limited time period to announce
and complete a de-SPAC transaction. Specifically, to comply with the safe harbor, the Proposed Rules would require a company to file a
Current Report on Form 8-K announcing that it has entered into an agreement with a target company for an initial Business Combination
no later than 18 months after the effective date of the SPAC's registration statement for its IPO. The Company would then be required
to complete its initial Business Combination no later than 24 months after the effective date of such registration statement. There is
currently uncertainty concerning the applicability of the Investment Company Act to a SPAC, including this Company. The Company has not
yet entered into a definitive Business Combination agreement, however, there is a risk that the Company may not complete an initial Business
Combination within 24 months of such date. As a result, it is possible that a claim could be made that the Company has been operating
as an unregistered investment company. If the Company were deemed to be an investment company for purposes of the Investment Company Act,
the Company may be forced to abandon its efforts to complete an initial Business Combination and instead be required to liquidate. If
the Company is required to liquidate, the investors would not be able to realize the benefits of owning stock in a successor operating
business, including the potential appreciation in the value of our stock and warrants following such a transaction.

 The Investment Company Act defines an investment
company as any issuer which

 (i)
 is or holds itself out as being engaged primarily, or proposes
to engage primarily, in the business of investing, reinvesting, or trading in securities;

 (ii)
 is engaged or proposes to engage in the business of issuing
face-amount certificates of the installment type, or has been engaged in such business and has any such certificate outstanding; or

 (iii)
 is engaged or proposes to engage in the business of investing,
reinvesting, owning, holding, or trading in securities, and owns or proposes to acquire investment securities having a value exceeding
 40 % of the value of its total assets (exclusive of Government securities and cash items) on an unconsolidated basis.

 The Company has assessed its primary line of business,
and the value of its investment securities as compared to the value of total assets to determine whether the Company may be deemed an
investment company. The longer that the funds in the Trust Account are held in money market funds, there is a greater risk that the Company
may be considered an unregistered investment company. As a result, the Company has switched all funds to cash, and will likely receive
minimal interest, if any, in the funds held in the Trust Account after such time, which would reduce the dollar amount our public stockholders
would receive upon any redemption or liquidation of our Company. Currently, the funds in the Trust Account are held in mutual funds composed
of U.S. treasury securities and meeting certain conditions under Rule 2a-7 under the Investment Company Act.

 The Investment Company Act defines an investment
company as any issuer which:

 1.
 Is or holds itself out as being engaged primarily in the
business of investing, reinvesting, or trading in securities;

 2.
 Is engaged or proposes to engage in the business of issuing
face-amount certificates of the installment type; or

 3.
 Owns or proposes to acquire investment securities having
a value exceeding 40 % of the value of its total assets (exclusive of Government securities and cash items) on an unconsolidated basis.

 F- 16

2023

 In January 2024, the SEC adopted rules providing
guidance for SPACs analyzing their status under the Investment Company Act of 1940. This guidance emphasizes enhanced investor protections,
transparency in business combination transactions, and the importance of ensuring compliance with the definition of a "business"
under ASC 805-10-55. The safe harbor provision under the guidance requires SPACs to:

 Identify and enter into a de-SPAC transaction agreement within
18 months of their IPO; and

 Complete the de-SPAC transaction within 24 months of their
IPO.

 Failure to meet these criteria could result in
the SPAC being deemed an unregistered investment company under the Act, requiring liquidation and potentially preventing completion of
the proposed transaction. The Company completed its IPO within the SEC's safe harbor timeline, and has not yet entered into a business
combination, less than 48 months after its IPO. The transaction is expected to close within the SEC's prescribed 48-month timeline.
Currently, the Company does not hold itself out as being engaged in investing, reinvesting, or trading in securities. All funds in the
Trust Account is held in mutual funds composed of U.S. treasury securities that comply with Rule 2a-7 under the Investment Company Act.
The funds are not invested in marketable securities to avoid the risk of being deemed an unregistered investment company.

 As of the date of this filing, the Company's
Trust Account remains compliant with the safe harbor criteria outlined in SEC Release No. 33-11265. If the Company were deemed to be an
unregistered investment company under the Investment Company Act, it could be forced to abandon the Business Combination and liquidate.
In such a scenario, public stockholders would lose the opportunity to benefit from potential appreciation in the value of the Company's
stock and warrants following the Business Combination. In conclusion, the Company is committed to ensuring compliance with the Investment
Company Act and the updated SEC guidance. By adhering to the safe harbor provisions, the Company seeks to mitigate risks associated with
the potential application of the Investment Company Act.

 Note 2 — Basis of Presentation and Summary of Significant
Accounting Policies

 Basis of Presentation

 The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.
GAAP") and pursuant to the accounting and disclosure rules and regulations of the SEC.

 Use of Estimates

 The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the
reporting period. Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate
of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management
considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates.

 Cash and Cash Equivalents

 The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2024 and 2023, the Company
had no cash equivalents.

 Cash and Investments Held in Trust Account

 At December 31, 2024 and 2023, the assets held
in the Trust Account, amounting to $ 5,285,060 and $ 45,356,234, respectively, were held in mutual funds composed of U.S. treasury securities.
Investments in mutual funds are presented on the balance sheets at fair value at the end of each reporting period. The estimated fair
values of investments held in the Trust Account are determined using available market information.

 Assets held in the Trust Account will not be released
from the Trust Account until the completion of its initial business combination or to the public shareholders until the earliest of the
completion of an initial business combination and in connection with those Class A ordinary shares that such shareholders properly elect
to redeem.

 Concentration of Credit Risk

 Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal
Deposit Insurance Corporation ("FDIC") coverage limit of $ 250,000 per institution. The Company has not experienced losses
on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 F- 17

2023

 Financial Instruments

 The fair value of the Company's assets
and liabilities which qualify as financial instruments under the ASC Topic 820, "Fair Value Measurements" ("ASC Topic
820"), equal or approximate the carrying amounts represented in the balance sheets primarily due to their short-term nature.

 Fair Value Measurements

 Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

 Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical
 instruments in active markets;

 Level 2, defined as inputs other than quoted prices in active markets that are either
 directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical
 or similar instruments in markets that are not active; and

 Level 3, defined as unobservable inputs in which little or no market data exists, therefore
 requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant
 inputs or significant value drivers are unobservable.

 In some circumstances, the inputs used to measure
fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is
categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 Offering Costs Associated with the Initial Public Offering

 The Company complies with the requirements of
ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related
to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial
instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering
costs allocated to the derivative warrant liabilities were charged to operations. Offering costs associated with the Class A ordinary
shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial
Public Offering.

 Derivative Financial Instruments

 The Company does not use derivative instruments
to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of the financial instruments, including
issued stock purchase warrants, and forward purchase agreements, to determine if such instruments are derivatives or contain features
that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Topic 815, "Derivatives and Hedging" ("ASC
Topic 815"). The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, will be re-assessed at the end of each reporting period. Derivative warrant liabilities will be classified as non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 The 22,050,000 warrants that were issued in connection
with the Initial Public Offering (including the 11,500,000 warrants included in the Units and the 10,550,000 Private Placement Warrants)
and the 4,000,000 forward purchase securities ("Forward Purchase Securities"), were recognized as derivative liabilities
in accordance with ASC Topic 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and adjust
the instruments to fair value at each reporting period. The liabilities will be subject to re-measurement at each balance sheet date
until exercised. The fair value of the Forward Purchase Securities, Public Warrants (as defined below) and the Private Placement Warrants
were initially measured using a Monte Carlo simulation. The fair value of Public Warrants issued in connection with the Initial Public
Offering have subsequently been measured based on the listed market price of such Public Warrants. On December 26, 2023, in connection
with the Securities Purchase Agreement, the Forward Purchase Agreement was terminated and the Convertible Note was converted into contingently
issuable private placement warrants on the balance sheet and marked to market at each reporting period (Note 5). As of December 31, 2024
and 2023, the fair value of Private Placement Warrants and contingently issuable Private Placement Warrants was determined based on the
quoted price of the Public Warrants.

 F- 18

2023

 Class A ordinary shares Subject to Possible Redemption

 The Company accounts for the Class A ordinary
shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory
redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary
shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other
times, Class A ordinary shares are classified as shareholders' equity. The Company's Class A ordinary shares feature certain
redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly,
as of December 31, 2024 and 2023, 455,736 and 4,151,134 Class A ordinary shares subject to possible redemption are presented at redemption
value as temporary equity, outside of the shareholders' deficit section of the Company's balance sheets, respectively.

 On May 12, 2023, the Company held the Special
Meeting at which the Company's shareholders approved a proposal to amend the Company's existing Amended and Restated Memorandum
and Articles of Association to extend from May 15, 2023 to November 15, 2023 (the "Extended Date") and to allow the board
of directors of the Company, without another shareholder vote, to elect to further extend the date to consummate an initial Business
Combination after the Extended Date up to three times, by an additional month each time, up to February 15, 2024, the date by which,
if the Company has not consummated an initial Business Combination, the Company must: (a) cease all operations except for the purpose
of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the shares sold in the Company's
Initial Public Offering; and (c) as promptly as reasonably possible following such redemption, subject to the approval of the Company's
remaining shareholders and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to
provide for claims of creditors and in all cases subject to the other requirements of applicable law. In connection with such shareholder
vote, the holders of an aggregate of 18,848,866 Class A ordinary shares of the Company exercised their right to redeem their shares for
an aggregate of approximately $ 197,854,025 in cash held in the Trust Account.

 On December 13, 2023 and January 15, 2024, the
Board adopted resolutions to extend the Company's business operations until January 15, 2024 and February 15, 2024, respectively.

 On February 7, 2024, the Company held the Meeting,
at which the shareholders voted on the Amendment Proposal. Shareholders voted to approve the Amendment Proposal. In connection with the
Meeting, the holders of an aggregate of 3,144,451 Class A ordinary shares of the Company exercised their right to redeem their shares
for an aggregate of approximately $ 34,530,234.77 in cash held in the Trust Account.

 On November 14, 2024, the Company held its General
Meeting at which the shareholders voted to approve the Amendment Proposal. In connection with the General Meeting, the holders of an aggregate
of 550,947 Class A ordinary shares of the Company exercised their right to redeem their shares for an aggregate of approximately $ 6,336,383
in cash held in the Trust Account.

 The Company recognizes changes in redemption
value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal
the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the
redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment
option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in capital (to the extent available) and accumulated deficit.

 As of December 31, 2024 and 2023, the amounts
of Class A ordinary shares reflected on the balance sheets are reconciled in the following table:

 Class A ordinary shares subject to possible redemption, December 31, 2022

 237,696,114

 Plus:

 Deemed dividend - increase in redemption value of Class A ordinary shares subject to possible redemption

 5,414,145

 Less:

 Redemptions of Class A ordinary shares

 ( 197,854,025
)

 Class A ordinary shares subject to possible redemption, December 31, 2023

 $
 45,256,234

 Plus:

 Deemed dividend - increase in redemption value of Class A ordinary shares subject to possible redemption

 733,829

 Proceeds received from Sponsor for Trust Account contribution

 61,615

 Less:

 Redemptions of Class A ordinary shares

 ( 40,866,618
)

 Class A ordinary shares subject to possible redemption, December 31, 2024

 $
 5,185,060

 F- 19

2023

 Net (Loss) Income Per Share

 The Company complies with accounting and disclosure
requirements of ASC Topic 260, "Earnings Per Share" ("ASC Topic 260"). The Company has two classes of shares,
which are referred to as Class A ordinary shares and Class B ordinary shares. Income (Loss) is shared pro rata between the two classes
of shares. Net (loss) income per ordinary share is calculated by dividing the net income (loss) by the weighted average shares of ordinary
shares outstanding for the respective period.

 The calculation of diluted net (loss) income
per share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation
of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 23,200,000 Class A ordinary shares in the calculation
of diluted (loss) income per share, because their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted
net (loss) income) per share is the same as basic net (loss) income per share for the year ended December 31, 2024 and 2023. Accretion
associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair
value.

 The Company has considered the effect of Class
B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by
the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the
beginning of the period to determine the dilutive impact of these shares.

 For the Year Ended

 2024

 2023

 Class A

 Redeemable

 Class A and

Class B Non-

Redeemable

 Class A

Redeemable

 Class B Non-

Redeemable

 Basic and diluted net (loss) income per ordinary share

 Numerator:

 Allocation of net (loss) income

 $
 ( 257,456
)

 $
 ( 1,166,113
)

 $
 5,041,607

 $
 2,582,350

 Denominator:

 Basic and diluted weighted average ordinary shares outstanding

 1,269,492

 11,225,914

 Basic and diluted net (loss) income per ordinary share

 $
 ( 0.20
)

 $
 ( 0.20
)

 $
 0.45

 $
 0.45

 Income Taxes

 ASC Topic 740 accounts for income taxes requiring an asset and liability
approach to financial accounting and reporting for income taxes including the parameters for the recognition of deferred tax assets and
liabilities. The Company is exempt from Cayman Islands as well as US taxation. Accordingly, there is no reported tax provision nor any
net deferred tax asset or liability position in the accompanying financial statements.

 Recent Accounting Pronouncements

 In June 2022, the FASB issued ASU 2022-03, ASC
Topic 820 "Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions". The ASU amends ASC Topic
820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce
new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies
to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for
the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted
for both interim and annual financial statements that have not yet been issued or made available for issuance. The adoption of ASU 2023-09
did not have a material impact on the Company's financial statements and disclosures.

 In December 2023, the FASB issued ASU 2023-09,
Income Taxes (ASC Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax
information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09
is effective for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company's management does not
believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures.

 F- 20

2023

 In March 2024, the FASB issued ASU No. 2024-01,
"Compensation—Stock Compensation (Topic 718): Scope Applications of Profits Interests and Similar Awards" ("ASU
2024-01"). ASU 2024-01 adds an example to Topic 718 which illustrates how to apply the scope guidance to determine whether profits
interests and similar awards should be accounted for as share-based payment arrangements under Topic 718 or under other U.S. GAAP. ASU
2024-01 is effective for annual periods beginning after December 15, 2025, although early adoption is permitted. Upon adoption, ASU 2024-01
is not expected to have an impact on the Company's financial statements.

 In March 2024, the FASB issued ASU No 2024-02,
"Codification Improvements - Amendments to Remove References to the Concepts Statements" ("ASU 2024-02"). ASU
2024-02 removes references to various Concepts Statements. In most instances, the references are extraneous and not required to understand
or apply the guidance. ASU 2024-02 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. ASU 2024-02
can be applied prospectively or retrospectively. Upon adoption, ASU 2024-01 is not expected to have an impact on the Company's financial
statements.

 In November 2024, the FASB issued ASU No. 2024-03,
"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)." This standard
requires disclosure of specific information about costs and expenses and becomes effective January 1, 2027. Upon adoption, ASU 2024-03
is not expected to have an impact on the Company's financial statements.

 In November 2024, the FASB issued ASU 2024-04,
"Debt - Debt with Conversions and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments" ("ASU
2024-04"). ASU 2024-04 clarifies the requirements for accounting for induced conversions of convertible debt instruments, specifically
addressing the recognition and measurement of inducement offers made to holders of convertible debt. The amendments provide guidance on
determining whether an inducement offer should be accounted for as an extinguishment of debt or as a modification, and clarify the related
disclosure requirements. ASU 2024-04 is effective for fiscal years beginning after December 15, 2025, including interim periods within
those fiscal years, with early adoption permitted.

 In November 2023, the FASB issued ASU 2023-07, Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures,
on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker
("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss.
The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the
reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities
will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a
single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment
disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods
within fiscal years beginning after December 15, 2024, with early adoption permitted.

 Management does not believe that any other recently
issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 Note 3 — Initial Public Offering

 On November 15, 2021, the Company consummated
its Initial Public Offering of 23,000,000 Units, including 3,000,000 Over-Allotment Units, at $ 10.00 per Unit, generating gross proceeds
of $ 230.0 million, and incurring offering costs of approximately $ 5.7 million, of which approximately $ 254,000 was for offering costs
allocated to derivative warrant liabilities.

 Each Unit consists of one Class A ordinary share
and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at
an exercise price of $ 11.50 per share, subject to adjustment (see Note 8).

 Note 4 — Private Placement Warrants

 Simultaneously with the closing of the Initial
Public Offering, the Company consummated the Private Placement of 10,550,000 Private Placement Warrants, at a price of $ 1.00 per Private
Placement Warrant to CBG and CB Co-Investment, generating proceeds of approximately $ 10.6 million.

 Each whole Private Placement Warrant is exercisable
for one whole Class A ordinary share at a price of $ 11.50 per share. A portion of the proceeds from the sale of the Private Placement
Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business
Combination prior to November 15, 2025, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be
non-redeemable except as described below in Note 8 and exercisable on a cashless basis.

 Fulton AC, CBG, CB Co - Investment and the Company's
officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants
until 30 days after the completion of the initial Business Combination.

 F- 21

2023

 Note 5 — Related Party Transactions

 Class B Ordinary Shares

 On February 3, 2021, CBG and CB Co-Investment
paid an aggregate of $ 25,000 for certain expenses on behalf of the Company in exchange for issuance of an aggregate of 8,625,000 Class
B ordinary shares. CBG purchased 7,195,714 of the Class B ordinary shares and CB Co-Investment purchased 1,429,286 of the Class B ordinary
shares. On April 9, 2021, CB Co-Investment transferred 28,571 Class B ordinary shares to CBG at their original purchase price. On October
1, 2021, CBG forfeited 2,408,095 and CB Co-Investment forfeited 466,905 Class B ordinary shares, in each case, for no consideration.

 On November 9, 2021, CBG transferred an aggregate
of 156,000 Class B ordinary shares to three of the Company's directors, the chief financial officer and two of the Company's
advisors. As a result, CBG had 4,660,190 Class B ordinary shares and CB Co-Investment had 933,810 Class B ordinary shares outstanding.
The transfer of the Class B ordinary shares is in the scope of ASC Topic 718, "Compensation-Stock Compensation" ("ASC
Topic 718"). Under ASC Topic 718, stock-based compensation associated with equity-classified awards is measured at fair value upon
the grant date. The Class B ordinary shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination).
Compensation expense related to the Class B ordinary shares is recognized only when the performance condition is probable of occurrence
under the applicable accounting literature in this circumstance. As of December 31, 2024, the Company determined that a Business Combination
is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be
recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount
equal to the number of Class B ordinary shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently
modified) less the amount initially received for the purchase of the Class B ordinary shares.

 CBG and CB Co-Investment agreed to forfeit up
to an aggregate of 750,000 Class B ordinary shares to the extent that the option to purchase additional Units was not exercised in full
by the underwriters, so that the Class B ordinary shares would represent 20 % of the Company's issued and outstanding shares after
the Initial Public Offering. The underwriters exercised their over-allotment option in full on November 15, 2021; thus, these 750,000
Class B ordinary shares were no longer subject to forfeiture.

 Fulton AC, CBG, CB Co - Investment, and the current
and former executive officers and directors of the Company, agreed not to transfer, assign or sell any of their Class B ordinary shares
until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial
Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $ 12.00 per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -trading day period commencing
at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share
exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their
ordinary shares for cash, securities or other property, Notwithstanding the foregoing, if the closing price of the Class A ordinary shares
equals or exceeds $ 12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like) for any 20 trading days within any 30 -trading day period commencing at least 150 days after the initial Business Combination,
the Class B ordinary shares will be released from the lockup.

 Pursuant to those certain Voting Agreements,
dated December 29, 2023, entered into by each of CBG and CB Co - Investment, immediately upon approval of the Amendment Proposal at the
Meeting, CBG and CB Co - Investment exercised their right to convert all of their Class B ordinary shares (an aggregate of 2,559,000
Class B ordinary shares) on a one - for - one basis into an aggregate of 2,559,000 Class A ordinary shares which are not entitled to
receive funds from the Trust Account through redemptions or otherwise.

 Related Party Loans

 Convertible Note — Related Party

 Upon closing of the Initial Public Offering,
CB Co-Investment loaned the Company approximately $ 1.15 million to deposit into Trust Account, in exchange for a non-interest bearing,
unsecured convertible promissory note ("Convertible Note"). Such Convertible Note would not be repaid in the event that the
Company is unable to close a Business Combination unless there are funds available outside the Trust Account to do so. Such promissory
note would either be paid upon consummation of the Company's initial Business Combination, or, at the discretion of CB Co-Investment
and/or its designees, converted into additional warrants at a price of $ 1.00 per warrant.

 On November 16, 2022, CBG agreed to loan the
Company up to $ 1.2 million pursuant to an unsecured non-interest bearing convertible promissory note ("Additional Convertible Note").
Such Additional Convertible Note will not be repaid in the event that the Company is unable to close a Business Combination unless there
are funds available outside the Trust Account to do so. Such Additional Convertible Note would either be paid upon consummation of the
Company's initial Business Combination, or, at the discretion CBG, converted into additional warrants at a price of $ 1.00 per warrant,
which warrants will be identical to the Private Placement Warrants.

 F- 22

2023

 In connection with the consummation of the transactions
contemplated by the Securities Purchase Agreement, CB Co-Investment irrevocably agreed to convert the $ 1.15 million loan (the "Conversion
Amount") by CB Co-Investment to the Company at a conversion price of $ 1.00 per warrant, or 1,150,000 warrants upon consummation
of a Business Combination. Upon consummation of a Business Combination, 805,000, 273,431 and 71,569 of the contingently issuable Private
Placement Warrants will be issued to Fulton AC, CBG and CB Co-Investment, respectively. All other existing indebtedness was terminated
as of the Closing Date. As a result, the Convertible Note was converted into contingently issuable private placement warrants on the
balance sheet and marked to market as of December 31, 2024 and 2023.

 Additionally, CBG irrevocably agreed to terminate
all outstanding loans to the Company. Accordingly, all debt proceeds received under the Additional Convertible Note was recognized as
a capital contribution from CBG.

 Working Capital Loan

 In addition, in order to fund working capital
deficiencies or finance transaction costs in connection with a Business Combination, On December 29, 2023, Fulton AC agreed to loan the
Company up to $ 1.5 million pursuant the Fulton AC Note. The Fulton AC Note will not be repaid in the event that the Company is unable
to close a Business Combination unless there are funds available outside the Trust Account to do so. The Fulton AC Note will either be
paid upon consummation of the Company's initial Business Combination, or, at the discretion Fulton AC, converted into additional
warrants at a price of $ 1.00 per warrant, which warrants will be identical to the Private Placement Warrants.

 On May 9, 2024, the Company entered into the
Exchange Agreement with Fulton AC, pursuant to which Fulton AC and the Company agreed to exchange the Fulton AC Note for the Exchange
Note. The Exchange Note is substantially similar to the Fulton AC Note, except that (i) the governing law and jurisdiction was changed
from New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation of the Company's
initial business combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy the purchase price
of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35 %. No new consideration was
paid in conjunction with the Exchange.

 As provided under the Exchange Agreement, following
the delivery of the Exchange Note, the Fulton AC Note was cancelled, with the Company owing no further obligations thereunder. The issuance
of the Exchange Note in exchange for the Fulton AC Note was made pursuant to Section 3(a)(9) of the Securities Act.

 The Company accounts for its Exchange Note within
the scope of ASC Topic 470. Pursuant to ASC Topic 470, the new or modified terms of the Exchange Note when compared with the original
terms of the Fulton AC Note are not substantially different; therefore, the Company will account for the Exchange Agreement as a debt
modification. As a result, the Exchange Note is measured at the amount of cash proceeds received from the holder. As of December 31,
2024 and 2023, there was $ 296,942 and $ 0, respectively, outstanding under the Exchange Note.

 Administrative Services Agreement

 On November 9, 2021, the Company entered into
an agreement that provided that, the Company pay CBG $ 20,000 per month for office space, secretarial and administrative services provided
to the Company through the earlier of consummation of the initial Business Combination and the liquidation. On July 14, 2022, the Company
entered into an Amended and Restated Administrative Services Agreement with CBG, to increase the amount payable to CBG (in an amount not
to exceed the aggregate sum of $ 30,000 per month). For the year ended December 31, 2023, the Company incurred expenses of $ 350,323 under
this agreement.

 On December 29, 2023, the Company and CBG entered
into a Letter Agreement terminating the administrative service agreement, dated November 9, 2021, by and between the Company and CBG.

 In addition, Fulton AC, the Company's officers
and directors, and any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities
on the Company's behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations.
The audit committee will review on a quarterly basis all payments that were made by the Company to Fulton AC, the Company's officers
or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the
Trust Account.

 On December 29, 2023, Fulton AC entered into
a Services Agreement with the Company (the "Fulton Services Agreement") pursuant to which the Company will pay Fulton AC
up to $ 30,000 per month for the cost of the use of the Company's office space, administrative and support services. Upon completion
of our initial Business Combination or our liquidation, we will cease paying these monthly fees. As of December 31, 2024 and 2023, the
Company had $ 120,000 and $ 0, respectively, outstanding balance payable to a related party as it relates to this agreement.

 F- 23

2023

 Note 6 — Commitments and Contingencies

 Litigation

 From time to time, the Company may become involved
in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent
uncertainties, and an adverse result in these or other matters may arise from time to time that may harm the Company's business.
The Company is not aware of any such legal proceedings that will have, individually or in the aggregate, a material adverse effect on
its business, financial condition or operating results.

 Contingently Issuable Private Placement Warrants

 In connection with the consummation of the transactions contemplated
by the Securities Purchase Agreement, CB Co-Investment irrevocably agreed to convert the $ 1.15 million loan (the "Conversion Amount")
by CB Co-Investment to the Company at a conversion price of $ 1.00 per warrant, or 1,150,000 warrants upon consummation of a Business Combination.
Upon consummation of a Business Combination, 805,000, 273,431 and 71,569 of the contingently issuable Private Placement Warrants will
be issued to Fulton AC, CBG and CB Co-Investment, respectively.

 Registration Rights and Shareholder Rights

 The holders of the Class B ordinary shares, Private
Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants, the Forward Purchase Securities and warrants that
may be issued upon conversion of the Convertible Note and the Working Capital Loans (and any Class A ordinary shares issuable upon the
exercise of the Private Placement Warrants, Forward Purchase Warrants and warrants that may be issued upon conversion of such loans)
were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the
Initial Public Offering. The Forward Purchase Securities were terminated on December 29, 2023. The holders of these securities are entitled
to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have
certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of the
initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 Business Combination Marketing Agreement

 On November 9, 2021, the Company entered into
an agreement with one of the underwriters in its Initial Public Offering, Cowen and Company, LLC, as advisors in connection with the
Company's Business Combination to assist the Company in holding meetings with the shareholders to discuss the potential Business
Combination and the target business' attributes, introduce the Company to potential investors that are interested in purchasing
the Company's securities in connection with the potential Business Combination, assist the Company in obtaining shareholder approval
for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination.
The Company agreed to pay a fee for such services (the "Marketing Fee") upon the consummation of the initial Business Combination
in an amount equal to, in the aggregate, 3.5 % of the gross proceeds of the Initial Public Offering, or approximately $ 8.1 million in
the aggregate. The Marketing Fee was waived by Cowen as of December 29, 2023.

 Forward Purchase Agreement

 The Forward Purchase Agreement provided for the
purchase by Franklin, in the aggregate, of 6,000,000 Forward Purchase Securities, for an aggregate purchase price of $ 40.0 million, with
each Forward Purchase Security consisting of one Class A ordinary share and one-half of one redeemable warrant in each case, for an aggregate
of 4,000,000 Class A ordinary shares and 2,000,000 redeemable warrants, for $ 10.00 per Forward Purchase Security, in a private placement
to close substantially concurrently with the closing of the initial Business Combination. Effective as of the Closing Date, in connection
with the Securities Purchase Agreement, the Company and Franklin entered into a Letter Agreement terminating the Forward Purchase Agreement.

 Non-Redemptions Agreements

 As discussed more fully in Note 1, in exchange
for the commitments not to redeem certain Class A ordinary shares in connection with the Special Meeting, CBG and CB Co-Investment agreed
to transfer an aggregate of 1,000,000 ordinary shares of the Company held by CBG or CB Co-Investment, as applicable, plus up to an additional
aggregate of 500,000 ordinary shares of the Company held by CBG or CB Co-Investment, with such number of additional ordinary shares of
the Company to be determined based upon the date of the consummation of the Company's initial Business Combination.

 F- 24

2023

 The Company estimated the aggregate fair value
of a weighted number of Class B ordinary shares, based on the likelihood of consummating an initial Business Combination beyond November
15, 2023, or 1,166,663 Class B ordinary shares, attributable to the non-redeeming shareholder be $ 4,802,931 or $ 4.12 per share. Each
non-redeeming shareholder acquired from CBG an indirect economic interest in the Class B ordinary shares. The excess of the fair value
of the Class B ordinary shares was determined to be an offering cost in accordance with the SEC Staff Accounting Bulletin ("SAB")
Topic 5A – Expenses of Offering. Accordingly, in substance, it was recognized by the Company as a capital contribution by CBG to
induce these holders of the Class A ordinary shares not to redeem, with a corresponding charge to additional paid-in capital to recognize
the fair value of the shares transferred as an offering cost.

 May 10,

2023

 Stock price

 $
 10.42

 Risk free rate

 4.25
 %

 Remaining life

 1.56

 Volatility

 5.4
 %

 Probability of transaction

 %

 Letter and Joinder Agreement

 On October 13, 2022, David G. Brown executed
a joinder to become a party to the Letter Agreement and be bound by, and subject to, all of the terms and conditions of the Letter Agreement,
including to vote any Class B ordinary shares and Class A ordinary shares held by him in favor of the Company's initial Business
Combination and certain transfer restrictions with respect to the Company's securities. On October 13, 2022, the Company entered
into letter agreements with Mr. Brown, pursuant to which, among other things, the Company agreed to grant to him 30,000 RSUs, subject
to the terms and conditions set forth therein, including consummation of the Business Combination and shareholder approval of an equity
plan pursuant to which RSUs would be issued. Such RSU grant terminated on December 29, 2023 upon Mr. Brown's resignation from the
Board.

 Pursuant to the Letter Agreement dated June 15,
2023 ("2023 RSU Letter Agreement") and Joinder Agreement dated June 20, 2023 (the "Joinder Agreement"), the Company
agreed to grant to Mr. Lazarus 30,000 RSUs of the Company subject to the terms and conditions set forth therein, including consummation
of the Business Combination and shareholder approval of an equity plan pursuant to which RSUs would be issued and Mr. Lazarus agreed
to vote any Class B ordinary shares and Class A ordinary shares held by him in favor of the Company's initial Business Combination,
to facilitate the liquidation and winding up of the Company if an initial Business Combination is not consummated within the time period
required by its Second Amended and Restated Memorandum and Articles of Association and to certain transfer restrictions with respect
to the Company's securities. The 2023 RSU Letter Agreement terminated on April 1, 2024 upon Mr. Lazarus' resignation as Chief
Financial Officer of the Company. Pursuant to the Joinder Agreement, Mr. Lazarus became a party to that certain Registration and Shareholder
Rights Agreement, dated November 9, 2021, among the Company, CBG, CB Co-Investment and certain equity holders of the Company, which provides
for, among other things, customary demand and piggy-back registration rights.

 On December 29, 2023, the Letter Agreement was
amended to add Fulton AC as a party thereto, subject to all of the terms and conditions of the Letter Agreement. Pursuant to the Letter
Agreement Amendment, Fulton AC also agreed that it will indemnify the Trust Account for certain amounts as further described in Note
1.

 On December 29, 2023, each Mr. Wainstein, Mr.
Cohen, Mr. Silberman and Mr. Baron executed joinders to become a party to the Letter Agreement and be bound by, and subject to, all of
the terms and conditions of the Letter Agreement, including to vote any Class B ordinary shares and Class A ordinary shares held by each
of them in favor of the Company's initial Business Combination and certain transfer restrictions with respect to the Company's
securities. On December 29, 2023, the Company entered into letter agreements with each Mr. Silberman, Mr. Baron and Mr. Lazarus, pursuant
to which, among other things, the Company agreed to grant each of them 50,000, 50,000 and 70,000 RSUs, respectively, subject to the terms
and conditions set forth therein, including consummation of the Business Combination and shareholder approval of an equity plan pursuant
to which RSUs would be issued.

 On February 21, 2024, the Board of Directors
appointed Oliver Wiener as a director. In connection with Mr. Wiener's appointment, the Board increased its size to five (5) directors.
Mr. Wiener will not receive compensation of any kind for service to the Board prior to the consummation of an initial Business Combination.
On February 21, 2024, Mr. Wiener become a party to the Letter Agreement, and became bound by, and subject to, all of the terms and conditions
of the Letter Agreement, including certain transfer restrictions with respect to the Company's securities.

 On February 21, 2024, the Company entered into
a letter agreement with Mr. Wiener, pursuant to which, among other things, the Company agreed to grant Mr. Wiener 50,000 RSUs, to be
issued after the consummation of an initial Business Combination and approval of an equity incentive plan by the Company's shareholders,
subject to the terms and conditions set forth therein.

 F- 25

2023

 Bridge Financing Note

 On June 26, 2024, Phytanix Bio ("Phytanix")
agreed to loan the Company $ 1,590,995.12, pursuant to an unsecured non-interest bearing promissory note (the "Bridge Financing
Note"). The maturity date of the Bridge Financing Note is the later of (x) June 29, 2025 and (y) the consummation of the Company's
initial business combination. The Bridge Financing Note may not be repaid with funds from the trust account that the Company established
for the benefit of its public holders. The proceeds from the Bridge Financing Note will be used (i) to pay off certain working capital
loans issued by the Company to Fulton AC, (ii) to pay for certain fees and expenses incurred in connection with the transactions contemplated
in the Bridge Financing Note and the Company's initial business combination and (iii) for other general corporate purposes.

 As of December 31, 2024, the outstanding balance
under the Bridge Financing Note was $ 1,063,235 in the accompanying balance sheets.

 Business Combination Agreement

 On July 22, 2024, the Company, CB Holdings, Inc.,
a Nevada corporation ("HoldCo"), CB Merger Sub 1, a Cayman Islands exempted company ("CBRG Merger Sub"), Phytanix
Bio, a Nevada corporation (the "Phytanix"), and CB Merger Sub 2, Inc., a Nevada corporation ("Phytanix Merger Sub"),
entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the "Business
Combination Agreement"). As used herein, "New Phytanix" refers to HoldCo after giving effect to the consummation of
the transactions contemplated by the Business Combination Agreement. Capitalized terms used but not otherwise defined herein have the
meanings set forth in the Business Combination Agreement.

 Business Combination Agreement

 The Business Combination Agreement and the transactions
contemplated thereby were approved by the boards of directors of each of the Company and Phytanix. The Business Combination Agreement
provides for, among other things, the consummation of the following transactions (the transactions contemplated by the Business Combination
Agreement, collectively, the "Business Combination"):

 (i)

 CBRG Merger Sub will merge with and into the Company (the "CBRG Merger")
 and Phytanix Merger Sub will merge with and into Phytanix (the "Phytanix Merger" and, together with the CBRG Merger,
 the "Mergers"), with the Company and Phytanix surviving the Mergers and, after giving effect to such Mergers, each of
 the Company and Phytanix becoming a wholly owned subsidiary of HoldCo, on the terms and subject to the conditions in the Business
 Combination Agreement;

 (ii)
 (A) each issued and outstanding Class A ordinary share, par value $ 0.0001 per share, of the Company (the "CBRG Class A Shares") will be automatically cancelled, extinguished and converted into the right to receive one share of common stock, par value $ 0.0001 per share, of HoldCo (the "HoldCo Shares"); and (B) each issued and outstanding Class B ordinary share, par value $ 0.0001 per share, of the Company (the "CBRG Class B Shares" and together with the CBRG Class A Shares, the CBRG Shares), will be automatically cancelled, extinguished and converted into the right to receive one HoldCo Share;

 (iii)
 each outstanding warrant to purchase one CBRG Class A Share will be automatically exchanged for a warrant to purchase one HoldCo Share; and

 (iv)
 (A) each warrant of Phytanix to purchase Phytanix common stock will be exchanged for a warrant to purchase HoldCo Shares; (B) each warrant of Phytanix to purchase Phytanix preferred stock will be exchanged for a warrant to purchase HoldCo preferred stock; (C) all promissory notes of Phytanix issued in connection with its June 2024 financing will be exchanged for HoldCo Series A convertible preferred stock, and any remaining issued and outstanding promissory notes of Phytanix will be automatically and fully cancelled; (D) each share of preferred stock, par value $ 0.000000001 per share, of Phytanix (the "Phytanix Preferred Stock") that is issued and outstanding will be automatically converted into shares of HoldCo preferred stock; and (E) all issued and outstanding shares of Phytanix Common Stock (other than treasury shares and shares with respect to which appraisal rights under the Delaware General Corporation Law, as amended, are properly exercised and not withdrawn) will be automatically cancelled, extinguished and converted into the right to receive HoldCo Shares based on the exchange ratio set forth in the Business Combination Agreement.

 F- 26

2023

 Prior to the closing of the Business Combination
(the "Closing"), (A) HoldCo will file with the Secretary of State of the State of Nevada an amended and restated certificate
of incorporation of HoldCo, and (B) the board of directors of HoldCo will approve and adopt amended and restated bylaws of HoldCo, each
in a form to be mutually agreed between the Company and Phytanix. Following the Business Combination, HoldCo will change its name to
Phytanix, Inc. and will be a publicly listed holding company which is expected to be listed on the Nasdaq Capital Market under the ticker
symbol "PHYX."

 Under the terms of the Business Combination Agreement,
the aggregate consideration to be paid in the Business Combination is derived from an equity value of $ 58 million. In addition, HoldCo
will issue 17,000 shares of HoldCo Series A convertible preferred stock and issue additional shares of HoldCo preferred stock in exchange
for certain short term debt obligations of Phytanix.

 The Business Combination Agreement contains representations,
warranties and covenants of each of the parties thereto that are customary for transactions of this type. HoldCo has agreed to take all
action as may be necessary or appropriate such that, immediately after the Closing, HoldCo's board of directors will consist of
up to seven directors, which shall be divided into three classes and be comprised of seven individuals determined by the Company, Fulton
AC and Phytanix prior to the effectiveness of the Registration Statement on Form S-4 (the "Registration Statement"), two
of which directors shall be designated by Phytanix, in consultation with the Company and Fulton AC, two of which directors shall be designated
by Fulton AC, in consultation with the Company, and three of which directors shall be mutually agreed upon by Fulton AC and Phytanix.
In addition, the board of directors of HoldCo will adopt an equity incentive plan and an employee stock purchase plan prior to the closing
of the Business Combination.

 The obligation of the Company, HoldCo, CBRG Merger
Sub, Phytanix Merger Sub and Phytanix to consummate the Business Combination is subject to certain customary closing conditions, including,
but not limited to, (i) the absence of any order, law or other legal restraint or prohibition issued by any court of competent jurisdiction
or other governmental entity of competent jurisdiction prohibiting or preventing the consummation of the transactions contemplated by
the Business Combination Agreement, (ii) the effectiveness of the Registration Statement to be filed by HoldCo, in accordance with the
provisions of the Securities Act, registering certain shares of HoldCo to be issued in the Business Combination, (iii) the required approval
of Phytanix's stockholders, (iv) the required approval of the Company's shareholders, (v) HoldCo having at least $ 5,000,001
of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) after giving effect to the transactions
contemplated by the Business Combination Agreement (provided such limitation has not been validly removed from the Second Amended and
Restated Memorandum and Articles of Association prior to the Closing Date), (vi) the approval by Nasdaq of HoldCo's initial listing
application in connection with the Business Combination, (vii) entry into employment agreements with certain key Company executives,
(viii) formation of a capital markets and financing advisory committee made up of certain CBRG directors, (ix) assumption or cancellation
of certain existing Phytanix and Company notes, and (x) entry into an agreement providing for a $ 100 million equity line of credit with
Keystone Capital Partners, LLC or its affiliates.

 The Business Combination Agreement may be terminated
under certain customary and limited circumstances prior to the closing of the Business Combination, including, but not limited to, (i)
by mutual written consent of the Company and Phytanix, (ii) by the Company if the representations and warranties of Phytanix are not
true and correct or if Phytanix fails to perform any covenant or agreement set forth in the Business Combination Agreement (including
an obligation to consummate the Closing), in each case such that certain conditions to closing cannot be satisfied and the breach or
breaches of such representations or warranties or the failure to perform such covenant or agreement, as applicable, are not cured or
cannot be cured within certain specified time periods, (iii) by Phytanix if the representations and warranties of the Company are not
true and correct or if the Company fails to perform any covenant or agreement set forth in the Business Combination Agreement (including
an obligation to consummate the Closing), in each case such that certain conditions to closing cannot be satisfied and the breach or
breaches of such representations or warranties or the failure to perform such covenant or agreement, as applicable, are not cured or
cannot be cured within certain specified time periods, (iv) by either the Company or Phytanix if the required approvals are not obtained
from the Company's shareholders after the conclusion of a meeting of the Company's shareholders held for such purpose at
which such shareholders voted on such approvals, (v) by either the Company or Phytanix, if any governmental entity of competent jurisdiction
shall have issued an order permanently enjoining, restraining or otherwise prohibiting the transactions contemplated under the Business
Combination Agreement and such order shall have become final and nonappealable, (vi) by the Company if Phytanix does not deliver, or
cause to be delivered to the Company the written consent of the requisite shareholders of Phytanix adopting and approving the Business
Combination and such failure is not cured within specified time periods, and (vii) by either the Company or Phytanix if the transactions
contemplated by the Business Combination Agreement have not been consummated on or prior to the last deadline for the Company to consummate
its initial business combination pursuant to the Second Amended and Restated Memorandum and Articles of Association.

 F- 27

2023

 If the Business Combination Agreement is validly
terminated, none of the parties to the Business Combination Agreement will have any liability or any further obligation under the Business
Combination Agreement, except in the case of a willful and material breach or fraud and for customary obligations that survive the termination
thereof (such as confidentiality obligations).

 The Company and Phytanix have mutually agreed
to terminate the Business Combinaiton Agreement and, on April 7, 2025, the Company and Phyantix entered into a Termination Agreement,
which immediately terminated the Business Combination Agreement (the "Termination Agreement").

 Sponsor Letter Agreement

 Concurrently with the execution of the Business
Combination Agreement, the Company and Fulton AC, entered into a letter agreement (the "Sponsor Letter Agreement"), pursuant
to which, among other things, (i) Fulton AC agreed to vote its Class B Ordinary Shares in favor of each of the transaction proposals
to be voted upon at the meeting of the Company's shareholders, including approval of the Business Combination Agreement and the
transactions contemplated thereby, (ii) Fulton AC agreed to waive any adjustment to the conversion ratio set forth in the governing documents
of the Company or any other anti-dilution or similar protection with respect to the Class B Ordinary Shares (whether resulting from the
transactions contemplated by the Subscription Agreements (as defined below) or otherwise), and (iii) Fulton AC agreed to be bound by
certain transfer restrictions with respect to his, her or its shares in the Company prior to the Closing.

 Company Stockholder Transaction Support Agreements

 Pursuant to the Business Combination Agreement,
certain stockholders of Phytanix entered into transaction support agreements (collectively, the "Company Transaction Support Agreements")
with the Company and Phytanix, pursuant to which such stockholders of Phytanix agreed to, among other things, (i) vote in favor of the
Business Combination Agreement and the transactions contemplated thereby and (ii) be bound by certain covenants and agreements related
to the Business Combination.

 Investor Rights Agreement

 Concurrently with the execution of the Business
Combination Agreement, the Company, HoldCo, Fulton AC, and certain Phytanix stockholders entered into an investor rights agreement (the
"Investor Rights Agreement") pursuant to which, among other things, Fulton AC, and certain Phytanix stockholders will be
granted certain customary registration rights. Further, subject to customary exceptions set forth in the Investor Rights Agreement, the
shares of HoldCo beneficially owned or owned of record by Fulton AC, certain officers and directors of the Company and HoldCo (including
any shares of HoldCo issued pursuant to the Business Combination Agreement) will be subject to a lock-up period beginning on the date
the Closing occurs (the "Closing Date") until the date that is the earlier of (i) 365 days following the Closing Date (or
six months after the Closing Date if a lock up party is an independent director) or (ii) the first date subsequent to the Closing Date
with respect to which the closing price of HoldCo Shares equals or exceeds $ 12.00 per share for any 20 trading days within any 30-trading
day period commencing at least 150 days after the Closing Date.

 Note 7 — Shareholders' Deficit

 Preference Shares — The
Company is authorized to issue 1,000,000 preference shares, par value $ 0.0001 per share, with such designations, voting and other rights
and preferences as may be determined from time to time by the Company's board of directors. As of December 31, 2024 and 2023, there
were no preference shares issued or outstanding.

 Class A ordinary shares — The
Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $ 0.0001 per share. Holders of the Company's
Class A ordinary shares are entitled to one vote for each share. As of December 31, 2024 and 2023, there were 455,736 and 4,151,134 redeemable
Class A ordinary shares outstanding, all of which were classified as temporary equity in the accompanying balance sheets, respectively.
As of December 31, 2024, there were 2,559,000 nonredeemable Class A ordinary shares outstanding which were classified as permanent equity
in the accompanying balance sheet.

 F- 28

2023

 Class B ordinary shares —
The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $ 0.0001 per share. As of December 31, 2024
and 2023, there were 3,191,000 and 5,750,000 Class B ordinary shares issued and outstanding, respectively.

 Class A and Class B ordinary shareholders of
record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders
of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a
vote of the shareholders except as required by law. Prior to the initial Business Combination, only holders of the Class B ordinary shares
will have the right to vote on the appointment of directors. Holders of the Public Shares will not be entitled to svote on the appointment
of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of the
Class B ordinary shares may remove a member of the board of directors for any reason. The provisions of the Second Amended and Restated
Memorandum and Articles of Association governing the appointment or removal of directors prior to the initial Business Combination may
only be amended by a special resolution passed by holders representing at least two-thirds of the issued and outstanding Class B ordinary
shares.

 The Class B ordinary shares will automatically
convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio
such that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate,
on an as-converted basis, 20 % of the sum of (i) the total number of ordinary shares issued and outstanding upon the consummation of the
Initial Public Offering, plus the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion
or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the
consummation of the initial Business Combination (net of any redemptions of Class A ordinary shares by Public Shareholders), excluding
any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued,
or to be issued, to any seller in the initial Business Combination, and any Forward Purchase Securities and any Private Placement Warrants
issued to Fulton AC, CBG or CB Co-Investment, former and current officers and directors of the Company or any of their affiliates upon
conversion of the Convertible Note and Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary
shares at a rate of less than one-to-one. The Forward Purchase Securities were terminated effective as of December 29, 2023.

 Waiver of offering costs allocated to Class
A ordinary shares subject to redemption – In connection with the consummation of the transactions contemplated by the Securities
Purchase Agreement, during the year ended December 31, 2023, the Company's former legal counsel agreed to waive all outstanding
legal fees. As a result, the Company recognized approximately $ 18,800 as a gain on forgiveness of legal fees, with the remaining balance
of approximately $ 248,600 recorded as an increase to additional paid-in capital.

 Note 8 —Warrants

 As of December 31, 2024 and 2023, the Company
had 11,500,000 Public Warrants and 10,550,000 Private Placement Warrants outstanding.

 Public Warrants may only be exercised for a whole
number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade.
The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and
(b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration
statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus
relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky,
laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under certain
circumstances). The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing
of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement
covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class
A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering
the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60 th day after the closing of the initial
Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when
the Company will have failed to maintain an effective registration statement, exercise warrants on a "cashless basis" in
accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares
are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a
"covered security" under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public
Warrants who exercise their warrants to do so on a "cashless basis" and, in the event the Company so elects, the Company
will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will
use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not
available.

 F- 29

2023

 The warrants have an exercise price of $ 11.50
per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption
or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising
purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $ 9.20 per
Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of
any such issuance to Franklin, CBG, CB Co-Investment and each other holder of Class B ordinary shares upon the consummation of the Initial
Public Offering or their affiliates, without taking into account any Class B ordinary shares held by CBG, CB Co-Investment and each other
holder of Class B ordinary shares upon the consummation of the Initial Public Offering or such affiliates, as applicable, prior to such
issuance including any transfer or reissuance of such shares) (the "Newly Issued Price"), (y) the aggregate gross proceeds
from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for the funding of the
initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume
weighted average trading price of Class A ordinary shares during the 10 -trading day period starting on the trading day prior to the day
on which the Company consummates its initial Business Combination (such price, the "Market Value") is below $ 9.20 per
share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115 % of the higher of the Market
Value and the Newly Issued Price, the $ 18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal
to 180 % of the higher of the Market Value and the Newly Issued Price (and the $ 10.00 per share redemption trigger price will be
adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price See "— Redemption
of warrants for cash when the price per class A ordinary share equals or exceeds $ 18.00 " and "— Redemption of warrants
for Class A ordinary shares when the price per class A ordinary share equals or exceeds $ 10.00 " as described below).

 The Private Placement Warrants are identical
to the Public Warrants underlying the Units sold in the Initial Public Offering, except (i) that the Private Placement Warrants and the
Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days
after the completion of a Business Combination, subject to certain limited exceptions, (ii) except as described below, the Private Placement
Warrants will be non-redeemable so long as they are held by Fulton AC, CBG, CB Co-Investment or their respective permitted transferees
and (iii) Fulton AC, CBG, CB Co-Investment or their respective permitted transferees will have the option to exercise the Private Placement
Warrants on a cashless basis and have certain registration rights. If the Private Placement Warrants are held by someone other than Fulton
AC, CBG, CB Co-Investment or their respective permitted transferees, the Private Placement Warrants will be redeemable by the Company
in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants.

 Redemption of warrant when the price per
share of Class A ordinary shares equals or exceeds $ 18.00. Once warrants become exercisable, the Company may redeem the outstanding
warrants for cash:

 in whole and not in part;

 at a price of $ 0.01 per warrant;

 upon a minimum of 30 days' prior written notice of redemption to each warrant holder and

 if, and only if, the closing price of Class A ordinary shares equals or exceeds $ 18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the "Reference Value").

 Redemption of warrants when the price per
share of Class A ordinary shares equals or exceeds $ 10.00. Once the warrants become exercisable, the Company may redeem the outstanding
warrants:

 in whole and not in part;

 at $ 0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the "fair value" of Class A ordinary shares;

 F- 30

2023

 if, and only if, the closing price of Class A ordinary shares equals or exceeds $ 10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within the 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and

 if the Reference Value is less than $ 18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder's ability to cashless exercise its warrants) as the outstanding Public Warrants as described above.

 The "fair value" of Class A ordinary
shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately
following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable
on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).

 In no event will the Company be required to net
cash settle any warrant. If the Company is unable to complete a Business Combination prior to November 15, 2024 and the Company liquidates
the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will
they receive any distribution from the Company's assets held outside of the Trust Account with the respect to such warrants. Accordingly,
the warrants may expire worthless.

 On December 29, 2023, in connection with the
Securities Purchase Agreement, CB Co-Investment irrevocably agreed to convert the $ 1.15 million loan by CB Co-Investment to the Company
into contingently issuable Private Placement Warrants. Upon consummation of a Business Combination, 805,000, 273,431 and 71,569 of the
contingently issuable Private Placement Warrants will be issued to Fulton AC, CBG and CB Co-Investment, respectively.

 Note 9 —Fair Value Measurements

 The following table presents information about
the Company's assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2024 and 2023 and
indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

 The carrying amounts of prepaid expenses, accounts payable, accrued expenses
and accrued expense-related party approximate their fair values due to their short term maturities and the nature of these instruments.

 December 31, 2024

 Quoted

 Prices in

 Significant

Other

 Significant

Other

 Active

Markets

 Observable

 Inputs

 Unobservable

 Inputs

 Description

 (Level 1)

 (Level 2)

 (Level 3)

 Assets:

 Investments held in Trust Account - U.S. Treasury Securities

 $
 5,285,060

 $
 —

 $
 —

 Liabilities:

 Contingently issuable private placement warrants

 $
 —

 $
 4,600

 $
 —

 Derivative liabilities- Public Warrants

 $
 46,000

 $
 —

 $
 —

 Derivative liabilities- Private Placement Warrants

 $
 —

 $
 42,200

 $
 —

 F- 31

2023

 December 31, 2023

 Quoted

Prices in

 Significant

Other

 Significant

Other

 Active

Markets

 Observable

 Inputs

 Unobservable

Inputs

 Description

 (Level 1)

 (Level 2)

 (Level 3)

 Assets:

 Investments held in Trust Account - U.S. Treasury Securities

 $
 45,356,234

 $
 —

 $
 —

 Liabilities:

 Contingently issuable private placement warrants

 $
 —

 $
 5,865

 $
 —

 Derivative liabilities- Public Warrants

 $
 58,650

 $
 —

 $
 —

 Derivative liabilities- Private Placement Warrants

 $
 —

 $
 53,810

 $
 —

 Transfers to/from Levels 1, 2, and 3 are recognized
at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a
Level 1 measurement, when the Public Warrants were separately listed and traded in an active market in December 2021. The estimated fair
value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement in January 2022,
as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants
having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant
is equivalent to that of each Public Warrant. There were no other transfers between levels of the hierarchy for the year ended December
31, 2024.

 Level 1 assets consists of investments in U.S.
treasury securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar
sources to determine the fair value of its investments.

 The initial estimated fair value as of November
15, 2021, of the Public Warrants, the Private Placement Warrants, and the Forward Purchase Agreement is measured at fair value using
a Monte Carlo simulation, determined using Level 3 inputs. The fair value of Public Warrants issued in connection with the Initial Public
Offering have subsequently been measured based on the listed market price of such warrants. As of December 31, 2023, the fair value of
the Convertible Note was measured using a Black-Scholes model. Inherent in a Monte Carlo simulation and Black-Scholes model are assumptions
related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. As of December 31, 2024 and 2023,
the fair value of Private Placement Warrants and the contingently issuable Private Placement Warrants were determined based on the quoted
price of the Public Warrants.

 The following table provides quantitative information
regarding Level 2 fair value measurements inputs at December 31, 2024 measurement date for contingently issuable Private Placement Warrants
and Private Placement Warrants:

 Exercise price

 $
 11.50

 Stock price

 $
 11.02

 Term (years)

 5.58

 Volatility

 6.0
 %

 Risk-free rate

 4.31
 %

 Dividend yield

 0.0
 %

 F- 32

2023

 The following table provides quantitative information
regarding Level 2 fair value measurements inputs at December 31, 2023 measurement date (audited):

 Exercise price

 $
 11.50

 Stock price

 $
 10.85

 Term (years)

 5.67

 Volatility

 6.0
 %

 Risk-free rate

 3.78
 %

 Dividend yield

 0.0
 %

 The change in the fair value of the derivative
liabilities – forward purchase agreement measured using Level 3 inputs for the year ended December 31, 2023, is summarized as follows:

 Derivative liabilities – forward purchase agreement at December 31, 2022

 $
 342,235

 Change in fair value of derivative liabilities - forward purchase agreement

 ( 10,707
)

 Gain on extinguishment of forward purchase agreement

 ( 331,528
)

 Derivative liabilities – forward purchase agreement at December 31, 2023

 $
 —

 The change in the fair value of the derivative
liabilities – public and private placement warrants measured using Level 3 inputs for the year ended December 31, 2023 and 2024,
is summarized as follows:

 Derivative liabilities – public and private placement warrants at December 31, 2022

 $
 2,205,000

 Change in fair value of derivative warrant liabilities - public and Private Placement Warrants

 ( 2,092,540
)

 Derivative liabilities – public and private placement warrants at December 31, 2023

 112,460

 Change in fair value of derivative warrant liabilities - public and Private Placement Warrants

 ( 24,260
)

 Derivative liabilities – public and private placement warrants at December 31, 2024

 $
 88,200

 The change in the fair value of the Convertible
Note – related party measured using Level 3 inputs the year ended December 31, 2023, is summarized as follows:

 Convertible note - related party at December 31, 2022

 $
 1,431,546

 Additional issuance of convertible note - related party

 851,899

 Capital contribution from CBG - forgiveness of additional convertible note

 ( 1,201,899
)

 Conversion to contingently issuable derivative liabilities

 ( 1,150,000
)

 Loss on conversion of note to contingently issuable private placement warrants

 69,293

 Change in fair value of convertible note - related party

 ( 839
)

 Convertible note - related party at December 31, 2023

 $
 —

 The change in the fair value of the Contingently
issuable private placement warrants measured using Level 3 inputs for the year ended December 31, 2023 and 2024, is summarized as follows:

 Contingently issuable private placement warrants at December 31, 2022

 $
 —

 Conversion from Convertible Note – related party to Contingently issuable private placement warrants

 1,150,000

 Change in fair value of contingently issuable private placement warrants

 ( 1,144,135
)

 Contingently issuable private placement warrants at December 31, 2023

 5,865

 Change in fair value of contingently issuable private placement warrants

 ( 1,265
)

 Contingently issuable private placement warrants at December 31, 2024

 $
 4,600

 F- 33

2023

 NOTE 10 — SEGMENT INFORMATION

 ASC Topic 280, "Segment Reporting,"
establishes standards for companies to report in their financial statement information about operating segments, products, services,
geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial
information is available that is regularly evaluated by the Company's chief operating decision maker, or group, in deciding how
to allocate resources and assess performance.

 The Company's chief operating decision
maker has been identified as the Chief Executive Officer ("CODM"), who reviews the operating results for the Company as a
whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the
Company only has one operating segment.

 When evaluating the Company's performance
and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

 For the
 Year Ended
 December
 31,

 2024

 For the

 Year Ended

 2023

 General and administrative expenses

 $
 2,182,923

 $
 1,319,471

 Interest earned on the Trust Account

 $
 733,829

 $
 5,414,145

 The key measures of segment profit or loss reviewed
by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews interest earned on the
Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account
funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM
to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination
period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs
are aligned with all agreements and budget.

 Note 11 — Income Tax

 ASC Topic 740 accounts for income taxes requiring an asset and liability
approach to financial accounting and reporting for income taxes including the parameters for the recognition of deferred tax assets and
liabilities. The Company is exempt from Cayman Islands as well as US taxation. Accordingly, there is no reported tax provision nor any
net deferred tax asset or liability position in the accompanying financial statements.

 Note 12 — Subsequent Events

 The Company has evaluated subsequent events and
transactions that occurred up to the date the financial statements were issued. Except for the identified below, the Company did not
identify any subsequent events, that would have required adjustment or disclosure in the financial statements.

 As previously disclosed, on April 7, 2025, the Company and Phytanix mutually agreed to terminate the Business Combination Agreement and
entered into a Termination Agreement, which immediately terminated the Business Combination Agreement (the "Termination Agreement").

 On January 16, 2025, February 14, 2025, March 17, 2025, May 15, 2025
and June 16, 2025, the Sponsor contributed approximately $ 4,557, $ 4,557, $ 4,557, $ 9,115 and $ 4,557, respectively, into the Company's
Trust Account to extend the life of the Company through July 15, 2025.

 F- 34

 NONE NONE NONE 0001845149 false FY

 cbrgu: UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantToAcquireOneClassAOrdinaryShareMember

 cbrgu: ClassAOrdinarySharesParValue00001PerShareMember

 cbrgu: RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member

 2024-06-30

 2025-06-16

 2025-06-16

 2024-10-01

 us-gaap: OverAllotmentOptionMember

 us-gaap: WarrantMember

 us-gaap: PrivatePlacementMember

 us-gaap: PrivatePlacementMember

 cbrgu: AdditionalConvertibleNoteRelatedPartyMember

 2022-11-16

 2022-11-16

 srt: DirectorMember

 2022-10-13
 2022-10-13

 cbrgu: NonRedemptionAgreementsMember

 cbrgu: NonRedemptionAgreementsMember

 cbrgu: NonRedemptionAgreementsMember

 2023-11-15
 2023-11-15

 srt: ChiefFinancialOfficerMember

 2023-06-14

 cbrgu: SecuritiesPurchaseAgreementMember

 cbrgu: SecuritiesPurchaseAgreementMember

 cbrgu: CbgMember
 cbrgu: InEventOfNotConsummationOfBusinessCombinationMember

 cbrgu: InEventOfNotConsummationOfBusinessCombinationMember

 cbrgu: UnsecuredNonInterestBearingConvertiblePromissoryNoteMember

 cbrgu: UnsecuredNonInterestBearingConvertiblePromissoryNoteMember

 2024-05-09
 2024-05-09

 cbrgu: LewisSilbermanMember

 cbrgu: PaulBaronMember

 srt: ChiefFinancialOfficerMember

 srt: DirectorMember

 2024-02-21
 2024-02-21

 cbrgu: BusinessCombinationExtendedTerminationDateMember

 cbrgu: BusinessCombinationExtendedTerminationDateMember

 cbrgu: BusinessCombinationExtendedTerminationDateMember

 cbrgu: BusinessCombinationExtendedTerminationDateMember

 2024-02-16
 2024-02-16

 2024-05-16
 2024-05-16

 cbrgu: ChainBridgeGroupAndCbCoInvestmentMember

 cbrgu: ChainBridgeGroupAndCbCoInvestmentMember

 cbrgu: GeneralMeetingMember

 2024-11-16

 us-gaap: TrustForBenefitOfEmployeesMember

 2024-12-16

 srt: MaximumMember

 srt: MinimumMember

 srt: ChiefFinancialOfficerMember

 2024-04-01

 2024-10-29
 2024-10-29

 2024-11-11
 2024-11-11

 cbrgu: BackstopInvestorSharesMember

 cbrgu: WorkingCapitalLoansWarrantMember

 cbrgu: UnsecuredNonInterestBearingConvertiblePromissoryNoteMember

 cbrgu: BridgeFinancingNotesMember

 2024-06-26

 2025-11-15
 2025-11-15

 cbrgu: ForwardPurchaseSecuritiesMember
 us-gaap: DerivativeFinancialInstrumentsLiabilitiesMember

 cbrgu: GeneralMeetingMember

 cbrgu: RedeemableSharesMember

 cbrgu: NonredeemableSharesMember

 cbrgu: RedeemableSharesMember

 cbrgu: NonredeemableSharesMember

 cbrgu: ChainBridgeGroupAndCbCoInvestmentMember

 2021-04-09
 2021-04-09

 2021-10-01
 2021-10-01

 2021-10-01
 2021-10-01

 2024-09-30

 cbrgu: ChainBridgeGroupAndCbCoInvestmentMember

 cbrgu: ConvertibleNoteRelatedPartyMember

 cbrgu: ConvertibleNoteRelatedPartyMember

 cbrgu: AdditionalConvertibleNoteRelatedPartyMember

 2022-11-16

 cbrgu: AdditionalConvertibleNoteRelatedPartyMember

 2022-11-16

 cbrgu: AdditionalConvertibleNoteRelatedPartyMember

 cbrgu: ConvertibleNoteRelatedPartyMember

 cbrgu: UnsecuredNonInterestBearingConvertiblePromissoryNoteMember

 cbrgu: AdministrativeServicesAgreementMember

 cbrgu: AmendedAndRestatedAdministrativeServicesAgreementMember

 2022-07-14
 2022-07-14

 cbrgu: AdministrativeServicesAgreementMember

 cbrgu: AdministrativeServicesAgreementMember

 cbrgu: AdministrativeServicesAgreementMember

 cbrgu: CbgMember

 us-gaap: ForwardContractsMember

 us-gaap: ForwardContractsMember

 us-gaap: ForwardContractsMember

 us-gaap: ForwardContractsMember
 cbrgu: RedeemableWarrantsExercisableForClassCommonStockMember

 srt: ChiefFinancialOfficerMember

 2023-06-15
 2023-06-15

 cbrgu: MrSilbermanMember

 cbrgu: MrBaronMember

 cbrgu: MrLazarusMember

 cbrgu: MrWienerMember

 2024-02-21
 2024-02-21

 cbrgu: BridgeFinancingNotesMember

 cbrgu: CbHoldingIncMember

 cbrgu: CbrgClassbSharesMember
 cbrgu: CbHoldingIncMember

 cbrgu: CbHoldingIncMember

 us-gaap: ConvertiblePreferredStockMember

 cbrgu: InvestorRightsAgreementMember

 us-gaap: MeasurementInputSharePriceMember

 us-gaap: MeasurementInputRiskFreeInterestRateMember

 us-gaap: MeasurementInputExpectedTermMember

 us-gaap: MeasurementInputPriceVolatilityMember

 cbrgu: MeasurementInputProbabilityOfTransactionMember

 cbrgu: ClassAOrdinarySharesNotSubjectToPossibleRedemptionMember

 us-gaap: WarrantMember

 us-gaap: WarrantMember

 cbrgu: MarketValueMember

 us-gaap: WarrantMember

 cbrgu: RedemptionOfWarrantsMember

 srt: MinimumMember

 srt: MaximumMember

 cbrgu: RedemptionOfWarrantsMember

 cbrgu: RedemptionOfWarrantsMember

 cbrgu: RedemptionOfWarrantsMember

 srt: MinimumMember

 srt: MaximumMember

 cbrgu: CBCoInvestmentsMember

 cbrgu: CbgMember

 us-gaap: MeasurementInputExercisePriceMember

 us-gaap: MeasurementInputSharePriceMember

 us-gaap: MeasurementInputExpectedTermMember

 us-gaap: MeasurementInputPriceVolatilityMember

 us-gaap: MeasurementInputRiskFreeInterestRateMember

 us-gaap: MeasurementInputExpectedDividendRateMember

 us-gaap: MeasurementInputExercisePriceMember

 us-gaap: MeasurementInputSharePriceMember

 us-gaap: MeasurementInputExpectedTermMember

 us-gaap: MeasurementInputPriceVolatilityMember

 us-gaap: MeasurementInputRiskFreeInterestRateMember

 us-gaap: MeasurementInputExpectedDividendRateMember

 us-gaap: SubsequentEventMember

 2025-01-16
 2025-01-16

 us-gaap: SubsequentEventMember

 2025-02-14
 2025-02-14

 us-gaap: SubsequentEventMember

 2025-03-17
 2025-03-17

 srt: ScenarioForecastMember

 2025-05-15
 2025-05-15

 srt: ScenarioForecastMember

 2025-06-16
 2025-06-16